0001841761-23-000047.txt : 20230511 0001841761-23-000047.hdr.sgml : 20230511 20230511170631 ACCESSION NUMBER: 0001841761-23-000047 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230511 DATE AS OF CHANGE: 20230511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grove Collaborative Holdings, Inc. CENTRAL INDEX KEY: 0001841761 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961] IRS NUMBER: 882840659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40263 FILM NUMBER: 23912109 BUSINESS ADDRESS: STREET 1: 1301 SANSOME STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: (800) 231-8527 MAIL ADDRESS: STREET 1: 1301 SANSOME STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94111 FORMER COMPANY: FORMER CONFORMED NAME: Virgin Group Acquisition Corp. II DATE OF NAME CHANGE: 20210122 10-Q 1 grov-20230331.htm 10-Q grov-20230331
0001841761December 312023Q1falseP60DP20DP30DP3D00018417612023-01-012023-03-310001841761us-gaap:CommonClassAMember2023-01-012023-03-310001841761us-gaap:WarrantMember2023-01-012023-03-310001841761us-gaap:CommonClassAMember2023-05-05xbrli:shares0001841761us-gaap:CommonClassBMember2023-05-0500018417612023-03-31iso4217:USD00018417612022-12-31iso4217:USDxbrli:shares0001841761us-gaap:CommonClassAMember2022-12-310001841761us-gaap:CommonClassAMember2023-03-310001841761us-gaap:CommonClassBMember2023-03-310001841761us-gaap:CommonClassBMember2022-12-3100018417612022-01-012022-03-310001841761us-gaap:CommonStockMember2022-12-310001841761us-gaap:AdditionalPaidInCapitalMember2022-12-310001841761us-gaap:RetainedEarningsMember2022-12-310001841761us-gaap:CommonStockMember2023-01-012023-03-310001841761us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001841761us-gaap:RetainedEarningsMember2023-01-012023-03-310001841761us-gaap:CommonStockMember2023-03-310001841761us-gaap:AdditionalPaidInCapitalMember2023-03-310001841761us-gaap:RetainedEarningsMember2023-03-310001841761us-gaap:ConvertiblePreferredStockMember2021-12-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2021-12-310001841761us-gaap:CommonStockMember2021-12-310001841761us-gaap:AdditionalPaidInCapitalMember2021-12-310001841761us-gaap:RetainedEarningsMember2021-12-3100018417612021-12-310001841761us-gaap:CommonStockMember2022-01-012022-03-310001841761us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-01-012022-03-310001841761us-gaap:RetainedEarningsMember2022-01-012022-03-310001841761us-gaap:ConvertiblePreferredStockMember2022-03-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-03-310001841761us-gaap:CommonStockMember2022-03-310001841761us-gaap:AdditionalPaidInCapitalMember2022-03-310001841761us-gaap:RetainedEarningsMember2022-03-3100018417612022-03-310001841761us-gaap:CommonClassBMembergrov:TwoThousandAndTwentyTwoEquityIncentivePlanMember2022-06-16xbrli:pure0001841761us-gaap:SalesRevenueNetMembergrov:FiveSuppliersMemberus-gaap:SupplierConcentrationRiskMember2022-01-012022-03-310001841761us-gaap:SalesRevenueNetMembergrov:FiveSuppliersMemberus-gaap:SupplierConcentrationRiskMember2023-01-012023-03-310001841761grov:GroveBrandsMember2023-01-012023-03-310001841761grov:GroveBrandsMember2022-01-012022-03-310001841761grov:ThirdPartyProductsMember2023-01-012023-03-310001841761grov:ThirdPartyProductsMember2022-01-012022-03-310001841761grov:DeferredRevenueMember2023-03-310001841761us-gaap:OtherCurrentLiabilitiesMember2023-03-310001841761grov:DeferredRevenueMember2022-12-310001841761us-gaap:OtherCurrentLiabilitiesMember2022-12-310001841761grov:DeferredRevenueMember2023-01-012023-03-310001841761us-gaap:OtherCurrentLiabilitiesMember2023-01-012023-03-310001841761us-gaap:ShippingAndHandlingMember2023-01-012023-03-310001841761us-gaap:ShippingAndHandlingMember2022-01-012022-03-310001841761grov:FulfillmentLaborMember2023-01-012023-03-310001841761grov:FulfillmentLaborMember2022-01-012022-03-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-03-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMemberus-gaap:FairValueInputsLevel2Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:EarnOutShareMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:EarnOutShareMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:EarnOutShareMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:PrivatePlacementWarrantMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PrivatePlacementWarrantMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:PublicWarrantMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PublicWarrantMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PublicWarrantMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:StructuralDerivativeMember2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:StructuralDerivativeMember2023-03-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalSharesMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:EarnOutShareMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:EarnOutShareMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:EarnOutShareMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:PrivatePlacementWarrantMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PrivatePlacementWarrantMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:PublicWarrantMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PublicWarrantMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:PublicWarrantMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:StructuralDerivativeMember2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761us-gaap:FairValueMeasurementsRecurringMembergrov:StructuralDerivativeMember2022-12-310001841761grov:AdditionalShareMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761grov:AdditionalShareMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001841761grov:AdditionalShareMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761us-gaap:FairValueInputsLevel2Membergrov:PrivatePlacementWarrantMember2022-12-310001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2022-12-310001841761us-gaap:FairValueInputsLevel2Membergrov:PrivatePlacementWarrantMember2023-01-012023-03-310001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-03-310001841761us-gaap:FairValueInputsLevel2Membergrov:PrivatePlacementWarrantMember2023-03-310001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2023-03-310001841761grov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel3Member2022-12-310001841761grov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001841761grov:StructuralDerivativeMemberus-gaap:FairValueInputsLevel3Member2023-03-310001841761grov:StructuralLendersMembergrov:StructuralDebtFacilityMember2023-03-310001841761grov:StructuralLendersMembergrov:StructuralDebtFacilityMember2022-12-310001841761grov:SienaLendingGroupLLCMembergrov:SienaRevolverMember2023-03-310001841761grov:SienaLendingGroupLLCMembergrov:SienaRevolverMember2022-12-310001841761grov:AtelMembergrov:AtelLoanFacilityTrancheThreeMember2023-03-310001841761grov:AtelMembergrov:AtelLoanFacilityTrancheThreeMember2022-12-310001841761grov:AtelMembergrov:AtelLoanFacilityTrancheFourMember2023-03-310001841761grov:AtelMembergrov:AtelLoanFacilityTrancheFourMember2022-12-310001841761srt:MinimumMembergrov:StructuralLendersMembergrov:StructuralDebtFacilityMember2022-12-310001841761grov:StructuralLendersMembergrov:StructuralDebtFacilityMemberus-gaap:PrimeRateMember2022-12-012022-12-310001841761grov:StructuralLendersMembergrov:StructuralDebtFacilityMemberus-gaap:CommonClassAMember2022-12-212022-12-210001841761grov:StructuralLendersMembergrov:StructuralDebtFacilityMember2022-12-210001841761srt:ScenarioForecastMembergrov:StructuralLendersMembergrov:StructuralDebtFacilityMember2025-07-210001841761srt:ScenarioForecastMembergrov:StructuralLendersMembergrov:StructuralDebtFacilityMemberus-gaap:CommonClassAMember2025-07-210001841761grov:StructuralLendersMembergrov:StructuralDebtFacilityMember2022-12-012022-12-310001841761grov:StructuralLendersMembergrov:StructuralDerivativeMembergrov:StructuralDebtFacilityMemberus-gaap:FairValueInputsLevel3Member2022-12-012022-12-310001841761grov:SienaLendingGroupLLCMemberus-gaap:RevolvingCreditFacilityMembergrov:LoanAndSecurityAgreementMember2023-03-100001841761us-gaap:LineOfCreditMembergrov:LoanAndSecurityAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-03-310001841761us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembergrov:SecuredOvernightFinancingRateSOFRMember2023-03-012023-03-310001841761us-gaap:LineOfCreditMembergrov:FederalFundsRateMemberus-gaap:RevolvingCreditFacilityMember2023-03-012023-03-310001841761us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMember2023-03-012023-03-310001841761srt:MinimumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMember2023-03-012023-03-310001841761us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:BaseRateMember2023-03-012023-03-310001841761srt:MinimumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembergrov:SecuredOvernightFinancingRateSOFRMember2023-03-012023-03-310001841761us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembergrov:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMember2023-03-012023-03-310001841761us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-03-310001841761grov:TrancheThreeMembergrov:AtelMembergrov:AtelLoanFacilityMember2023-03-310001841761grov:AtelMembergrov:AtelLoanFacilityMembergrov:TrancheFourMember2023-03-310001841761grov:AtelLoanFacilityTrancheThreeMember2023-03-310001841761grov:AtelLoanFacilityTrancheFourMember2023-03-310001841761us-gaap:StandbyLettersOfCreditMember2023-03-310001841761us-gaap:StandbyLettersOfCreditMember2022-12-3100018417612022-06-1600018417612022-06-162022-06-1600018417612023-03-012023-03-310001841761us-gaap:CommonClassBMember2022-06-160001841761us-gaap:CommonClassAMember2022-06-160001841761us-gaap:CommonClassBMember2022-06-162022-06-160001841761grov:ReverseRecapitalizationTrancheOneMemberus-gaap:CommonClassAMember2022-06-162022-06-160001841761grov:ReverseRecapitalizationTrancheOneMemberus-gaap:CommonClassAMember2022-06-160001841761grov:ReverseRecapitalizationTrancheTwoMemberus-gaap:CommonClassAMember2022-06-162022-06-160001841761grov:ReverseRecapitalizationTrancheTwoMemberus-gaap:CommonClassAMember2022-06-160001841761grov:PrivatePlacementWarrantMember2023-03-310001841761grov:PublicWarrantMember2023-03-310001841761grov:PublicWarrantMemberus-gaap:CommonClassAMember2022-07-160001841761grov:PrivatePlacementWarrantMember2022-07-160001841761srt:MinimumMembergrov:PublicWarrantMemberus-gaap:CommonClassAMember2022-07-160001841761grov:PublicWarrantMembersrt:MaximumMemberus-gaap:CommonClassAMember2022-07-160001841761grov:CorvinaHoldingsLimitedMemberus-gaap:CommonClassAMember2023-03-310001841761grov:StandbyEquityPurchaseAgreementMember2022-07-182022-07-180001841761grov:StandbyEquityPurchaseAgreementMember2022-07-180001841761grov:StandbyEquityPurchaseAgreementMember2023-01-012023-03-310001841761grov:HGISubscriptionAgreementMemberus-gaap:CommonClassAMember2022-11-102022-11-100001841761grov:HGISubscriptionAgreementAdditionalSharesMemberus-gaap:CommonClassAMember2022-11-100001841761grov:HGISubscriptionAgreementAdditionalSharesMemberus-gaap:CommonClassAMember2022-11-102022-11-100001841761grov:HGISubscriptionAgreementAdditionalSharesMembergrov:SaleOfStockMeasurementPeriodOneMember2022-11-102022-11-100001841761grov:HGISubscriptionAgreementAdditionalSharesMembergrov:SaleOfStockMeasurementPeriodTwoMember2022-11-102022-11-100001841761grov:HGISubscriptionAgreementAdditionalSharesMembergrov:SaleOfStockMeasurementPeriodThreeMember2022-11-102022-11-100001841761grov:HGISubscriptionAgreementAdditionalSharesMemberus-gaap:CommonClassAMember2022-11-102023-03-3100018417612022-11-102022-11-100001841761grov:HGIWarrantsMember2022-11-102022-11-100001841761grov:HGIWarrantsMember2022-11-100001841761grov:VestedWarrantsMember2023-01-012023-03-310001841761grov:UnvestedWarrantMember2023-01-012023-03-310001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMemberus-gaap:CommonClassAMember2023-03-310001841761us-gaap:CommonClassBMembergrov:TwoThousandAndTwentyTwoEquityIncentivePlanMember2023-03-310001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMemberus-gaap:CommonClassAMember2022-12-310001841761us-gaap:CommonClassBMembergrov:TwoThousandAndTwentyTwoEquityIncentivePlanMember2022-12-3100018417612022-01-012022-06-300001841761grov:MarketBasedStockOptionsMember2021-02-012021-02-280001841761grov:MarketBasedStockOptionsMember2021-02-280001841761us-gaap:RestrictedStockUnitsRSUMember2022-12-310001841761us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001841761us-gaap:RestrictedStockUnitsRSUMember2023-03-310001841761us-gaap:EmployeeStockMember2022-05-012022-05-310001841761us-gaap:EmployeeStockMember2022-05-012023-03-310001841761us-gaap:ConvertiblePreferredStockMember2023-01-012023-03-310001841761us-gaap:ConvertiblePreferredStockMember2022-01-012022-03-310001841761grov:ContingentlyRedeemableConvertiblePreferredStockMember2023-01-012023-03-310001841761grov:ContingentlyRedeemableConvertiblePreferredStockMember2022-01-012022-03-310001841761us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001841761us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001841761us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001841761us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001841761grov:ConvertiblePreferredStockWarrantsMember2023-01-012023-03-310001841761grov:ConvertiblePreferredStockWarrantsMember2022-01-012022-03-310001841761us-gaap:WarrantMember2023-01-012023-03-310001841761us-gaap:WarrantMember2022-01-012022-03-310001841761grov:PrivateAndPublicPlacementWarrantsMember2023-01-012023-03-310001841761grov:PrivateAndPublicPlacementWarrantsMember2022-01-012022-03-310001841761grov:EarnOutShareMember2023-01-012023-03-310001841761grov:EarnOutShareMember2022-01-012022-03-310001841761grov:SharesSubjectToRepurchaseMember2023-01-012023-03-310001841761grov:SharesSubjectToRepurchaseMember2022-01-012022-03-310001841761us-gaap:SubsequentEventMember2023-04-19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________
FORM 10-Q
_____________________________________
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-40263
_____________________________________
Grove Collaborative Holdings, Inc.
(Exact name of registrant as specified in its charter)
_____________________________________
Delaware88-2840659
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1301 Sansome Street
San Francisco, California 94111
Tel.: (800) 231-8527
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, par value $0.0001GROVNew York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per shareGROV.WSNew York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
x
Smaller reporting company
x
Emerging growth company
x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

The registrant had outstanding 128,876,248 shares of Class A common stock and 49,874,913 shares of Class B common stock as of May 5, 2023.
1

Table of Contents
Page





2


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This quarterly report on Form 10-Q (this "Form 10-Q”), including, without limitation, statements under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations," includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Generally, statements that are not historical facts, including statements concerning Grove Collaborative Holdings, Inc. (the “Company,” “we,” “us,” or “our”) possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "may," "will," "potential," "projects," "predicts," "continue," or "should," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations.
The forward-looking statements contained in this Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, without limitation, those factors described under Part II, Item 1A: "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. These risks and others described under Part II, Item 1A: "Risk Factors" may not be exhaustive.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this Form 10-Q. In addition, even if our results or operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in this Form 10-Q, those results or developments may not be indicative of results or developments in subsequent periods.
3

Part I - Financial Information
Item 1. Financial Statement
Grove Collaborative Holdings, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
March 31,
2023
December 31,
2022
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $81,653 $81,084 
Restricted cash5,850 11,950 
Inventory, net40,930 44,132 
Prepaid expenses and other current assets5,806 4,844 
Total current assets134,239 142,010 
Restricted cash2,951 2,951 
Property and equipment, net13,852 14,530 
Operating lease right-of-use assets11,721 12,362 
Other long-term assets2,817 2,192 
Total assets$165,580 $174,045 
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$12,293 $10,712 
Accrued expenses13,967 31,354 
Deferred revenue9,152 10,878 
Operating lease liabilities, current3,762 3,705 
Other current liabilities565 249 
Debt, current340 575 
Total current liabilities40,079 57,473 
Debt, noncurrent69,049 60,620 
Operating lease liabilities, noncurrent15,233 16,192 
Derivative liabilities
13,519 13,227 
Total liabilities137,880 147,512 
Commitments and contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value - 100,000,000 shares authorized at March 31, 2023 and December 31, 2022; no shares outstanding at March 31, 2023 and December 31, 2022
  
Common stock - $0.0001 par value – 600,000,000 Class A shares authorized at March 31, 2023 and December 31, 2022; 128,870,368 and 125,617,015 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively; 200,000,000 Class B shares authorized at March 31, 2023 and December 31, 2022; 49,874,913 and 52,240,311 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively
18 18 
Additional paid-in capital618,609 604,373 
Accumulated deficit(590,927)(577,858)
Total stockholders’ equity27,700 26,533 
Total liabilities and stockholders’ equity$165,580 $174,045 
The accompanying notes are an integral part of these condensed consolidated financial statements.
4

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(In thousands, except share and per share amounts)
Three Months Ended
March 31,
20232022
Revenue, net$71,565 $90,479 
Cost of goods sold34,310 47,742 
Gross profit37,255 42,737 
Operating expenses:
Advertising8,673 32,793 
Product development4,216 6,240 
Selling, general and administrative38,021 50,970 
Operating loss(13,655)(47,266)
Interest expense 3,729 2,087 
Change in fair value of Additional Shares liability223  
Change in fair value of Earn-Out liability143  
Change in fair value of Public and Private Placement Warrants liability(674) 
Change in fair value of Structural Derivative liability600  
Other income, net (4,617)(1,992)
Interest and other expense (income), net(596)95 
Loss before provision for income taxes(13,059)(47,361)
Provision for income taxes10 23 
Net loss$(13,069)$(47,384)
Net loss per share attributable to common stockholders, basic and diluted$(0.08)$(5.05)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted168,739,298 9,387,142 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit)
(Unaudited)
(In thousands)
Common  Stock
Additional
Paid-In
Capital
Accumulated
Deficit
Total Stockholders’ Equity
SharesAmount
Balances at December 31, 2022177,857 $18 $604,373 $(577,858)$26,533 
Issuance of common stock upon exercise of stock options179 — 68 — 68 
Cancellation of Earn-Out Shares(986)— — — — 
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings1,695 — (356)— (356)
Reduction in transaction costs— — 9,609 — 9,609 
Stock-based compensation— — 4,915 — 4,915 
Net loss— — — (13,069)(13,069)
Balances at March 31, 2023 (unaudited)
178,745 $18 $618,609 $(590,927)$27,700 

Convertible Preferred Stock (1)
Contingently Redeemable Convertible Common Stock (1)
Common  Stock (1)
Additional
Paid-In
Capital
Accumulated
Deficit
Total Stockholders’ Deficit
SharesAmountSharesAmountSharesAmount
Balances at December 31, 2021114,795$487,918 $ 9,368$1 $33,863 $(490,143)$(456,279)
Issuance of common stock upon exercise of stock options87171171
Issuance of convertible common stock2,75027,473
Vesting of early exercise of options125125
Stock-based compensation4,5014,501
Net loss(47,384)(47,384)
Balances at March 31, 2022 (unaudited)114,795$487,9182,750$27,4739,455$1$38,660$(537,527)$(498,866)
(1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement
The accompanying notes are an integral part of these condensed consolidated financial statements.
6

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In thousands)
Three Months Ended March 31,
20232022
Cash Flows from Operating Activities
Net loss$(13,069)$(47,384)
Adjustments to reconcile net loss to net cash used in operating activities:
Remeasurement of convertible preferred stock warrant liability (1,886)
Stock-based compensation4,893 4,460 
Depreciation and amortization1,448 1,410 
Changes in fair value of derivative liabilities292  
Reduction in transaction costs allocated to derivative liabilities upon Business Combination(3,745) 
Non-cash interest expense948 195 
Inventory reserve124 856 
Other non-cash expenses77 8 
Changes in operating assets and liabilities:
Inventory3,078 3,038 
Prepaids and other assets(828)(3,312)
Accounts payable1,554 10,287 
Accrued expenses162 2,917 
Deferred revenue(1,726)159 
Operating lease right-of-use assets and liabilities(261)(22)
Other liabilities316 (229)
Net cash used in operating activities(6,737)(29,503)
Cash Flows from Investing Activities
Purchase of property and equipment(784)(1,352)
Net cash used in investing activities(784)(1,352)
Cash Flows from Financing Activities
Proceeds from issuance of contingently redeemable convertible common stock 27,500 
Payment of transaction costs related to the Business Combination(4,150)(489)
Proceeds from issuance of debt7,500  
Payment of debt issuance costs(837) 
Repayment of debt(235)(275)
Proceeds from exercise of stock options and settlement of restricted stock units, net of withholding taxes paid related to common stock issued to employees(288)171 
Net cash provided by financing activities1,990 26,907 
Net decrease in cash, cash equivalents and restricted cash(5,531)(3,948)
Cash, cash equivalents and restricted cash at beginning of period95,985 78,376 
Cash, cash equivalents and restricted cash at end of period $90,454 $74,428 



7


Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Cash Flows - Continued
(Unaudited)
(In thousands)

Supplemental Disclosure
Cash paid for taxes$9 $21 
Cash paid for interest2,734 1,461 
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Purchase of property and equipment in accounts payable and accrued liabilities$113 $286 
Reduction in transaction costs allocated to equity instruments9,609  
Transaction and contingently redeemable convertible common stock issuance costs in accounts payable and accrued liabilities 2,582 
Vesting of early exercised stock options  125 


Reconciliation of cash, cash equivalents, and restricted cash:
March 31,
20232022
Cash and cash equivalents$81,653 $74,428 
Restricted cash8,801  
Total cash, cash equivalents and restricted cash$90,454 $74,428 

The accompanying notes are an integral part of these condensed consolidated financial statements.
8


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

1.    Description of Business
Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II, or “VGAC II”) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016.

On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”).

The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing.
Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 7, Common Stock and Warrants for additional details.
2.    Summary of Significant Accounting Policies
Basis of Presentation and Liquidity
The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.
These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should be read in conjunction with the Company’s financial statements and accompanying notes as of and for the year ended
9


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
December 31, 2022 (the “audited financial statements”) that were included in the Company’s Form 10-K filed with the SEC on March 16, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and the results of operations for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any other future interim or annual period.
The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $590.9 million as of March 31, 2023. The Company’s existing sources of liquidity as of March 31, 2023 include cash and cash equivalents of $81.7 million and availability of debt from the Siena Revolver (defined in Note 5, Debt). Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock, contingently redeemable convertible common stock and the incurrence of debt. The Company believes its existing cash and cash equivalents will be sufficient to fund its operations for a period of at least one year from the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.
Comprehensive Loss
Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.
Significant Accounting Policies
There have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, Summary of Significant Accounting Policies, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2022.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, the fair value of Additional Shares liabilities, the fair value of the Structural Derivative Liability and stock based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.

Restricted Cash

10


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
Short-term restricted cash primarily represents cash on deposit with a financial institution to collateralize short-term obligations related to company credit cards. Long-term restricted cash primarily represents cash on deposit with a financial institution to collateralize letters of credit related to the Company’s non-cancellable operating leases for its corporate headquarters. Restricted cash is stated at cost, which approximates fair value.
Concentration of Risks
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains the majority of its cash, cash equivalents and restricted cash in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
The Company depends on a limited number of vendors to supply products sold by the Company. For the three months ended March 31, 2023 and 2022, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases.
Revenue Recognition
The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment.
The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.
In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.
A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.
The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a
11


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).
At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. The Company records a refund reserve based on historical refund patterns. As of March 31, 2023 and December 31, 2022 the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was not material.
Disaggregation of Revenue
The following table sets forth revenue by product type (in thousands):
Three Months Ended
March 31,
20232022
Revenue, net:
Grove Brands $34,976 $46,796 
Third-party products36,589 43,683 
Total revenue, net$71,565 $90,479 
Contractual Liabilities
The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. Contractual liabilities included in deferred revenue and other current liabilities were $9.2 million and $0.2 million, respectively, as of March 31, 2023 and $10.9 million and $0.2 million, respectively, as of December 31, 2022. The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the three months ended March 31, 2023 that was previously included in deferred revenue and other current liabilities as of December 31, 2022 was $6.6 million and $0.2 million, respectively.
Fulfillment Costs
Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative
12


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
expenses in the condensed consolidated statements of operations. For the three months ended March 31, 2023 and 2022, the Company recorded fulfillment costs of $17.0 million and $24.4 million, respectively, which included $10.4 million and $14.3 million in shipping and handling expenses, respectively, and $3.9 million and $6.6 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors.
3.    Fair Value Measurements and Fair Value of Financial Instruments
The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt, Additional Shares, Earn-Out Shares Public and Private Placement Warrants and Structural Derivative. Cash equivalents, Earn-Out Shares, Public and Private Placement Warrants and Structural Derivative are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.
The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exceptions as defined in Note 7, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.
The Structural Derivative Liability is a compound embedded derivative related to features within the Structural Debt Facility, including an increase in interest rate upon an event of default and the contingent issuance of the Structural Subsequent Shares as defined in Note 5, Debt. This liability is classified as Level 3 and is valued using a risk-neutral income approach related to an event of default occurring and expected cash flows in such a scenario and an income and Black-Scholes pricing model for the contingent issuance of the Structural Subsequent Shares utilizing assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.
13


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 by level within the fair value hierarchy (in thousands):
March 31, 2023
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$78,213 $ $ $78,213 
Total$78,213 $ $ $78,213 
Financial Liabilities:
Additional Shares  803 803 
Earn-Out Shares  4,265 4,265 
Private Placement Warrants 364  364 
Public Warrants437   437 
Structural Derivative Liability  7,650 7,650 
Total$437 $364 $12,718 $13,519 
December 31, 2022
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$74,990 $ $ $74,990 
Total$74,990 $ $ $74,990 
Financial Liabilities:
Additional Shares  580 580 
Earn-Out Shares  4,122 4,122 
Private Placement Warrants 670  670 
Public Warrants805   805 
Structural Derivative Liability  7,050 7,050 
Total$805 $670 $11,752 $13,227 
There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented.
Additional Shares Liability
At the closing of the HGI Subscription Agreement defined in Note 7, Common Stock and Warrants, the Company recorded a liability related to the potential issuance of Additional Shares. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations.
The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):
Balance at December 31, 2022$580 
Change in fair value of Additional Shares Liability223 
Balance at March 31, 2023$803 
14


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
Earn-Out Shares
At Closing of the Business Combination, certain Earn-Out Shares were accounted for as a liability. Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations.
The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):
Balance at December 31, 2022$4,122 
Cancellation of Earn-Out Shares$(347)
Change in fair value490 
Balance at March 31, 2023$4,265 
Private Placement and Public Warrant Liabilities
As of March 31, 2023, the Company has Private Placement and Public Warrants. Such warrants are measured at fair value on a recurring basis.
The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands):

Private Placement WarrantsPublic Warrants
Balance at December 31, 2022$670 $805 
Changes in fair value(306)(368)
Balance at March 31, 2023$364 $437 
Structural Derivative Liability
At closing of the Structural Debt Facility, the Company recorded a liability related to the features that are required to be bifurcated and accounted for as a compound derivative at fair value. Subsequent changes in fair value of the Structural Derivative Liability until settlement is recognized in the statement of operations.
The following table provides a summary of changes in the estimated fair value of the Structural Derivative Liability (in thousands):
Balance at December 31, 2022$7,050 
Change in fair value600 
Balance at March 31, 2023$7,650 


15


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
4.    Accrued Expenses
Accrued expenses consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Inventory purchases$2,530 $2,757 
Compensation and benefits2,861 1,714 
Advertising costs1,020 1,203 
Fulfillment costs1,335 1,725 
Sales taxes1,509 1,374 
Transaction costs 17,500 
Other accrued expenses4,712 5,081 
Total accrued expenses$13,967 $31,354 
        
5.    Debt
The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Structural Debt Facility$61,549 $60,620 
Siena Revolver7,500  
Atel Loan Facility Draw 3292 480 
Atel Loan Facility Draw 448 95 
Total debt69,389 61,195 
Less: debt, current(340)(575)
Total debt, noncurrent$69,049 $60,620 
Structural Debt Facility
In December 2022, the Company entered into a Loan and Security Agreement (“Structural Debt Facility”) with Structural Capital Investments III, LP, Structural Capital Investments IV, LP and Series PCI Grove series of Structural Capital Primary Co-Investment Fund, LLC (collectively, “Structural Funds”) and Avenue Sustainable Solutions Fund, L.P. (“Avenue”) (collectively “Structural Lenders”) to borrow $72.0 million which was used primarily to settle previously outstanding obligations with a prior lender. The Structural Debt Facility bears an annual rate of interest at the greater of 15.00% or 7.50% plus the prime rate, payable monthly. The principal repayment period commences on July 1, 2025 and continues until the maturity date of December 21, 2026. The Company may prepay all outstanding amounts under this facility at anytime. Under the agreement, when amounts are prepaid or repaid in full at the Maturity Date, the Company may be obligated to pay additional fees which would allow for Structural Funds and Avenue to reach a Minimum Return, as defined by the agreement.
The Structural Debt Facility is collateralized by the assets of the Company and includes financial covenants the Company must meet in order to avoid an Event of Default, as defined by the agreement. Such covenants include (i) maintaining a minimum of $57.0 million in unrestricted cash at all times and (ii) achieving certain revenue targets for the trailing four quarter period beginning with this fiscal quarter ended March 31, 2023. The Structural Debt Facility contains a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, Structural has been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that Structural Lenders would exercise the subjective acceleration clause is remote. As of March 31, 2023, the Company was in compliance with these debt covenants.
16


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
On December 21, 2022, in connection with the closing of the Structural Debt Facility, the Company issued to Structural Funds, including certain affiliates, and to Avenue a total of 4,950,000 shares of the Company’s Class A common stock (the “Structural Closing Shares”). The Company recorded a debt discount of $1.1 million related to the issuance of these shares, with a corresponding offset to the Company’s Class A common stock and additional paid-in capital. Further, if there are outstanding obligations relating to the Structural Debt Facility on July 21, 2025, representing the thirty-month anniversary of such closing, the Company agrees to issue to Structural Funds, including certain affiliates, and to Avenue, the aggregate number of shares of the Company’s Class A common stock equal to $9,900,000, divided by the lower of (i) $2.00 and (ii) the volume weighted average price of the Company’s Class A common stock for the sixty trading days prior to such date, as further described in the related issuance agreements (the "Structural Subsequent Shares”).
The Company has identified several features within the Structural Debt Facility consisting of the contingent obligation to issue the Structural Subsequent Shares, mandatory and voluntary prepayment features and default interest rate (“Structural Derivative Liability”), which are required to be bifurcated and accounted for as a compound embedded derivative at fair value. Changes in fair value of the Structural Derivative Liability are recognized through the statements of operations and was $0.6 million for the three months ended March 31, 2023.
Closing costs consisted of $3.3 million in costs directly related to the issuance of the Structural Facility to third parties, issuance of certain Structural Closing Shares amounting to $1.1 million and incurrence of an additional Structural Derivative Liability amount of $7.1 million. At March 31, 2023, the Company had $72.0 million in principal outstanding under the Structural Debt Facility with an effective interest rate of 20.34%.
Siena Revolver
In March 2023, the Company entered into a Loan and Security Agreement (the “Siena Revolver”) with Siena Lending Group, LLC (“Siena”) which permits the Company to receive funding through a revolving line of credit with an initial commitment of $35.0 million. The Company’s borrowing capacity under the Siena Revolver is subject to certain conditions, including the Company’s eligible inventory and accounts receivable balances among other limitations as specified in the agreement. In connection with this facility the Company incurred $1.0 million of debt issuance costs which have been included in other assets on the Company’s balance sheet and being amortized through the Revolver’s scheduled maturity date. Additional borrowing capacity from the Siena Revolver was $10.2 million as of March 31, 2023.
The interest rates applicable to borrowings under the Siena Revolver are based on a fluctuating rate of interest measured by reference to either, at the Company’s option, (i) a Base Rate, plus an applicable margin, or (ii) the Term SOFR rate then in effect, plus 0.10% and an applicable margin. The Base Rate is defined as the greatest of: (1) Prime Rate as published in the Wall Street Journal, (2) Federal Funds Rate plus 0.5% and (3) 5.0% per annum. The applicable margin for Siena Revolver borrowings is based on the Company’s monthly average principal balance outstanding and ranges from 2.75% to 4.50% per annum in the case of Base Rate Borrowings and 3.75% to 5.50% per annum in the case of Term SOFR borrowings. The Siena Revolver also contains various financial covenants the Company must maintain to avoid an Event of Default, as defined by the agreement, including a subjective acceleration clause in the event that Siena determines that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the agreement, Siena has been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that Siena would exercise the subjective acceleration clause is remote. As of March 31, 2023, the Company was in compliance with these debt covenants.

The Siena Revolver matures at the earlier of March 10, 2026 or the maturity date of the Structural Debt Facility. As of March 31, 2023, the Company has an outstanding principal balance of $7.5 million under the Siena Revolver. The interest rate on the outstanding balance at March 31, 2023 is 8.52%.
Atel Loan Facility
In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default.
17


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
As of March 31, 2023, the Company had $0.3 million outstanding on its third draw and less than $0.1 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.

6.    Commitments and Contingencies
Merchandise Purchase Commitments
As of March 31, 2023 and December 31, 2022, the Company had obligations to purchase $15.3 million and $18.7 million, respectively, of merchandise.
Letters of Credit
The Company had irrevocable standby letters of credit in the amount of $3.5 million and $3.1 million as of March 31, 2023 and December 31, 2022, respectively, primarily related to the Company’s operating leases. The letters of credit have expiration dates through January 2029.
Contingencies
The Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.
7.    Common Stock and Warrants

As discussed in Note 1, Description of the Business, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination. During the year ended December 31, 2022, the Company recorded $24.4 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were allocated on a relative fair value basis between the issuance of equity and liability instruments.

Direct and incremental transaction costs allocated to equity-classified instruments were recorded within equity as an offset against proceeds upon accounting for the consummation of the Business Combination in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net in the condensed consolidated statements of operations. The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows.

As per the original agreement, the Company had $17.5 million of transaction costs accrued as of December 31, 2022. In March 2023, the Company entered into an amended agreement with a vendor to reduce this liability by $13.4 million. This reduction of costs was allocated between the liability and equity instruments with $3.8 million being recorded to other income, net on the Company’s statement of operations and $9.6 million recorded to additional paid-in capital, within equity.

On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of approximately 1.1760, each outstanding restricted
18


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760.

Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant.
Earn-Out
At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of the Company’s Class B Common Stock (“Earn-Out Shares”). During the three months ended March 31, 2023, certain shareholders surrendered an aggregate 985,722 Earn-Out Shares which, per terms of the Merger Agreement, were cancelled by the Company and not reallocated among the remaining holders. The remaining 13,014,238 Earn-Out Shares will vest (i) with respect to 6,507,310 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,506,928 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Business Combination (the “Earn-Out Period”).
If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.
If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of March 31, 2023, the Company did not meet any Earn-Out thresholds.
Class A Common Stock Warrants
As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assumed 6,700,000 Private Placement Warrants for the Company’s Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 of the Company’s Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation.
Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of the Company’s Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock, and therefore classified as liabilities on the condensed consolidated balance sheets. As of March 31, 2023, the following Warrants were outstanding:

Warrant TypeSharesExercise Price
Public Warrants8,050,000 $11.50 
Private Placement Warrants6,700,000 $11.50 
Public Warrants
19


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
The Public Warrants become exercisable into shares of the Company’s Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments.
The Company may redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any twenty trading days within the thirty trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.
Private Placement Warrants
The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants were not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. At Closing, the Company assumed 6,700,000 Private Placement Warrants.
Backstop Warrants

In connection with the Business Combination, the Company issued to the Corvina Holdings limited 3,875,028 warrants to purchase the Company’s Class A common stock (each warrant exercisable to purchase one share of the Company’s Class A common stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. None of these warrants have been exercised as of March 31, 2023.
Standby Equity Purchase Agreement
On July 18, 2022, the Company entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, LTD (“Yorkville” or “SEPA Investor”), pursuant to which Yorkville has agreed to purchase up to $100 million of common stock from time to time over a period of 36 months, subject to certain conditions. The shares of the Company’s common stock that may be issued under the SEPA may be sold by us to Yorkville at our discretion from time to time and sales of the Company’s common stock under the SEPA will depend upon market conditions and other factors. Additionally, in no event may the Company sell more than 32,557,664 shares of common stock to Yorkville under the SEPA, which number of shares is equal to 19.99% of the shares of the Company's common stock outstanding immediately prior to the execution of the Equity Purchase Agreement (the “Exchange Cap”), unless stockholder approval is obtained to issue shares of common stock in excess of the Exchange Cap in accordance with applicable NYSE rules or comply with certain other requirements as described in the Equity Purchase Agreement. As a result, unless the Company’s stock price exceeds $3.07, the Company will be unable to sell the full $100.0 million commitment to Yorkville without seeking stockholder approval to issue additional shares in excess of the Exchange Cap. The purchase price per share for Class A common stock will be 97.55% of the Volume-Weighted Average Price (“VWAP”) of the Company’s Class A common stock over the Pricing Period, as defined by the agreement. The Company deferred $0.7 million of transaction costs related to the SEPA and will offset these costs against proceeds of any sales under the SEPA. As of March 31, 2023, the Company has sold 739,825 shares under the SEPA for total gross proceeds of $2.4 million. Issuance costs related to these shares are not material. As of March 31, 2023, there were 31,817,839 shares available to be sold to Yorkville under the Exchange Cap.
20


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
HGI Subscription Agreement
On November 10, 2022, the Company entered into a subscription agreement (the “HGI Subscription Agreement”) with HCI Grove LLC (“HGI”), pursuant to which, among other things, the Company issued to HGI 1,984,126 shares of the Company’s Class A common stock (“Subscribed Shares”) for aggregate proceeds of $2.5 million. Under the terms of the HGI Subscription Agreement, the Company is required to file a registration statement for the Subscribed Shares upon the Company becoming eligible to file a registration statement on Form S-3 and in any event prior to July 15, 2023 (the “Subscribed Shares Registration Statement”).
The HGI Subscription Agreement also provides that the Company will issue additional shares (the “HGI Additional Shares”) of the Company’s Class A common stock to HGI in the event that the volume weighted average price of the Company’s Class A common stock is less than $1.26 during the three trading days commencing on the first trading day after (i) the Company files the Subscribed Shares Registration Statement (the “Registration Date”), (ii) the three-month anniversary of the Registration Date, (iii) the six-month anniversary of the Registration Date, or (iv) the nine-month anniversary of the Registration Date (“Measurement Periods” and each “Measurement Period”) upon HGI’s election to receive such additional shares. HGI may use all or a portion of each Subscribed Share once to determine the amount of any issuance of Additional Shares in connection with the Measurement Periods such that HGI may utilize, for example, half of the Subscribed Shares to receive further Additional Shares, and leave the remaining half of the Subscribed Shares available to utilize in connection with the remaining Measurement Periods. HGI must elect to receive HGI Additional Shares for one Measurement Period, or the right lapses or is superseded by the next measurement period. There have been no shares have been issued related to the HGI Additional shares as of March 31, 2023.
Concurrent with the HGI Subscription Agreement, the Company also entered into a consulting services agreement (the “Consulting Agreement”) with HCI Grove Management LLC (the “Consultant”). In consideration for the services under the Consulting Agreement, the Company (i) paid the Consultant an upfront fee of $150,000 and (ii) issued the Consultant 4,525,000 warrants (the “HGI Warrant Shares”) to purchase shares of the Company’s Class A common stock (the “HGI Warrants”), at an exercise price per share of $1.26 (the “Exercise Price”). On November 10, 2022, 40% of the HGI Warrant Shares vested and became issuable (the “Vested Warrants”), and the remaining HGI Warrant Shares (the “Unvested Warrants”) shall vest and become exercisable if, prior to December 31, 2024, the Company achieves at least $100.0 million in quarterly net revenue on a consolidated basis or if the Company consummates a Change of Control, as defined in HGI Warrants. If, as a result of the Change of Control, the Company’s equity holders own less than 25% of the equity securities of the surviving entity in such Change of Control, the Exercise Price shall be increased by 50%.
The Company determined the Vested Warrants and Unvested Warrants qualify as stock based compensation to a nonemployee. The Company recorded $1.2 million in stock based compensation expense on the execution date of the HGI Subscription Agreement. The Company performs a probability reassessment related to the Unvested Warrants each reporting period and will recognize the cumulative catch-up adjustment based on the grant-date fair value when the vesting conditions are probable of being achieved. Any remaining expense will continue to ratably recognized until the date the revenue target is achieved, and the Unvested Warrants are fully vested.
The fair value of Vested Warrants and Unvested Warrants granted to HGI was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
Fair value of common stock$1.26
Expected term (in years)4.5
Volatility62.50%
Risk-free interest rate4.00%
Dividend yield

Reserved for Issuance
The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:
21


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
March 31, 2023December 31, 2022
Class A Common StockClass B Common StockClass A Common StockClass B Common Stock
Private Placement Warrants6,700,000  6,700,000  
Public Warrants8,050,000  8,050,000  
Backstop Warrants3,875,028  3,875,028  
Common Stock Warrants4,525,000 568,905 4,525,000 568,905 
Outstanding Stock Options5,969,813 4,202,678 6,318,978 4,198,917 
Outstanding Restricted Stock Units29,238,710 175,184 19,322,240 263,052 
Remaining Shares available for issuance under 2022 Equity Incentive Plan9,338,297  20,794,363  
Shares available for issuance under 2022 Employee Stock Purchase Plan5,052,643  3,274,070  
Total shares of common stock reserved72,749,491 4,946,767 72,859,679 5,030,874 
8.    Stock-Based Compensation
Stock Options
Stock option activity under the Company’s incentive plan is as follows (in thousands, except share and per share amounts):
Options Outstanding
Number of Options Weighted–Average Exercise PriceWeighted-Average Remaining Contractual Life (years)Aggregate Intrinsic Value
Balance – December 31, 202210,521,571 $1.59 4.87$61 
Exercised(178,564)0.38 
Cancelled/forfeited(170,516)2.82 
Balance – March 31, 202310,172,491 1.59 4.0598 
Options vested and exercisable – March 31, 20239,040,393 $1.32 3.58$98 
No options were granted during three months ended March 31, 2023 and 2022. The total grant date fair value of options that vested during three months ended March 31, 2023 and 2022 was $0.1 million and $4.4 million, respectively. The aggregate intrinsic value of options exercised during the three months ended March 31, 2023 and 2022 was nominal and $0.4 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options.
Market-Based Stock Options
In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of the stock options vest upon
22


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for service periods completed prior to the Business Combination. As of March 31, 2023, the market-based vesting criteria had not been met.
Restricted Stock Units
The following table summarizes the activity for all RSU’s under all of the Company’s equity incentive plans for the three months ended March 31, 2023:
Number of shares Weighted–Average Grant Date Fair Value Per Share
Unvested – December 31, 202219,482,427 $1.75 
Granted13,314,042 0.43 
Vested(2,549,326)2.28 
Cancelled/forfeited(833,249)2.69 
Balance – March 31, 202329,413,894 1.08 

Employee Stock Purchase Plan
In May 2022, the Company’s board of directors adopted the 2022 Employee Stock Purchase Plan (the “ESPP”), which was subsequently approved by the Company’s stockholders. The ESPP went into effect on November 16, 2022. Subject to certain limitations contained therein, the ESPP allows eligible employees to contribute, through payroll deductions, up to 20% of their eligible compensation to purchase the Company’s Class A common stock at a discounted price per share. As of March 31, 2023, no shares of Class A common stock had been purchased under the ESPP.

Stock-Based Compensation Expense
For the three months ended March 31, 2023 and 2022, the Company recognized a total of $4.9 million and $4.5 million of stock-based compensation expense, respectively, related to stock options and RSUs granted to employees and non-employees. Stock-based compensation expense was predominately recorded in selling, general and administrative expenses in the statements of operations for each period presented. As of March 31, 2023, the total unrecognized compensation expense related to unvested options and RSUs was $28.6 million, which the Company expects to recognize over an estimated weighted average period of 2.3 years.
23


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
9.    Net loss Per Share Attributable to Common Stockholders

The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
March 31,
20232022
Convertible preferred stock 115,287,015 
Contingently redeemable convertible common stock 2,750,000 
Common stock options10,172,491 25,691,329 
Restricted stock units29,413,894 3,224,181 
Convertible preferred stock warrants 735,763 
Common stock warrants5,093,905 688,362 
Private and Public Placement Warrants14,750,000  
Earn-Out Shares13,005,238  
Shares subject to repurchase 16,539 
Total72,435,528 148,393,189 
10.    Subsequent Events
On April 19, 2023, the Company entered into an amendment to the lease agreement for its warehousing facility located in St. Peters, Missouri to provide for, among other things, an extension of the lease term to September 2028. At the option of the Company, the lease may be extended an additional 5 years. The amendment requires the Company to make escalating undiscounted annual payments of up to $0.7 million, payable monthly. The Company is currently evaluating all the terms of this lease modification and its impact on the consolidated financial statements.
24


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of the financial condition and results of operations of Grove Collaborative Holdings, Inc. (“Grove,” “we,” “us,” and “our”) should be read with the condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022. This discussion and analysis contains forward-looking statements based upon current expectations that involve risks and uncertainties. Grove’s actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the section entitled “Risk Factors” herein or in our Annual Report on Form 10-K for the year ended December 31, 2022 or in other parts of this Quarterly Report on Form 10-Q. Grove’s historical results are not necessarily indicative of the results that may be expected for any period in the future. Except as otherwise noted, all references to 2022 refer to the year ended December 31, 2022.

References to Virgin Group Acquisition Corp. II. or “VGAC II” refer to the Company prior to the consummation of the Business Combination (described below).
OVERVIEW

Grove Collaborative Holdings, Inc., formerly Virgin Group Acquisition Corp. II, is a digital-first, sustainability-oriented consumer products innovator. We use our connection with consumers to create and curate authentic, disruptive brands and products. We build natural products that perform as well as or better than many leading CPG brands (both conventional and natural), while being healthier for consumers and the planet.
Our omnichannel distribution strategy enables us to reach consumers where they want to shop. We operate an online direct-to-consumer website and mobile application (“DTC platform”) where we both sell our Grove-owned brands (“Grove Brands”) and partner with other leading natural and mission-based CPG brands, providing consumers the best selection of curated products across many categories and brands.

Grove is a public benefit corporation and a Certified B Corporation, meaning we adhere to third party standards for prioritizing social, environmental, and community well-being. We have a history of doing well by doing good, which is supported by our flywheel: as we have grown, our product development capabilities and data have improved. Over the long term, we believe that improved innovation will fuel both topline growth and margin expansion as our innovation has historically tended to be both market expanding and margin accretive. Since inception, we have grown and invested heavily in building out both our e-commerce platform and Grove Brands, and over this period we have operated at a loss and have an accumulated deficit of $590.9 million as of March 31, 2023. Beginning in the second half of 2022, we have moved to substantially reduce our operating expenses across the business in support of our drive toward profitability. These expense reductions, particularly in advertising, have resulted in a substantial decline in our revenue. While we have made significant progress, we anticipate that we will continue to incur losses in the future unless and until we can rekindle revenue growth to the point where our revenue exceeds our operating expenses. Refer to Liquidity, Capital Resources and Requirements below for more information.
Business Combination

On June 16, 2022 (the “Closing Date”), we became a publicly traded company as a result of the consummation of Grove Collaborative, Inc.’s (“Legacy Grove”) merger with Virgin Group Acquisition Corp. II, a Cayman-domiciled blank check company (“VGAC II”), which we refer to herein as the “Business Combination”. Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively.
Key Factors Affecting Our Operating Performance
We believe that the growth of our business and our future success are dependent on many factors. While each of these factors presents significant opportunities for us, they also pose important challenges that we must successfully address to enable us to sustain the growth of our business and improve our operations while staying true to our mission, including those discussed below and in the section entitled “Risk Factors”.
25

Ability To Grow our Brand Awareness
Our brand is integral to the growth of our business and is essential to our ability to engage with our community. Our performance will depend on our ability to attract new customers and encourage consumer spending across our product portfolio. We believe the core elements of continuing to grow our awareness, and thus increase our penetration, are highlighting our products’ qualities of being natural, sustainable and effective, the efficacy of our marketing efforts and the success of our continued retail rollout. Beyond preserving the integrity of our brand, our performance will depend on our ability to augment our reach and increase the number of consumers aware of Grove and our product portfolio.
Ability to Continue to Innovate in Products and Packaging
Our continued product innovation is integral to our future growth. We have successfully developed and launched over 500 individual products in recent years. The research, development, testing and improvement has been led by our R&D team, which includes experienced chemists and formulators, who work closely with our Sustainability team. These new and innovative products, as well as our focus on environmentally responsible packaging, have been key drivers of our value proposition to date. An important element of our product development strategy is our ability to engage directly with customers through our DTC platform to assess demand and market preferences. To the extent our customers increasingly access our products through retail channels, we will need to innovate our modalities of customer engagement to maintain this important feedback loop. Our continued success in research and development and ability to assess customer needs and develop sustainable and effective products will be central to attracting and retaining consumers in the future and to growing our market penetration and our impact on human and environmental health.
Ability to Expand our Retail Distribution
We have a significant opportunity to expand our distribution in retail channels, both broadening our partner reach and introducing our products across more doors, as well as deepening our retail distribution in terms of the number of individual products. Our success and speed of doing so will impact our financial performance. We are pursuing partnerships with a wide variety of retailers, including big-box retailers, online retailers, grocery stores, drugstores and specialty retailers. Our ability to execute this strategy will depend on a number of factors, such as retailers’ satisfaction with the sales and profitability of our products. In the near-term, retail expansion will require partnerships with retailers on launches and we may choose to invest in promotions to drive sales and awareness over time. To the extent we are successful in retail expansion over the next several years, we expect to see potential negative effects on gross margins resulting from the retail cost structure to be approximately offset by savings in fulfillment costs driven by bulk shipping to retailers versus individualized fulfillment to consumers, through our fulfillment centers.
Cost-Efficient Acquisition of New Customers and Retention of Existing Customers on our DTC Platform
Our ability to attract new customers is a key factor for our future growth. To date we have successfully acquired new customers through many online and offline marketing channels. In recent periods, changes in the algorithms used for targeting and purchasing online advertising, changes to privacy and online tracking, supply and demand dynamics in the market, and other factors have caused the cost of marketing on these channels to increase consistently. Failure to effectively adapt to changes in online marketing dynamics or otherwise to attract customers on a cost- efficient basis would adversely impact our path to profitability and operating results. Recently, we have implemented a lower-spend strategy to optimize the cost of acquiring new customers. Our ability to balance cost-efficient acquisitions while driving consumer awareness may impact the cost of acquiring new customers, profitability and operating results.
The future activity level and profitability of our DTC customer base will depend on our ability to continue to offer a compelling value proposition to consumers including strong selection, pricing, customer service, smooth and compelling web and mobile app experience, fast and reliable fulfillment, and curation within natural and sustainable products. Our success is also dependent on our ability to maintain relevance with our consumers on a regular basis through high performing products and a consumer-friendly refill and fulfillment process, and most importantly to provide consumers with products that consistently outperform their expectations. Our ability to execute on these key value-driving areas for consumers, and to remain competitive and compelling in a post-pandemic landscape, are necessary for our future growth. Failure to achieve these things would materially impact our operating results and financial performance.
Ability to Drive Operating Efficiency and Leverage as We Scale
We believe we are in the early stages of realizing a substantial opportunity to transform the consumer products industry into a force for human and environmental good by relentlessly creating and curating planet-first, high-performance brands and products. We have made substantial operating and capital expenditures to build our operations for this opportunity and believe that realization will require sustained levels of investment for the foreseeable future. To achieve
26

profitability over the longer term, we will need to leverage economies of scale in sourcing our products, generating brand awareness, acquiring customers, creating operating leverage over headcount and other overhead, and fulfilling orders. Our retail strategy is designed, in part, to help accelerate achievement of this scale, as we leverage the retail presence of our partners and minimize the fulfillment costs associated with our DTC platform and create new revenue streams for our product development efforts. However, we believe that maintaining our DTC presence will remain a key driver of our product innovation and customer satisfaction strategies and serves the needs of an important and growing group of consumers that want to shop online. If we are unable to achieve sufficient operating leverage in our business, we may need to curtail our expenditures, which would in turn compromise our prospects for growth and or negatively impact our ability to operate profitably.
Key Operating and Financial Metrics
In addition to our condensed consolidated financial statements, included elsewhere in this Form 10-Q, we assess the performance of our overall business based on the following metrics and measures, including identifying trends, formulating financial projections, making strategic decisions, assessing operational efficiencies and monitoring our business.
Over the coming years, we expect to grow our omnichannel presence both in core assortment, adjacent categories and sales channels.

We believe that the future of CPG brand building and consumer demand is omnichannel. Our DTC platform remains a core part of our strategy and customer value proposition in addition to providing key data and customer feedback driving our innovation process. We kicked off our expansion into brick and mortar retail in April 2021 with the launch of a curated assortment of Grove Co. products at Target. We continued to expand into other retailers, including Amazon, CVS, Walmart, Kohl’s, Meijer, and Giant Eagle. As we aim to continue our leadership in both omnichannel and sustainability, we will aggressively expand our presence into physical retail over the next few years to reach more consumers no matter where they shop.
Our current operating metrics reflect our core strategic focus on growing Grove Brands’ omnichannel presence and revenue, as well as our key DTC platform metrics.
Three Months Ended March 31,
(in thousands, except DTC Net Revenue Per Order and percentages)
20232022
Financial and Operating Data
Grove Brands % Net Revenue
49 %52 %
DTC Total Orders
1,097 1,558 
DTC Active Customers
1,241 1,653 
DTC Net Revenue Per Order
$62 $55 
Grove Brands % Net Revenue
We define Grove Brands % Net Revenue as total net revenue across all channels attributable to Grove Brands, including: Grove Co., Honu, Peach, Rooted Beauty, Grove Co. Paper (previously named “Seedling”) and Superbloom divided by our total net revenue. On our DTC Platform, our total net revenue includes revenue from both Grove Brands and third-party brands that we carry, whereas for our retail sales total net revenues is comprised exclusively of revenue from Grove Brand products. We view Grove Brands % Net Revenue as a key indicator of the success of our product innovation and growth strategy, and customers’ acceptance of our products. In the three months ended March 31, 2023, Grove Brands % Net Revenue declined due to fewer new customer orders, which include more Grove branded products.
DTC Total Orders
We determine our number of DTC Total Orders by counting the number of customer orders submitted through our website and mobile application that have been shipped within the period. The metric includes orders that have been refunded, excludes reshipments of customer orders for any reason including damaged and missing products, and excludes retail orders. Refunded orders are included in DTC Total Orders as we believe this provides more meaningful order management performance metrics, including fulfillment cost efficacy and refund rates. Changes in DTC Total Orders in a reporting period capture both the inflow of new customers, changes in order frequency of existing customers and customer attrition. We view the number of Total DTC Orders as a key indicator of trends in our DTC platform, and our future success in this channel will depend in part on our ability to drive growth through new customer acquisition and by
27

increasing existing customer engagement. In the three months ended March 31, 2023, DTC Total Orders declined primarily due to our reduction in advertising spend, resulting in fewer new customers and therefore fewer overall orders. We expect this trend to continue through 2023 as advertising remains at current levels.
DTC Active Customers
As of the last day of each reporting period, we determine our number of DTC Active Customers by counting the number of individual customers who submitted orders through our DTC platform, and for whom an order has shipped, at least once during the preceding 364-day period. The change in active customers in a reporting period captures both the inflow of new customers as well as the outflow of customers who have not made a purchase in the last 364 days. We view the number of active customers as one of the key indicators of growth in our DTC channel. In the three months ended March 31, 2023, DTC Active Customers declined primarily due to our reduction in advertising spend resulting in fewer new customers.
DTC Net Revenue Per Order

We define DTC Net Revenue Per Order as our DTC Total Net Revenue in a given reporting period, divided by the DTC Total Orders in that period. We view DTC Net Revenue per Order as a key indicator of the performance of our DTC business. DTC Net Revenue Per Order increased in the three months ended March 31, 2023 compared to the prior year comparative periods as a result of net revenue management initiatives including the introduction of strategic price increases on Grove Brands and third party products, as well as the launch of the Supply Chain Fee, which allows us to continue prioritizing sustainability and maintain our commitment to fair wages.
Non-GAAP Financial Measures: Adjusted EBITDA and Adjusted EBITDA Margin
We prepare and present our financial statements in accordance with U.S. GAAP (“GAAP”). In addition, we believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. For these reasons, management uses Adjusted EBITDA in evaluating our operating performance and resource allocation and forecasting. As such, we believe Adjusted EBITDA provides investors with additional useful information in evaluating our performance.

We calculate Adjusted EBITDA as net loss, adjusted to exclude: (1) stock-based compensation expense; (2) depreciation and amortization; (3) remeasurement of convertible preferred stock warrant liability; (4) changes in fair values of Additional Shares, Earn-out Shares, Public Private Placement Warrant, Structural Derivative liabilities; (5) transaction costs allocated to derivative liabilities upon Business Combination; (6) interest income; (7) interest expense; (8) restructuring costs and (9) provision for income taxes. We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue. Because Adjusted EBITDA excludes these elements that are otherwise included in our GAAP financial results, this measure has limitations when compared to net loss determined in accordance with GAAP. Further, Adjusted EBITDA is not necessarily comparable to similarly titled measures used by other companies. For these reasons, investors should not consider Adjusted EBITDA in isolation from, or as a substitute for, net loss determined in accordance with GAAP.
28

The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted EBITDA, for each of the periods presented.
Three Months Ended March 31,
20232022
Reconciliation of Net Loss to Adjusted EBITDA
(in thousands)
Net loss$(13,069)$(47,384)
Stock-based compensation
4,893 4,460 
Depreciation and amortization
1,448 1,410 
Remeasurement of convertible preferred stock warrant liability
— (1,886)
Change in fair value of Additional Shares liability223 — 
Change in fair value of Earn-Out liability143 — 
Change in fair value of Public and Private Placement Warrants liability(674)— 
Change in fair value of Structural Derivative liability600 — 
Reduction in transaction costs allocated to derivative liabilities upon Business Combination(3,745)— 
Interest income(424)— 
Interest expense
3,729 2,087 
Restructuring costs— 1,636 
Provision for income taxes
10 23 
Total Adjusted EBITDA
$(6,866)$(39,654)
Net loss margin
(18.3)%(52.4)%
Adjusted EBITDA margin
(9.6)%(43.8)%
Components of Results of Operations
Revenue, Net
We generate revenue primarily from the sale of both third-party and our Grove Brands products through our DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by our recurring shipment recommendation engine, and featured products that appear in marketing on-site, in emails and on our mobile app. Most customers purchase a combination of products recommended by us based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. We also generate revenue from the sale of our Grove Brands products to the retail channel.
We recognize revenue from the sale of our products through our DTC platform net of discounts, sales tax, customer service credits and estimated refunds. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities.
Cost of Goods Sold
Cost of goods sold consists of the product costs of merchandise, inbound freight costs, vendor allowances, costs associated with inventory shrinkage and damages and inventory write-offs and related reserves.
Gross Profit and Gross Margin
Gross profit represents revenue less cost of goods sold. Gross margin is gross profit expressed as a percentage of revenue. We generally record higher gross margins associated with sales of Grove Brands products compared to sales of third-party products. To help induce first-time customers to purchase on our DTC platform, we generally offer higher discounts and free product offerings, and as a result our overall margins can be adversely affected in periods of rapid new customer acquisition. Our gross margin also fluctuates from period to period based on promotional activity, product and channel mix, the timing of promotions and launches, and inbound transportation rates, among other factors. Our gross profit and gross margin may not be comparable with that of other retailers because we include certain fulfillment related costs in selling, general, and administrative expenses while other retailers may include these expenses in cost of merchandise sold.
29

Operating Expenses
Our operating expenses consist of advertising, product development, and selling, general and administrative expenses.
Advertising

Advertising expenses are expensed as incurred and consist primarily of our customer acquisition costs associated with online advertising, as well as advertising on television, direct mail campaigns and other media. Costs associated with the production of advertising are expensed when the first advertisement is shown. We expect advertising costs to continue to decrease from the 2022 fiscal year as we implement a lower-spend strategy which optimizes the cost of acquiring new customers, while balancing driving consumer awareness and cash flow management.
Product Development
Product development expenses are related to the ongoing support and maintenance of our proprietary technology, including our DTC platform, as well as amortization of capitalized, internally developed software, and related to the product and packaging innovation in our Grove Brands products. Product development expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits and stock-based compensation expenses. Product development costs also include allocated facilities, equipment, depreciation and overhead costs. We expect product development costs as a percentage of revenue to be consistent with 2022 as we balance our investments in our proprietary technology, the expansion of our product line, innovative packaging and product improvements with revenue growth.
Selling, General and Administrative

Selling, general and administrative expenses consist primarily of compensation and benefit costs for personnel involved in general corporate functions, including stock-based compensation expense, and certain fulfillment costs, as further outlined below. Selling, general and administrative expenses also include the allocated facilities, equipment, depreciation and overhead costs, marketing costs including qualified cost of credits issued through our referral program, costs associated with our customer service operation, and costs of environmental offsets. While selling, general and administrative expenses increased as a result of activities related to the Business Combination and becoming a public company, we expect them to continue decreasing as part of our cost management initiatives offsetting inflationary pressures.
Fulfillment costs represent those costs incurred in operating and staffing our fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packing and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packing materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative expenses in the statements of operations. We expect fulfillment costs to continue improving in the future on a per order basis, compared to the 2022 fiscal year.
Interest and Other Income, Net

Interest expense consists primarily of interest expense associated with our debt financing arrangements. Due to higher interest rates on our Structural Debt Facility (as defined below) and increases in the prime rate, we anticipate cash payments for interest and interest expense to increase in the future.
Other income, net consists primarily of losses or gains on remeasurement of our convertible preferred stock warrant liabilities, changes in fair values of Additional Shares, Earn-Out Shares, Public and Private Placement Warrant and Structural Derivative liabilities, and transaction costs allocated to derivative liabilities upon Business Combination. These changes in fair value may fluctuate significantly in future periods primarily due to fluctuations in the fair value of our common stock.
Provision for Income Taxes
We account for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statements and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. We recognize the benefits of tax-return positions in the financial statements when they are more likely than not to be sustained by the taxing authority, based on the technical merits at the reporting date. We consider many factors when evaluating and estimating our tax positions
30

and tax benefits, which may require periodic adjustments, and which may not accurately forecast actual outcomes. We recognize interest and penalties related to unrecognized tax benefits, if any, as income tax expense.
Results of Operations
The following table sets forth our results of operations for each period presented:
Three Months Ended
March 31,
20232022
Revenue, net$71,565 $90,479 
Cost of goods sold34,310 47,742 
Gross profit37,255 42,737 
Operating expenses:
Advertising8,673 32,793 
Product development4,216 6,240 
Selling, general and administrative38,021 50,970 
Operating loss(13,655)(47,266)
Interest expense 3,729 2,087 
Change in fair value of Additional Shares liability223 — 
Change in fair value of Earn-Out liability143 — 
Change in fair value of Public and Private Placement Warrants liability(674)— 
Change in fair value of Structural Derivative liability600 — 
Other income, net (4,617)(1,992)
Interest and other expense (income), net(596)95 
Loss before provision for income taxes(13,059)(47,361)
Provision for income taxes10 23 
Net loss$(13,069)$(47,384)
31

The following table sets forth our statements of operations data expressed as a percentage of revenue:
Three Months Ended
March 31,
20232022
Revenue, net100 %100 %
Cost of goods sold48 53 
Gross profit52 47 
Operating expenses:
Advertising12 36 
Product development
Selling, general and administrative53 56 
Operating loss(19)(52)
Interest expense
Change in fair value of Additional Shares liability— — 
Change in fair value of Earn-Out liability— — 
Change in fair value of Public and Private Placement Warrants liability(1)— 
Change in fair value of Structural Derivative liability— 
Other income, net (6)(2)
Interest and other expense (income), net(1)— 
Loss before provision for income taxes(18)(52)
Provision for income taxes— — 
Net loss(18)%(52)%
32

Comparisons of the Three Months Ended March 31, 2023 and March 31, 2022
Revenue, Net
Three Months Ended March 31,Change
20232022Amount %

(in thousands)
Revenue, net:
Grove Brand$34,976 $46,796 $(11,820)(25)%
Third-party product36,589 43,683 (7,094)(16)%
Total revenue, net$71,565 $90,479 $(18,914)(21)%
Revenue decreased by $18.9 million, or 21% for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, primarily driven by a decrease in DTC Total Orders caused by a reduction in DTC Active Customers from primarily from the reduction in advertising spend, partially offset by increases in DTC Net Revenue Per Order.

Cost of Goods Sold and Gross Profit
Three Months Ended March 31,Change
20232022Amount %
(in thousands)
Cost of goods sold$34,310 $47,742 $(13,432)(28)%
Gross profit 37,255 42,737 (5,482)(13)%
Gross margin52 %47 %%
Cost of goods sold decreased by $13.4 million, or 28%, for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, primarily due to a decrease in DTC Total Orders, offset by reductions in inventory reserves.

Gross margin in the three months ended March 31, 2023 increased by 462 basis points compared to the three months ended March 31, 2022 due to the decrease in number of lower-margin first orders as a percentage of total orders, impacts of net revenue management initiatives including the introduction of a Supply Chain Fee and strategic price increases on Grove Brands and third party products, decreases in inventory reserves, offset by increase in product costs and decrease in Grove Brands mix as a percentage of total revenue.
Operating Expenses
Advertising Expenses
Three Months Ended March 31,Change
20232022Amount %
(in thousands)
Advertising
8,673 $32,793 $(24,120)(74)%
Advertising expenses decreased by $24.1 million, or 74%, for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, primarily due to implementing a lower-spend strategy which optimizes the cost of acquiring new customers, while balancing driving consumer awareness and cash flow management. Online advertising expenses decreased by $12.6 million, television advertising expenses decreased by $7.6 million and creative content production costs decreased by $1.9 million.
33

Product Development Expenses
Three Months Ended March 31,Change
20232022Amount %
(in thousands)
Product development
$4,216 $6,240 $(2,024)(32)%

Product development expenses decreased by $2.0 million, or 32% for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, primarily due to a $1.7 million decrease in salaries and benefits from reductions in headcount.
Selling, General and Administrative Expenses
Three Months Ended March 31,Change
20232022Amount %
(in thousands)
Selling, general and administrative
$38,021 $50,970 $(12,949)(25)%

Selling, general and administrative expenses decreased by $12.9 million, or 25% for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022. Fulfillment costs decreased by $7.4 million, including $3.9 million decrease in shipping and handling expenses and $2.6 million decrease in Fulfillment Labor. The decrease in shipping and handling expenses was driven by a decrease in the volume of orders and carrier mix, partially offset by an increase in carrier rates. The decrease in Fulfillment Labor was due to decrease in the volume of orders and the ability to fulfill orders more efficiently. Other general and administrative expenses decreased by $5.5 million, from decreases in corporate salaries and benefits from reductions in headcount and decrease in marketing expenses related to our cost management initiatives, offset by an increase in costs related to being a public company.
Three Months Ended March 31,Change
20232022Amount %
(in thousands)
Interest expense
$3,729 $2,087 $1,642 79 %

Interest expense increased by $1.6 million, or 79% for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 primarily due to increases in rates incurred on our debt facilities. See the section titled “Liquidity and Capital Resources — Loan Facilities” below for further details.
34

Other income, net
Three Months Ended March 31,Change
20232022Amount %
(in thousands)
Change in fair value of Additional Shares liability$223 $— $223 *
Change in fair value of Earn-Out liability143 — 143 *
Change in fair value of Public and Private Placement Warrants liability(674)— (674)*
Change in fair value of Structural Derivative liability600 — 600 *
Other income, net (4,617)(1,992)(2,625)132 %

*Percent change not meaningful

The change in the fair value of Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants liability and Structural Derivative liability for the three months ended March 31, 2023 was driven by the changes in our stock price from the December 31, 2022 through March 31, 2023.

Other income, net increased by $2.6 million, or 132% for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 primarily due to a $3.8 million reduction of transaction costs allocated to liability instruments acquired in the Business Combination offset by a $1.9 million decrease in a gain on remeasurement of the preferred stock warrant liability.

Liquidity, Capital Resources and Requirements

As of March 31, 2023, we had $81.7 million in unrestricted cash (excluding restricted cash of $8.8 million) and cash equivalents and working capital of $94.2 million, and we incurred negative cash flows from operating activities of $6.7 million for the three months ended March 31, 2023. We have incurred significant losses since inception and have an accumulated deficit of approximately $590.9 million. To date, we have funded our operations principally through convertible preferred stock and common stock financings, the incurrence of debt and the Closing of the Business Combination. We have total outstanding indebtedness of $69.4 million, net of debt issuance costs, as of March 31, 2023.

On March 10, 2023, we entered into the Siena Revolver (defined below) with Siena Lending Group, LLC (“Siena”) which permits us to receive funding through a revolving line of credit with an initial commitment of $35.0 million. The total borrowing capacity under the Siena Revolver is subject to certain conditions, including our inventory and accounts receivable balances and other limitations as specified in the agreement. Available borrowing capacity from the Siena Revolver was $10.2 million as of March 31, 2023.

In December 2022, we repaid other outstanding debt obligations with a prior lender with the Structural Debt Facility (as defined below) and will begin to make principal payments on the Structural Debt Facility beginning on July 1, 2025 over a period of 18 months.

On July 18, 2022, we entered into the Standby Equity Purchase Agreement (“SEPA”) with YA II PN, LTD. (“Yorkville”), whereby we have the right, but not the obligation, to sell to Yorkville up to $100.0 million of our shares of common stock at our request until July 18, 2025, subject to certain conditions. The shares of our common stock that may be issued under the SEPA may be sold by us to the Yorkville at our discretion from time to time and sales of our common stock under the SEPA will depend upon market conditions and other factors. Additionally, in no event may we sell more than 32,557,664 shares of our common stock to Yorkville under the SEPA, which number of shares is equal to 19.99% of the shares of the Company's common stock outstanding immediately prior to the execution of the Equity Purchase Agreement (the “Exchange Cap”), unless we obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap in accordance with applicable NYSE rules or comply with certain other requirements as described in the Equity Purchase Agreement. As a result, unless our average stock price under the SEPA exceeds $3.07, we will be unable to sell the full $100.0 million commitment to Yorkville without seeking stockholder approval to issue additional shares in excess of the Exchange Cap. As of March 31, 2023, our average trading price in 2023 was $0.46, without considering our average daily trading volumes and other market demand factors for our stock, we would be able to raise approximately
35

$14.0 million, net of issuance costs, under the Equity Purchase Agreement. As of March 31, 2023, we have sold 739,825 shares under the SEPA and there were 31,817,839 shares available to be sold to Yorkville under the Exchange Cap.

Management believes that currently available resources will provide sufficient funds to enable the Company to meet its obligations for at least one year past the date these condensed consolidated financial statements are available to be issued. We anticipate that we will continue to incur operating losses and generate negative cash flows from operations in the future as we continue to invest in advertising and other strategic incentives planned for future growth. Cash from operations could be affected by our customers and other risks detailed in the section of our titled “Risk Factors.” As a result, we will need additional capital resources to execute strategic initiatives and fund our operations, prior to achieving break even or positive operating cash flow. We expect to continue to opportunistically seek access to additional funds by utilizing the SEPA, through additional public or private equity offerings or debt financings, through partnering or other strategic arrangements, through the exercise of certain of our warrants, or a combination of the foregoing. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.

Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide, including the trading price of common stock. To the extent that we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution. Debt financing arrangements may require us to pledge certain assets or enter into covenants that could restrict our operations or our ability to pay dividends or other distributions on our common stock or incur further indebtedness. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. In addition, our Class A Common Stock trading price may not exceed the respective exercise prices of our Public Warrants, Private Placement Warrants, warrants granted to HGI (as defined below) and/or our Legacy Grove Warrants before the respective warrants expire, and therefore we may not receive any proceeds from the exercise of warrants to fund our operations. If we are unable to raise additional capital when desired, our business, results of operations, and financial condition would be materially and adversely affected.

Contractual Obligations and Other Commitments
Our most significant contractual obligations relate to our loan facilities, purchase commitments on inventory and operating lease obligations on our fulfillment centers and corporate offices. As of March 31, 2023, we had $15.3 million of enforceable and legally binding inventory purchase commitments predominantly due within one year. For information on our contractual obligations for operating leases, see “Leases” in Note 8 of the Notes to our audited consolidated financial statements as of and for the years ended December 31, 2022, 2021 and 2020 included in Form 10-K filed with the SEC on March 16, 2023.
Loan Facilities
Structural Debt Facility
In December 2022, we entered into a Loan and Security Agreement (“Structural Debt Facility”) with third-party lenders to borrow gross proceeds of $72.0 million which was used primarily to settle other outstanding obligations with a prior lender. The Structural Debt Facility bears an annual rate of interest at the greater of 15.00% or 7.50% plus the prime rate, payable monthly. The principal repayment period commences on July 1, 2025 and continues until the maturity date of December 21, 2026. The Company may prepay all outstanding amounts under this facility at any time. Under the agreement, when amounts are prepaid or repaid in full at the Maturity Date, the Company may be obligated to pay additional fees which would allow for the lenders to reach a Minimum Return.

The Structural Debt Facility is collateralized by the assets of the Company and includes financial covenants we must meet in order to avoid an Event of Default, as defined by the agreement. Such covenants include (i) maintaining a minimum of $57.0 million in unrestricted cash at all times and (ii) achieving certain revenue targets for the trailing four quarter period beginning with the fiscal quarter ending March 31, 2023. The Structural Debt Facility contains a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, Structural has been provided with the our periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. We believe the likelihood that lenders would exercise the subjective acceleration clause is remote. As of March 31, 2023, we were in compliance with these covenants.

Siena Revolver

36

On March 10, 2023, we entered into a Loan and Security Agreement (the “Siena Revolver”) with Siena Lending Group, LLC which permits us to receive funding through a revolving line of credit with an initial commitment of $35.0 million. The borrowing capacity under the Siena Revolver is subject to certain conditions, including our inventory and accounts receivable balances and other limitations as specified in the agreement. Total borrowing capacity from the Siena Revolver was $17.7 million as of March 31, 2023, of which there was an outstanding principal amount of $7.5 million

The interest rates applicable to borrowings under the Siena Revolver are based on a fluctuating rate of interest measured by reference to either, at our option, (i) a Base Rate, plus an applicable margin, or (ii) the Term SOFR rate then in effect, plus 0.10% and an applicable margin. The Base Rate is defined as the greatest of: (1) Prime Rate as published in the Wall Street Journal, (2) Federal Funds Rate plus 0.5% and (3) 5.0% per annum. The applicable margin for Siena Revolver borrowings is based on the Company’s monthly average principal balance outstanding and ranges from 2.75% to 4.50% per annum in the case of Base Rate Borrowings and 3.75% to 5.50% per annum in the case of Term SOFR borrowings. The Siena Revolver also contains various financial covenants we must maintain to avoid an Event of Default, as defined by the agreement, including a subjective acceleration clause in the event that Siena determines that a material adverse change has or will occur with the business. We believe the likelihood of Siena exercising the subjective acceleration clause is remote. In accordance with the agreement, Siena has been provided with the our periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Siena Revolver matures at the earlier of March 10, 2026 or the maturity date of the Structural Debt Facility. As of March 31, 2023, we were in compliance with all covenants related to the Siena Revolver.

Cash Flows
The following table summarizes our cash flows for the periods presented:
Three Months Ended March 31,
20232022
(in thousands)
Net cash used in operating activities$(6,737)$(29,503)
Net cash used in investing activities(784)(1,352)
Net cash provided by financing activities1,990 26,907 
Net decrease in cash, cash equivalents and restricted cash$(5,531)$(3,948)


Operating Activities
Net cash used in operating activities decreased by $22.8 million for the three months ended March 31, 2023 compared to March 31, 2022, primarily attributable to a decrease in net loss, net of noncash activities, of $33.3 million. This decrease in net loss, net of non-cash activities, was primarily driven by a decrease in advertising expenses of $24.1 million. This was offset by a decrease of inflow related to changes in net operating assets and liabilities of $10.5 million primarily driven by a decrease in accrued expenses and accounts payable due to timing of invoices from and payments to our vendors and suppliers.
Investing Activities
Net cash used in investing activities of $0.8 million and $1.4 million for the three months ended March 31, 2023 and 2022, respectively was due to purchases of property and equipment.
Financing Activities
Net cash provided by financing activities of $2.0 million for the three months ended March 31, 2023 primarily consisted of $7.5 million in proceeds from the Siena Revolver offset by the payment of transaction costs related to the Business Combination of $4.2 million and payment debt fees of $0.8 million.
Net cash provided by financing activities of $26.9 million for the three months ended March 31, 2022 primarily consisted of proceeds from issuance of contingently redeemable convertible common stock of $27.5 million partially offset by $0.5 million payment of deferred offering issuance costs.
37


Off-Balance Sheet Arrangements
We do not have any off-balance sheet financing arrangements, as defined in Item 303 of Regulation S-K, as of March 31, 2023.
Critical Accounting Estimates
There have been no significant changes to our critical accounting policies since December 31, 2022. For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our unaudited condensed consolidated financial statements, refer to Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in our Annual Report on Form 10-K.

Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. The Company evaluated, with the participation of the current chief executive officer and chief financial officer (the “Company’s Certifying Officers”), the effectiveness of the Company’s disclosure controls and procedures as of March 31, 2023, the end of the period covered by the Quarterly Report on Form 10-Q, pursuant to Rule 13a-15(b) under the Exchange Act. The Company’s Certifying Officers concluded that our disclosure controls and procedures were effective as of March 31, 2023.

(b) Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the three months ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Limitations on the Effectiveness of Controls
The Company does not expect that its disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure
38

controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
39

Part II - Other Information
Item 1. Legal Proceedings
From time to time, we are subject to various claims, charges and litigation matters that arise in the ordinary course of business. We believe these actions are a normal incident of the nature and kind of business in which we are engaged. While it is not feasible to predict the outcome of these matters with certainty, we do not believe that any asserted or unasserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations or prospects.
As noted in “Part I - Item 1A - Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission on March 16, 2023, the Consumer Protection Division of the Santa Clara County District Attorney’s Office, in conjunction with other county and city prosecutors, is currently investigating our automatic renewal practices, and the Federal Trade Commission is currently investigating our billing and automatic renewal practices. As of the date of this filing, no legal proceeding has commenced regarding these investigations.
Item 1A. Risk Factors
There have been no material changes to our risk factors that we believe are material to our business, results of operations and financial condition from the risk factors previously disclosed in our Annual Report on Form 10-K filed with the SEC on March 16, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information

None
Item 6. Exhibits
(a) Exhibits.
Exhibit
Number
Description
2.1†
2.2†
3.1
40

Exhibit
Number
Description
3.2
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
4.10
4.11
4.12
4.13
10.32*+
10.33
10.34*††
31.1*
41

Exhibit
Number
Description
31.2*
32.1*
101.INS*Inline Instance Document.
101.SCHInline Taxonomy Extension Schema Document.
101.CAL*Inline Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline Taxonomy Extension Label Linkbase Document.
101.PRE*Inline Taxonomy Extension Presentation Linkbase Document.
104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*    Filed herewith.
+    Indicates management contract or compensatory plan or arrangement.
†    Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule of exhibit to the SEC upon request.
††    The Registrant has redacted provisions or terms of this Exhibit pursuant to Regulation S-K Item 601(b)(10)(iv). The Registrant agrees to furnish an unredacted copy of the Exhibit to the SEC upon its request.
42

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 11, 2023
GROVE COLLABORATIVE HOLDINGS, INC.
By:/s/ Sergio Cervantes
Name:Sergio Cervantes
Title:Chief Financial Officer

43
EX-10.32 2 exhibit1032groveformofperf.htm FORM OF PERFORMANCE CASH AWARD Document
Exhibit 10.32
GROVE COLLABORATIVE HOLDINGS, INC.
2022 Equity and Incentive Plan
Performance Cash Award Notice
[HOLDER]
You have been awarded a performance cash award (the “Award”) by Grove Collaborative Holdings, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Grove Collaborative Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) and the Performance Cash Award Agreement (together with this Award Notice, the “Agreement”). Capitalized terms not defined herein shall have the meanings specified in the Plan or the Agreement.
Performance Cash Award:    [AWARD AMOUNT]
Performance Period:        [DATE RANGE]
Performance Goals:    [PERFORMANCE GOALS]
Negative Discretion:    Notwithstanding the foregoing, the Committee reserves the right to reduce or eliminate the payout for any factors deemed relevant by the Committee, in its sole discretion.


                    GROVE COLLABORATIVE HOLDINGS, INC.



                    By:    ______________________________
Name:
Title:







Acknowledgment, Acceptance and Agreement
:
By signing below and returning this Award Notice to Grove Collaborative Holdings, Inc., I hereby acknowledge receipt of the Agreement and the Plan, accept the Award granted to me and agree to be bound by the terms and conditions of this Award Notice, the Agreement and the Plan.

______________________________
Holder                

______________________________
Date

Signature Page to Performance Cash Award Agreement





GROVE COLLABORATIVE HOLDINGS, INC.
2022 Equity and Incentive Plan


Performance Cash Award Agreement
Grove Collaborative Holdings, Inc., a Delaware corporation (the “Company”), hereby grants to the individual (the “Holder”) named in the award notice attached hereto (the “Award Notice”) as of the date set forth in the Award Notice (the “Grant Date”), pursuant to the provisions of the Grove Collaborative Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”), a performance cash award (the “Award”) pursuant to Section 4.1 of the Plan for the target amount set forth in the Award Notice, upon and subject to the restrictions, terms and conditions set forth in the Plan, the Award Notice and this agreement (the “Agreement”). Capitalized terms not defined herein shall have the meanings specified in the Plan.
1.Award Subject to Acceptance of Agreement. The Award shall be null and void unless the Holder accepts this Agreement by executing the Award Notice in the space provided therefor and returning an original execution copy of the Award Notice to the Company.
2.Earned Award and Termination of Employment.
2.1 Earned Award. The Award shall only be earned to the extent the Holder remains employed through the settlement of the Award pursuant to Section 3.4.

2.2    Termination of Employment. In the event the employment of the Holder is terminated for any reason prior to the date on which the Award is settled pursuant to Section 3.4, then the Holder’s Award shall be immediately forfeited by the Holder upon such termination of employment.

     2.3     Change in Control. Upon a Change in Control, the Holder shall be entitled to receive a pro-rata portion of the Award, determined assuming target performance and pro-rated based on the number of days of service during the Performance Period set forth in the Award Agreement and prior to the Change in Control divided by 365 and subject to the Holder’s continuous employment through the consummation of the Change in Control, as determined by the Committee.

3.Additional Terms and Conditions of Award.
3.1.Award Confers No Rights to Continued Service. In no event shall the granting of the Award or its acceptance by the Holder, or any provision of the Agreement or the Plan, give or be deemed to give the Holder any right to continued service with the Company, any Subsidiary or any affiliate of the Company.
3.2.Decisions of Board or Committee. The Board or the Committee shall have the right to resolve all questions which may arise in connection with the Award. Any interpretation, determination or other action made or taken by the Board or the Committee regarding the Plan or this Agreement shall be final, binding and conclusive.
3.3.Successors. This Agreement shall be binding upon and inure to the benefit of any successor or successors of the Company and any person or persons who shall, upon the death of the Holder, acquire any rights hereunder in accordance with this Agreement or the Plan.




3.4.Payment of Award. Subject to Section 3.5 hereof, as soon as practicable after the conclusion of the Performance Period (or, if earlier, the Change in Control), the Company shall pay the Award to the Holder, as determined in accordance with the Award Notice and this Agreement; provided that (i) the Holder has remained continuously employed by the Company or any of its Subsidiaries or affiliates through the date on which the Award is settled pursuant to this Section 3.4 and (ii) such payment shall be made no later than March 15th following the conclusion of the Performance Period or, in the case of a Change in Control, no later than 60 days following the occurrence of the Change in Control. Notwithstanding any other provision of this Agreement to the contrary, no payment shall occur unless and until the Committee has certified that the applicable Performance Goals have been satisfied.
3.4.1     Proration of Payment. The Company reserves the right to prorate payment of the Award for the portion of any leave of absence or combined leaves of absence that exceeds sixteen (16) weeks during the Performance Period.

3.5.Taxation. The Holder understands that the Holder is solely responsible for all tax consequences to the Holder in connection with this Award. The Company will have the power and the right to deduct or withhold, or require the Holder or the Holder’s beneficiary to remit to the Company, an amount sufficient to satisfy any income or other withholding taxes with respect to any taxable event arising as a result of this Agreement.
3.6.Clawback Provision. The Holder agrees that the Company shall have the right to require the Holder to repay the value of the Award received by the Holder pursuant to this Agreement, as may be required by law (including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder) or as a result of: (i) a financial restatement if the value of the Award received was predicated upon achieving certain performance goals that were subsequently the subject of such financial restatement; and (ii) a lower Award would have been paid based on the restated results. This Section 3.6 shall survive the termination of the Holder’s employment for any reason. The foregoing remedy is in addition to and separate from any other relief available to the Company due to the Holder’s misconduct or fraud. Any determination by the Committee with respect to the foregoing shall be final, conclusive and binding upon the Holder and all persons claiming through the Holder.
3.7.Notices. All notices, requests or other communications provided for in this Agreement shall be made, if to the Company, to Grove Collaborative Holdings, Inc., Attn: General Counsel, 1301 Sansome Street, San Francisco, CA 94111, and if to the Holder, to the last known mailing address of the Holder contained in the records of the Company. All notices, requests or other communications provided for in this Agreement shall be made in writing either (a) by personal delivery, (b) by facsimile or electronic mail with confirmation of receipt, (c) by mailing in the United States mails or (d) by express courier service. The notice, request or other communication shall be deemed to be received upon personal delivery, upon confirmation of receipt of facsimile or electronic mail transmission or upon receipt by the party entitled thereto if by United States mail or express courier service; provided, however, that if a notice, request or other communication sent to the Company is not received during regular business hours, it shall be deemed to be received on the next succeeding business day of the Company.
3.8.Governing Law. This Agreement, the Award and all determinations made and actions taken pursuant hereto and thereto, to the extent not governed by the laws of the United States, shall be governed by the laws of the State of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws.
    2



3.9.Section 409A. This Agreement is intended to be exempt from Section 409A of the Code.
3.10.Agreement Subject to the Plan. This Agreement is subject to the provisions of the Plan and shall be interpreted in accordance therewith. In the event that the provisions of this Agreement and the Plan conflict, the Plan shall control. The Holder hereby acknowledges receipt of a copy of the Plan.
3.11.Entire Agreement. This Agreement, the Award Notice and the Plan constitute the entire agreement of the parties with respect to the Award and supersede in their entirety all prior undertakings and agreements of the Company and the Holder with respect to the Award, and may not be modified adversely to the Holder’s interest except by means of a writing signed by the Company and the Holder.
3.12.Partial Invalidity. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof and this Agreement shall be construed in all respects as if such invalid or unenforceable provision was omitted.
3.13.Amendment and Waiver. The provisions of this Agreement may be amended or waived only by the written agreement of the Company and the Holder, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding effect or enforceability of this Agreement.
3.14.Counterparts. The Award Notice may be executed in two counterparts, each of which shall be deemed an original and both of which together shall constitute one and the same instrument.


    3

EX-10.34 3 exhibit1034structural-amen.htm AMENDMENT NO. 1 TO LSA Document


Exhibit 10.34
AMENDMENT NO. 1 TO
LOAN AND SECURITY AGREEMENT


This Amendment No. 1 to Loan and Security Agreement (“Amendment No. 1”) is made effective as of March 10, 2023 (the “Amendment Date”) by and among Structural Capital Investments III, LP, Structural Capital Investments IV, LP, Avenue Sustainable Solutions Fund, L.P., and Series PCI Grove series of Structural Capital Primary Co-Investment Fund, LLC (collectively, together with any other party now or hereafter a lender hereunder, “Lenders” and each a “Lender”), Ocean II PLO LLC, a California limited liability company, as administrative and collateral agent for Lenders (“Agent”), Grove Collaborative Holdings, Inc., a Delaware public benefit corporation (“Holdings”), and Grove Collaborative, Inc., a Delaware public benefit corporation (“Grove”, and together with Holdings, each a “Borrower” and together, “Borrowers”).

Recitals

WHEREAS, on December 21, 2022, Borrowers, Lenders and Agent entered into that certain Loan and Security Agreement, which together with all exhibits, schedules, documents and agreement attached thereto and required thereby is referred to herein as the “Loan Agreement”; and

WHEREAS, Borrowers, Agent and Lenders desire to modify and amend of certain of the terms and conditions of the Loan Documents as set forth in this Amendment No. 1.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and without limiting or amending any other provisions of the Loan Agreement, the parties hereby agree to modify the Loan Agreement and to perform such other covenants and conditions as follows:

I.Amendments to Loan Agreement.

(a)Exhibit A. Exhibit A to the Loan Agreement is hereby amended to revise clause (f) of the definition of Excluded Assets to read in its entirety as follows:

“(f) rights in respect of directors and officer’s liability insurance and similar insurance; and”

(b)Section 6.8. Section 6.8 (c), subclause (b) of the Loan Agreement is hereby amended to read in its entirety as follows:

“(b) after the occurrence and during the continuance of an Event of Default, all proceeds payable under any such casualty policy or under any business interruption policy (other than on account of Approved ABL Collateral) shall, at the option of Agent, be payable to the Lenders on account of the Obligations.”

(c)Section 9.5. For purposes of clause (c) of Section 9.5 of the Loan Agreement, business interruption insurance shall be deemed to be discussed in Section 6.8 of the Loan Agreement.

II.Conditions Precedent to the Effectiveness to Amendment No. 1.
The effectiveness of this Amendment No. 1 is subject to the fulfillment of each and every of the following conditions precedent in form and substance satisfactory to the Agent in its sole discretion:

(a)This Amendment No. 1 shall have been duly executed and delivered by Borrowers.

(b)Borrowers shall pay all Lender’s Expenses for the preparation and negotiation of this Amendment No. 1 (including without limitation all reasonable attorneys’ fees) in the amount of $5,000.

(c)Such other documents, and completion of such other matters, as Agent may deem necessary or appropriate.

1
Grove Amendment No. 1



Exhibit 10.34


III.Additional and Terms and Conditions.

(a)Representations and Warranties of Borrowers. Borrowers represent, warrant and covenant to Agent and Lenders as of the date hereof as follows:

(i)This Amendment No. 1 has been duly executed and delivered by the Borrowers and each applicable Loan Party and constitutes legal, valid and binding obligations of the applicable Loan Party, enforceable in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws of general application relating to or affecting the enforcement of creditors’ rights or by general principal of equity.

(ii)The execution, delivery and performance by Borrowers of this Amendment No. 1 and any other agreements or instruments required hereunder (x) have been duly authorized, and are not in conflict with nor constitute a breach of any provision of the Borrowers’ organizational documents and (y) do not (1) require any authorization, consent or approval by any Governmental Authority, in each case other than has already been obtained or given will have been obtained or given prior to the time when required, (2) conflict with or result in a breach of any law or regulation, order, writ, injunction or decree of any court or Governmental Authority, except where such conflict or resulting breach would not reasonably be expected to cause a Material Adverse Effect, or
(3) require the approval, authorization or consent of any trustee or holder of any indebtedness or obligation of Borrowers or of any other Person under any material agreement, contract, lease or license or similar document or instrument to which any Loan Party is a party or by which any Loan Party is bound.

(b)No Waiver. No course of dealing on the part of Agent or any Lender or any employees, officers or directors of any of the foregoing, nor any failure or delay in the exercise of any right by Agent or any Lender, shall operate as a waiver thereof, and any single or partial exercise of any such right shall not preclude any later exercise of any such right. Any failure of Agent or of any Lender at any time to require strict performance by Borrowers of any provision shall not affect any right of Agent or Lenders thereafter to demand strict compliance and performance. Any suspension or waiver of a right must be in writing signed by an officer of Agent.

(c)Delivery of Business Interruption Insurance. Within thirty (30) days of the date of Amendment No. 1 (or such later date agreed by Agent in writing), Borrowers shall deliver policies of business interruption insurance containing a lender’s loss payable endorsement, in a form reasonably satisfactory to Agent, showing Agent for itself and the benefit of the Lenders as an additional loss payee thereof, and shall specify that the insurer must give at least thirty (30) days’ notice to Agent before canceling its policy for any reason (except for nonpayment, which shall be ten (10) days prior notice). Each Borrower shall promptly deliver to Agent, upon its request, its current copy of such policies of insurance, evidence of the payments of all premiums therefor and insurance certificates and, subject to the first sentence of this Section (d) related endorsements thereto, it being understood that any time there is a change or renewal of such insurance, it is such Borrower’s obligation to promptly deliver such materials to Agent. Failure at any time to timely perform any or all of the covenants in this Section (d), shall be an Event of Default under Section
8.3 of the Loan Agreement.

IV.Integration Clause.

The Loan Agreement, as amended by this is Amendment No. 1, and each of the other Loan Documents dated as amended, taken together constitute and contain the entire agreement among Borrowers, Agent and Lender and supersede any and all prior agreements, negotiations, correspondence, understandings and communications between the parties, whether written or oral, respecting the subject matter hereof. NONE OF THE LOAN AGREEMENT OR THIS AMENDMENT NO. 1 MAY BE MODIFIED EXCEPT BY A WRITING SIGNED BY THE AGENT, THE REQUIRED LENDERS AND BORROWER IN ACCORDANCE WITH THE LOAN AGREEMENT. Each provision
hereof shall be severable from every other provision when determining its legal enforceability under this Amendment No. 1 and the Loan Agreement, as amended by this Amendment No. 1, may be enforced to the maximum extent permitted under applicable law. This Amendment No. 1 shall be binding upon, and inure to the benefit of, each party’s respective

2
Grove Amendment No. 1



Exhibit 10.34

permitted successors and assigns. This Amendment No. 1 may be executed in counterpart originals, all of which, when taken together, shall constitute one and the same original document. In the event of any contradiction or inconsistency among the terms and conditions of this Amendment No. 1 or the Loan Agreement the terms and conditions of this Amendment No. 1 shall prevail.

V.Notice Provisions.

Agent hereby notifies Borrowers that Agent’s information for Notices under Section 11.1 of the Loan Agreement is hereby updated as follows:

Ocean II PLO LLC
800 Menlo Avenue, Suite 210 Menlo Park, CA 94025
Attn: Kai Tse
EMAIL: [*****]

VI.Miscellaneous.

Unless otherwise defined, all initially capitalized terms in this Amendment No. 1 shall be as defined in the Loan Agreement. The Loan Agreement, as amended hereby, shall be and remain in full force and effect in accordance with its respective terms and hereby is ratified and confirmed in all respects. Except as expressly set forth herein, the execution, delivery, and performance of this Amendment No. 1 shall not operate as a waiver of, or as an amendment of, any right, power, or remedy of Agent or any Lender under the Loan Agreement, as in effect prior to the date hereof. Except as amended hereby, the Loan Agreement remains unmodified and unchanged. This Amendment No. 1 may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument. This Amendment No. 1 and any amendments or waivers hereto, to the extent signed and delivered by means of facsimile, photocopy, scan by e-mail delivery of a “.pdf” format data file, or any electronic signature valid under the Electronic Signatures in Global and National Commerce Act, 15 U.S.C. § 7001, et. seq such as DocuSign shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto or to any such agreement or instrument shall raise the use of signature delivered or provided in that manner as a defense to the formation of a contract and each party hereto forever waives any such defense.


[Remainder of the page intentionally left blank. Signature page to follow.]
3
Grove Amendment No. 1


In Witness Whereof, the parties hereto have caused this Amendment No. 1 to be executed as of the date first above written.
BORROWERS:

Grove Collaborative Holdings, Inc.,
a Delaware public benefit corporation

By:    /s/ Stuart Landesberg    
Name: Stuart Landesberg
Title: Chief Executive Officer and President


Grove Collaborative, Inc.,
a Delaware public benefit corporation

By:    /s/ Stuart Landesberg    
Name: Stuart Landesberg
Title: Chief Executive Officer and President

Grove Amendment No. 1



In Witness Whereof, the parties hereto have caused this Amendment No. 1 to be executed as of the date first above written.


LENDERS:


STRUCTURAL CAPITAL INVESTMENTS III, LP
a Delaware limited partnership

By:    Structural Capital GP III, LLC,
a Delaware limited liability company, its General Partner


By: /s/ Kai Tse    
Name: Kai Tse
Title: Managing Member


STRUCTURAL CAPITAL INVESTMENTS IV, LP,
a Delaware limited partnership

By:    Structural Capital GP IV, LLC
a Delaware limited liability company its General Partner


By: /s/ Kai Tse    
Name: Kai Tse
Title: Managing Member


SERIES PCI GROVE, A SERIES OF STRUCTURAL CAPITAL PRIMARY CO-INVESTMENT FUND, LLC,
a Delaware series limited liability company

By:    Structural Capital GP III, LLC,
a Delaware limited liability company, its Manager


By: /s/ Kai Tse    
Name: Kai Tse
Title: Managing Member

Grove Amendment No. 1





LENDERS (CONT):


AVENUE SUSTAINABLE SOLUTIONS FUND, L.P.,
a Delaware limited partnership

By:    Avenue Sustainable Solutions Partners, LLC, its General Partner

By:    GL Sustainable Solutions Partners, LLC, its Managing Member


By: /s/ Sonia Gardner    
Name: Sonia Gardner
Title: Member

Grove Amendment No. 1



In Witness Whereof, the parties hereto have caused this Amendment No. 1 to be executed as of the date first above written.

AGENT:

OCEAN II PLO LLC,
a California limited liability company

By: Structural Capital Management Company II, LP,
a Delaware limited partnership, its Manager

By:    Structural Capital GP, LLC,
a Delaware limited liability company, its General Partner


By: /s/ Kai Tse    
Name: Kai Tse
Title:    Managing Member
Grove Amendment No. 1
EX-31.1 4 exhibit311q12023.htm EX-31.1 Document

Exhibit 31.1

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stuart Landesberg, certify that:

1.     I have reviewed this Quarterly Report on Form 10-Q of Grove Collaborative Holdings, Inc.;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.     The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: May 11, 2023
By:/s/ Stuart Landesberg
Stuart Landesberg
Chief Executive Officer


EX-31.2 5 exhibit312q12023.htm EX-31.2 Document

Exhibit 31.2

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Sergio Cervantes, certify that:

1.     I have reviewed this Quarterly Report on Form 10-Q of Grove Collaborative Holdings, Inc.;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.     The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date: May 11, 2023
By:/s/ Sergio Cervantes
Sergio Cervantes
Chief Financial Officer


EX-32.1 6 exhibit321q12023.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Grove Collaborative Holdings, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stuart Landesberg, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.     The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 11, 2023
By:/s/ Stuart Landesberg
Stuart Landesberg
Chief Executive Officer
In connection with the Quarterly Report of Grove Collaborative Holdings, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sergio Cervantes, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.     The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 11, 2023
By:/s/ Sergio Cervantes
Sergio Cervantes
Chief Financial Officer




EX-101.SCH 7 grov-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheets - Parenthetical link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - Parenthetical link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Common Stock and Warrants link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Net loss Per Share Attributable to Common Stockholders link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Debt and Convertible Preferred Stock and Common Stock Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Common Stock and Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Net loss Per Share Attributable to Common Stockholders (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Common Stock and Warrants - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Common Stock and Warrants - Schedule of Warrants Oustanding (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Common Stock and Warrants - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Common Stock and Warrants - Schedule of Reserved for Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Net loss Per Share Attributable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 grov-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 grov-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 grov-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Sale of stock, exchange cap, percentage of shares outstanding Sale Of Stock, Exchange Cap, Percentage Of Shares Outstanding Sale Of Stock, Exchange Cap, Percentage Of Shares Outstanding Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Long-term debt, gross Long-Term Debt, Gross Additional Share Additional Share [Member] Additional Share Entity Address, Postal Zip Code Entity Address, Postal Zip Code Reverse Recapitalization Tranche [Axis] Reverse Recapitalization Tranche [Axis] Reverse Recapitalization Tranche Proceeds from issuance of contingently redeemable convertible common stock Proceeds from Issuance of Redeemable Convertible Common Stock Proceeds from Issuance of Redeemable Convertible Common Stock Reverse Recapitalization Tranche [Domain] Reverse Recapitalization Tranche [Domain] Reverse Recapitalization Tranche [Domain] Common stock warrant, shares reserved for future issuance (in shares) Common Stock Warrant, Shares Reserved for Future Issuance Common Stock Warrant, Shares Reserved for Future Issuance Debt Instrument [Axis] Debt Instrument [Axis] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Remeasurement of convertible preferred stock warrant liability Adjustment of Convertible Preferred Stock Warrant Liability Adjustment of Convertible Preferred Stock Warrant Liability Additional paid-in capital Additional Paid in Capital Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Statistical Measurement [Domain] Statistical Measurement [Domain] Issuance of common stock upon exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Payment Arrangement [Abstract] Five Suppliers Five Suppliers [Member] Five Suppliers HGI Subscription Agreement HGI Subscription Agreement [Member] HGI Subscription Agreement Sale Of Stock, Measurement Period Three Sale Of Stock, Measurement Period Three [Member] Sale Of Stock, Measurement Period Three Temporary equity, shares outstanding (in shares) Temporary equity, balances at beginning of period (in shares) Temporary equity, balances at ending of period (in shares) Temporary Equity, Shares Outstanding Net loss Net loss Net Income (Loss) Attributable to Parent Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cancellation of Earn-Out Shares Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Cancellations Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Cancellations Subsequent Event Type [Axis] Subsequent Event Type [Axis] HGI Warrants HGI Warrants [Member] HGI Warrants Changes in fair value Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Private and Public Placement Warrants Private and Public Placement Warrants [Member] Private and Public Placement Warrants Reverse recapitalization, percentage of voting interests acquired Reverse Recapitalization, Percentage of Voting Interests Acquired Reverse Recapitalization, Percentage of Voting Interests Acquired Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Scenario [Axis] Scenario [Axis] Vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Earn-Out Shares Earn-Out Share [Member] Earn-Out Share Fair Value Measurement Fair Value Measurement, Policy [Policy Text Block] Plan Name [Axis] Plan Name [Axis] Unvested Warrant Unvested Warrant [Member] Unvested Warrant Agreement [Domain] Agreement [Domain] Agreement [Domain] Siena Lending Group, LLC Siena Lending Group, LLC [Member] Siena Lending Group, LLC Standby Letters of Credit Standby Letters of Credit [Member] Supplemental Disclosure Supplemental Cash Flow Information [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Reverse recapitalization, transaction costs Reverse Recapitalization, Transaction Costs Reverse Recapitalization, Transaction Costs Plan Name [Domain] Plan Name [Domain] Contingently issuable shares, calculation, maximum denominator Contingently Issuable Shares, Calculation, Maximum Denominator Contingently Issuable Shares, Calculation, Maximum Denominator Statement of Cash Flows [Abstract] Long-term line of credit Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Day Period Reverse Recapitalization, Contingent Consideration, Liability, Earnout Period, Threshold Trading Day Period Line of credit facility, additional borrowing capacity Line Of Credit Facility, Additional Borrowing Capacity Line Of Credit Facility, Additional Borrowing Capacity Employee Stock Employee Stock [Member] Options, outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Warrant, exercise price, increase, percentage Class Of Warrant Or Right, Exercise Price, Increase, Percentage Class Of Warrant Or Right, Exercise Price, Increase, Percentage Award Type [Axis] Award Type [Axis] Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Other non-cash expenses Other Noncash Expense Operating lease liabilities, current Operating Lease, Liability, Current Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Deferred Revenue Deferred Revenue [Member] Deferred Revenue Debt, noncurrent Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Document Type Document Type Debt instrument, anniversary of closing date Debt Instrument, Anniversary Of Closing Date Debt Instrument, Anniversary Of Closing Date Weighted–Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Share-based compensation arrangement by share-based payment award, options, grant date, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value Cancelled/forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Transaction costs Transaction Costs, Current Transaction Costs, Current Outstanding and unvested, beginning of period (in dollars per share) Outstanding and unvested, ending of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Debt Disclosure [Text Block] Stock-Based Compensation Compensation and Employee Benefit Plans [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Class B Common Stock Common Class B [Member] Accrued expenses Increase (Decrease) in Accrued Liabilities Tranche [Axis] Tranche [Axis] Tranche Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation Subsequent Event Subsequent Event [Member] Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Proceeds from exercise of stock options and settlement of restricted stock units, net of withholding taxes paid related to common stock issued to employees Proceeds From Issuance of Shares (Payments Of Tax Withholding) Share-Based Payment Arrangement Proceeds From Issuance of Shares (Payments Of Tax Withholding) Share-Based Payment Arrangement Private placement warrant, shares reserved for future issuance (in shares) Private Placement Warrant, Shares Reserved for Future Issuance Private Placement Warrant, Shares Reserved for Future Issuance Advertising costs Accrued Advertising, Current Convertible Preferred Stock Convertible preferred stock Convertible Preferred Stock [Member] Total assets Assets Debt Disclosure [Abstract] Earnings Per Share [Abstract] Sales taxes Sales and Excise Tax Payable, Current Additional Shares Additional Shares [Member] Additional Shares Antidilutive Securities [Axis] Antidilutive Securities [Axis] Change in fair value of Structural Derivative liability Change in fair value of structural derivative liability Fair Value Adjustment Of Derivative Instrument Fair Value Adjustment Of Derivative Instrument Debt instrument, covenant, minimum unrestricted cash required to maintain Debt Instrument, Covenant, Minimum Unrestricted Cash Required To Maintain Debt Instrument, Covenant, Minimum Unrestricted Cash Required To Maintain Accrued expenses Accrued expenses Accrued Liabilities, Current Debt, current Debt, current Long-Term Debt, Current Maturities Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Stockholders’ equity: Stockholders' Equity Note [Abstract] Market-based Stock Options Market-based Stock Options [Member] Market-based Stock Options Tranche Four Tranche Four [Member] Tranche Four Compensation and benefits Employee-related Liabilities, Current Line of Credit Line of Credit [Member] Preferred stock, $0.0001 par value - 100,000,000 shares authorized at March 31, 2023 and December 31, 2022; no shares outstanding at March 31, 2023 and December 31, 2022 Temporary equity, balances at beginning of period Temporary equity, balances at ending of period Temporary Equity, Carrying Amount, Attributable to Parent Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Net loss Per Share Attributable to Common Stockholders Earnings Per Share [Text Block] Customer [Axis] Customer [Axis] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Share-based compensation arrangement by share-based payment award, options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Award Type [Domain] Award Type [Domain] Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Public Warrants Public Warrant [Member] Public Warrant Derivative Contract [Domain] Derivative Contract [Domain] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name Number of shares issued Stock Issued During Period, Shares, New Issues Temporary equity, shares authorized (in shares) Temporary Equity, Shares Authorized Subsequent Events Subsequent Events [Text Block] Supplier Concentration Risk Supplier Concentration Risk [Member] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Fulfillment costs Accrued Fulfillment Costs, Current Accrued Fulfillment Costs, Current Entity Address, City or Town Entity Address, City or Town Atel Loan Facility Atel Loan Facility [Member] Atel Loan Facility Sale of stock, covenant, volume weighted average price threshold (in dollars per share) Sale Of Stock, Covenant, Volume Weighted Average Price Threshold Sale Of Stock, Covenant, Volume Weighted Average Price Threshold Operating Expenses [Abstract] Operating Expenses [Abstract] Contingently Redeemable Convertible Common Stock Contingently Redeemable Convertible Common Stock [Member] Contingently Redeemable Convertible Common Stock Minimum Minimum [Member] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Inventory reserve Inventory Write-down Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements and Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Share price (in dollars per share) Share Price Trading Symbol Trading Symbol Entity File Number Entity File Number Shares subject to repurchase Shares Subject to Repurchase [Member] Shares Subject to Repurchase Backstop warrant, shares reserved for future issuance (in shares) Backstop Warrant, Shares Reserved for Future Issuance Backstop Warrant, Shares Reserved for Future Issuance Payment of transaction costs related to the Business Combination Payment Of Transaction Costs, Reverse Recapitalization Payment Of Transaction Costs, Reverse Recapitalization Customer complementary membership period Revenue From Contract With Customer, Complementary, Membership Period Revenue From Contract With Customer, Complementary, Membership Period Product development Research and Development Expense Options vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Restricted cash Restricted Cash and Cash Equivalents Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock units Restricted Stock Units (RSUs) [Member] Entity Information [Line Items] Entity Information [Line Items] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Class of warrants or rights warrants issued during period (in shares) Class of Warrants or Rights Warrants Issued During Period Class of Warrants or Rights Warrants Issued During Period Cash equivalents: Cash and Cash Equivalents, Fair Value Disclosure Accounts payable Increase (Decrease) in Accounts Payable Class of warrants redemption notice period Class of Warrants Redemption Notice Period Class of Warrants Redemption Notice Period Balance at December 31, 2022 Balance at March 31, 2023 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Prime Rate Prime Rate [Member] Concentration risk, percentage Concentration Risk, Percentage Subsequent Events [Abstract] Corvina Holdings Limited Corvina Holdings Limited [Member] Corvina Holdings Limited Cancellation of Earn-Out Shares (in shares) Cancellation of earn-out shares (in shares) Shares Issued, Shares, Derivative Instrument, Contingent Consideration, Canceled Shares Issued, Shares, Derivative Instrument, Contingent Consideration, Canceled Credit Facility [Domain] Credit Facility [Domain] Outstanding stock option, shares reserved for future issuance (in shares) Outstanding Stock Option, Shares Reserved for Future Issuance Outstanding Stock Option, Shares Reserved for Future Issuance Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Net loss per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Basic Class of warrant or right redemption threshold consecutive trading days Class of Warrant or Right Redemption Threshold Consecutive Trading Days Class of Warrant or Right Redemption Threshold Consecutive Trading Days Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares) Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance Total stockholders’ equity Balances at beginning of period Balances at ending of period Stockholders' Equity Attributable to Parent Cancelled/forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Interactive Data Current Entity Interactive Data Current Siena Revolver Siena Revolver [Member] Siena Revolver Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Issuance of common stock upon settlement of restricted stock units, net of tax withholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Money market funds Money Market Funds [Member] Accumulated Deficit Retained Earnings [Member] Warrant shares, shares vesting rights, percentage Class Of Warrant Or Right, Vested Percent Warrant Shares, Shares Vesting Rights, Percentage Common Stock Common Stock [Member] Vested Warrants Vested Warrants [Member] Vested Warrants Convertible preferred stock warrants Convertible Preferred Stock Warrants [Member] Convertible Preferred Stock Warrants Class of Stock [Axis] Class of Stock [Axis] Transaction and contingently redeemable convertible common stock issuance costs in accounts payable and accrued liabilities Transaction Costs Incurred but Not yet Paid Transaction Costs Incurred but Not yet Paid Statement [Table] Statement [Table] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Debt instrument, interest rate, effective percentage Debt Instrument, Interest Rate, Effective Percentage Schedule of Performance-based Restricted Stock Units Activity Schedule of Nonvested Performance-Based Units Activity [Table Text Block] Operating lease, renewal term Lessee, Operating Lease, Renewal Term Document Quarterly Report Document Quarterly Report Reverse recapitalization, contingent consideration, liability (in shares) Reverse Recapitalization, Contingent Consideration, Shares Reverse Recapitalization, Contingent Consideration, Shares Temporary equity, shares issued (in shares) Temporary Equity, Shares Issued Current assets: Assets, Current [Abstract] Class of warrants or rights redemption price per unit (in dollars per share) Class of Warrants or Rights Redemption Price Per Unit Class of Warrants or Rights Redemption Price Per Unit Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Temporary equity, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Statistical Measurement [Axis] Statistical Measurement [Axis] Purchase agreement, equity interests issuable, not yet issued, transaction period Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period Tranche Three Tranche Three [Member] Tranche Three Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Number of shares purchased Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award Reduction in transaction costs Reduction in transaction costs allocated to equity instruments Increase to additional paid in capital due to reduction of transaction costs Adjustments To Additional Paid In Capital, Reduction Of Transaction Costs Adjustments To Additional Paid In Capital, Reduction Of Transaction Costs Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] Private Placement Warrants Private Placement Warrant [Member] Private Placement Warrant Fair Value, Recurring Fair Value, Recurring [Member] Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Sale Of Stock, Measurement Period [Domain] Sale Of Stock, Measurement Period [Domain] Sale Of Stock, Measurement Period [Domain] Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Outstanding and unvested, beginning of period (in shares) Outstanding and unvested, ending of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Interest and other expense (income), net Nonoperating Income (Expense) Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative Selling, General and Administrative Expense Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Purchase agreement, equity interests issuable, not yet issued Purchase Agreement, Equity Interests Issuable, Not Yet Issued Purchase Agreement, Equity Interests Issuable, Not Yet Issued Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Document Transition Report Document Transition Report Local Phone Number Local Phone Number Federal Funds Rate Federal Funds Rate [Member] Federal Funds Rate Share-Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating loss Operating Income (Loss) Inventory Increase (Decrease) in Inventories Shipping and Handling Shipping and Handling [Member] Sale of stock, number of shares available in transaction (in shares) Sale of Stock, Number of Shares Available In Transaction Sale of Stock, Number of Shares Available In Transaction Debt instrument, unamortized discount (premium), net Debt Instrument, Unamortized Discount (Premium), Net Prepaids and other assets Increase (Decrease) in Prepaid Expense and Other Assets Common stock, shares outstanding (in shares) Balances at beginning of period (in shares) Balances at ending of period (in shares) Common Stock, Shares, Outstanding Other Current Liabilities Other Current Liabilities [Member] Atel Loan Facility Draw 4 Atel Loan Facility Tranche Four [Member] Atel Loan Facility Tranche Four Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Warrants issued (in shares) Class Of Warrant Or Right, Issued Class Of Warrant Or Right, Issued Provision for income taxes Income Tax Expense (Benefit) Number of warrant or right, entitles to purchase (in shares) Number of Warrant or Right, Entitles to Purchase Number of Warrant or Right, Entitles to Purchase Operating lease, liability, undiscounted annual amount Lessee, Operating Lease, Liability, Undiscounted Annual Amount Lessee, Operating Lease, Liability, Undiscounted Annual Amount Sale of stock, covenant, volume weighted average price threshold, trading period Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Trading Period Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Trading Period Income Statement [Abstract] Income Statement [Abstract] Share-based compensation arrangement by share-based payment award, options, grants in period, gross Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross HGI Subscription Agreement, Additional Shares HGI Subscription Agreement, Additional Shares [Member] HGI Subscription Agreement, Additional Shares Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Restricted cash Restricted Cash, Noncurrent Cost of goods sold Cost of Goods and Services Sold Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Debt issuance costs, gross Debt Issuance Costs, Gross Base Rate Base Rate [Member] Public warrant, shares reserved for future issuance (in shares) Public Warrant, Shares Reserved for Future Issuance Public Warrant, Shares Reserved for Future Issuance Common stock - $0.0001 par value – 600,000,000 Class A shares authorized at March 31, 2023 and December 31, 2022; 128,870,368 and 125,617,015 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively; 200,000,000 Class B shares authorized at March 31, 2023 and December 31, 2022; 49,874,913 and 52,240,311 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Structural Debt Facility Structural Debt Facility [Member] Structural Debt Facility Fulfillment Labor Fulfillment Labor [Member] Fulfillment Labor Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Contingencies Commitments and Contingencies, Policy [Policy Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Lender [Axis] Lender [Axis] Lender Purchase agreement, deferred transaction cost Purchase Agreement, Deferred Transaction Cost Purchase Agreement, Deferred Transaction Cost 2022 Equity Incentive Plan Two Thousand and Twenty Two Equity Incentive Plan [Member] Two Thousand and Twenty Two Equity Incentive Plan Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Agreement [Axis] Agreement [Axis] Agreement Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Proceeds from issuance of debt Proceeds from Issuance of Long-Term Debt Warrants, equity ownership percentage Class Of Warrant Or Right, Equity Ownership Percentage Class Of Warrant Or Right, Equity Ownership Percentage Common stock, shares issued (in shares) Common Stock, Shares, Issued Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Deferred revenue Contractual liabilities Contract with Customer, Liability, Current Purchase of property and equipment in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Fulfillment Costs Fulfillment Costs [Policy Text Block] Fulfillment Costs Balance at December 31, 2022 Balance at March 31, 2023 Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Debt instrument, face amount Debt Instrument, Face Amount Structural Lenders Structural Lenders [Member] Structural Lenders Entity Current Reporting Status Entity Current Reporting Status Other current liabilities Other Liabilities, Current Other long-term assets Other Assets, Noncurrent Share redemption trigger price (in dollars per share) Share Redemption Trigger Price Share Redemption Trigger Price Atel Atel [Member] Atel Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Counterparty Name [Axis] Counterparty Name [Axis] Options outstanding, beginning of period (in shares) Options outstanding, ending of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Basis of Presentation and Liquidity Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property, Plant and Equipment, Net Entities [Table] Entities [Table] Sale of stock, ability to sell full commitment, share price threshold (in dollars per share) Sale Of Stock, Ability To Sell Full Commitment, Share Price Threshold Sale Of Stock, Ability To Sell Full Commitment, Share Price Threshold Repayment of debt Repayments of Long-Term Debt Sale of stock, exchange cap, maximum number of shares authorized to sell (in shares) Sale Of Stock, Exchange Cap, Maximum Number Of Shares Authorized To Sell Sale Of Stock, Exchange Cap, Maximum Number Of Shares Authorized To Sell Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Common stock options Share-Based Payment Arrangement, Option [Member] Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Change in fair value of Public and Private Placement Warrants liability Fair Value Adjustment of Warrants, Public and Private Fair Value Adjustment of Warrants, Public and Private Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Cancelled/forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total debt Long-Term Debt Other income, net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Maximum Maximum [Member] Third-party products Third-party Products [Member] Third-party Products Class A Common Stock Common Class A [Member] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Deferred revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Cash paid for taxes Income Taxes Paid, Net Contract with customer, liability, revenue recognized Contract with Customer, Liability, Revenue Recognized Entity Small Business Entity Small Business Lender [Domain] Lender [Domain] Lender [Domain] Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Common Stock and Warrants Stockholders' Equity Note Disclosure [Text Block] Revenues [Abstract] Revenues [Abstract] Share-based payment arrangement, nonvested award, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Proceeds from issuance of common stock, reverse recapitalization Proceed from Issuance of Common Stock, Reverse Recapitalization Proceed from Issuance of Common Stock, Reverse Recapitalization Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Non-cash interest expense Paid-in-Kind Interest Other long-term debt Other Long-Term Debt Options, outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Contingently issuable shares, calculation, numerator Contingently Issuable Shares, Calculation, Numerator Contingently Issuable Shares, Calculation, Numerator Title of 12(b) Security Title of 12(b) Security Contingently redeemable convertible common stock Contingently Redeemable Convertible Preferred Stock [Member] Contingently Redeemable Convertible Preferred Stock Operating lease right-of-use assets and liabilities Increase (Decrease) in Operating Right of Use Asset Increase (Decrease) in Operating Right of Use Asset Payables and Accruals [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Payment of debt issuance costs Payment of debt issuance costs Payments of Debt Issuance Costs Reduction in transaction costs allocated to derivative liabilities upon Business Combination Adjustments To Transaction Costs, Derivative Instrument, Reverse Recapitalization Adjustments To Transaction Costs, Derivative Instrument, Reverse Recapitalization Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Cancelled/forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Inventory, net Inventory, Net Accounts payable Accounts Payable, Current Grove Brands Grove Brands [Member] Grove Brands Structural Derivative Structural Derivative [Member] Structural Derivative Description of Business Nature of Operations [Text Block] Entity Filer Category Entity Filer Category Common stock warrants Warrant [Member] Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted-Average Remaining Contractual Life (years) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Reverse Recapitalization Tranche Two Reverse Recapitalization Tranche Two [Member] Reverse Recapitalization Tranche Two Options vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Stock-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies (Note 6) Commitments and Contingencies Recapitalization exchange ratio Reverse Recapitalization, Exchange Ratio Reverse Recapitalization, Exchange Ratio Security Exchange Name Security Exchange Name Options outstanding, beginning of period (in dollars per share) Options outstanding, ending of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Vesting of early exercised stock options Vesting of Early Exercised Stock Options Vesting of Early Exercised Stock Options Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Number of days after the completion of an initial business combination Number of Days After the Completion of an Initial Business Combination Number of Days After the Completion of an Initial Business Combination Restricted cash Restricted Cash, Current Reverse Recapitalization Tranche One Reverse Recapitalization Tranche One [Member] Reverse Recapitalization Tranche One Schedule of Reserved for Issuance Schedule of Reserved for Issuance [Table Text Block] Schedule of Reserved for Issuance Schedule of Debt Schedule of Debt [Table Text Block] Revenue, net Total revenue, net Revenue from Contract with Customer, Excluding Assessed Tax Issuance of convertible common stock Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock Number of shares exercised by warrants at period end Class Of Warrant Or Right, Number Of Securities Exercised By Warrants Or Rights At Period End Class Of Warrant Or Right, Number Of Securities Exercised By Warrants Or Rights At Period End Fulfillment cost Fulfillment Costs Fulfillment Costs Total shares of common stock reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Warrants, covenant, quarterly net revenue Class Of Warrant Or Right, Covenant, Quarterly Net Revenue Class Of Warrant Or Right, Covenant, Quarterly Net Revenue Sale Of Stock, Measurement Period One Sale Of Stock, Measurement Period One [Member] Sale Of Stock, Measurement Period One Forecast Forecast [Member] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger Total liabilities and stockholders’ equity Liabilities and Equity Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Vesting of early exercise of options Adjustments To Additional Paid-In-Capital, Early Exercise Of Stock Options Adjustments To Additional Paid-In-Capital, Early Exercise Of Stock Options Reverse recapitalization, contingent consideration, liability, earnout period Reverse Recapitalization, Contingent Consideration, Earnout Period Reverse Recapitalization, Contingent Consideration, Earnout Period Organization, Consolidation and Presentation of Financial Statements [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Purchase agreement, volume weighted average price, percentage Purchase Agreement, Volume Weighted Average Price, Percentage Purchase Agreement, Volume Weighted Average Price, Percentage Current Fiscal Year End Date Current Fiscal Year End Date Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation Net loss per share attributable to common stockholders, diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Share-based compensation arrangement by share-based payment award, maximum employee contributions, percentage of eligible compensation Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Contributions, Percentage Of Eligible Compensation Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Contributions, Percentage Of Eligible Compensation Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Changes in fair value of derivative liabilities Fair Value Adjustment of Warrants Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Sale Of Stock, Measurement Period [Axis] Sale Of Stock, Measurement Period [Axis] Sale Of Stock, Measurement Period Entity Ex Transition Period Entity Ex Transition Period Options vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Increase to other income, net Increase (Decrease) To Other Nonoperating Income (Expense) Increase (Decrease) To Other Nonoperating Income (Expense) Entity Address, Address Line One Entity Address, Address Line One Long-Term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Fair Value Disclosures [Abstract] Interest expense Interest Expense Options, vested and exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Credit Facility [Axis] Credit Facility [Axis] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Reconciliation of cash, cash equivalents, and restricted cash: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Long-Term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Tax Identification Number Entity Tax Identification Number Issuance of convertible common stock (in shares) Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock Consulting fee expense Consulting Fee Expense Consulting Fee Expense Shares available for future issuance under equity incentive plan (in shares) Shares Available For Future Issuance Under Equity Incentive Plan Shares Available For Future Issuance Under Equity Incentive Plan Advertising Advertising Expense Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Secured Overnight Financing Rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate (SOFR) Atel Loan Facility Draw 3 Atel Loan Facility Tranche Three [Member] Atel Loan Facility Tranche Three Inventory purchases Inventory Purchases, Current Inventory Purchases, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Tranche [Domain] Tranche [Domain] Tranche [Domain] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Concentration of Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Decrease in accrued transaction costs Increase (Decrease) In Accrued Transaction Costs, Current Increase (Decrease) In Accrued Transaction Costs, Current Other accrued expenses Other Accrued Liabilities, Current City Area Code City Area Code Long-term debt, percentage bearing variable interest, percentage rate Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate Assets Assets [Abstract] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Purchase obligation Purchase Obligation Statement of Stockholders' Equity [Abstract] Outstanding restricted stock unit, shares reserved for future issuance (in shares) Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance Sale of Stock [Axis] Sale of Stock [Axis] Trading days prior to such date Contingently Issuable Shares, Calculation, Denominator, Trading Days Prior To Thirty-Month Anniversary Of Closing Date Contingently Issuable Shares, Calculation, Denominator, Trading Days Prior To Thirty-Month Anniversary Of Closing Date Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financial Liabilities: Financial Liabilities Fair Value Disclosure Supplemental Disclosure of Non-Cash Investing and Financing Activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Fair value of common stock (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Sale of stock, covenant, volume weighted average price threshold, measurement period Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Measurement Period Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Measurement Period Sale Of Stock, Measurement Period Two Sale Of Stock, Measurement Period Two [Member] Sale Of Stock, Measurement Period Two Variable Rate [Axis] Variable Rate [Axis] Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Other liabilities Increase (Decrease) in Other Operating Liabilities Loan And Security Agreement Loan And Security Agreement [Member] Loan And Security Agreement Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Change in fair value of Earn-Out liability Fair Value Adjustment of Earn-Out Liability Fair Value Adjustment of Earn-Out Liability Change in fair value of Additional Shares liability Fair Value Adjustment of Warrants, Additional Shares Liability Fair Value Adjustment of Warrants, Additional Shares Liability Customer [Domain] Customer [Domain] Derivative liabilities Derivative Liability, Noncurrent EX-101.PRE 11 grov-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - shares
3 Months Ended
Mar. 31, 2023
May 05, 2023
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 001-40263  
Entity Registrant Name Grove Collaborative Holdings, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 88-2840659  
Entity Address, Address Line One 1301 Sansome Street  
Entity Address, City or Town San Francisco  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94111  
City Area Code 800  
Local Phone Number 231-8527  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Central Index Key 0001841761  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Class A Common Stock    
Entity Information [Line Items]    
Title of 12(b) Security Class A common stock, par value $0.0001  
Trading Symbol GROV  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   128,876,248
Common stock warrants    
Entity Information [Line Items]    
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share  
Trading Symbol GROV.WS  
Security Exchange Name NYSE  
Class B Common Stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   49,874,913
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 81,653 $ 81,084
Restricted cash 5,850 11,950
Inventory, net 40,930 44,132
Prepaid expenses and other current assets 5,806 4,844
Total current assets 134,239 142,010
Restricted cash 2,951 2,951
Property and equipment, net 13,852 14,530
Operating lease right-of-use assets 11,721 12,362
Other long-term assets 2,817 2,192
Total assets 165,580 174,045
Current liabilities:    
Accounts payable 12,293 10,712
Accrued expenses 13,967 31,354
Deferred revenue 9,152 10,878
Operating lease liabilities, current 3,762 3,705
Other current liabilities 565 249
Debt, current 340 575
Total current liabilities 40,079 57,473
Debt, noncurrent 69,049 60,620
Operating lease liabilities, noncurrent 15,233 16,192
Derivative liabilities 13,519 13,227
Total liabilities 137,880 147,512
Commitments and contingencies (Note 6)
Stockholders’ equity:    
Preferred stock, $0.0001 par value - 100,000,000 shares authorized at March 31, 2023 and December 31, 2022; no shares outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock - $0.0001 par value – 600,000,000 Class A shares authorized at March 31, 2023 and December 31, 2022; 128,870,368 and 125,617,015 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively; 200,000,000 Class B shares authorized at March 31, 2023 and December 31, 2022; 49,874,913 and 52,240,311 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 18 18
Additional paid-in capital 618,609 604,373
Accumulated deficit (590,927) (577,858)
Total stockholders’ equity 27,700 26,533
Total liabilities and stockholders’ equity $ 165,580 $ 174,045
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - Parenthetical - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Temporary equity, par value (in dollars per share) $ 0.0001 $ 0.0001
Temporary equity, shares authorized (in shares) 100,000,000 100,000,000
Temporary equity, shares issued (in shares) 0 0
Temporary equity, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Class A Common Stock    
Common stock, shares authorized (in shares) 600,000,000 600,000,000
Common stock, shares issued (in shares) 128,870,368 125,617,015
Common stock, shares outstanding (in shares) 128,870,368 125,617,015
Class B Common Stock    
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, shares issued (in shares) 49,874,913 52,240,311
Common stock, shares outstanding (in shares) 49,874,913 52,240,311
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues [Abstract]    
Revenue, net $ 71,565 $ 90,479
Cost of goods sold 34,310 47,742
Gross profit 37,255 42,737
Operating Expenses [Abstract]    
Advertising 8,673 32,793
Product development 4,216 6,240
Selling, general and administrative 38,021 50,970
Operating loss (13,655) (47,266)
Interest expense 3,729 2,087
Change in fair value of Additional Shares liability 223 0
Change in fair value of Earn-Out liability 143 0
Change in fair value of Public and Private Placement Warrants liability (674) 0
Change in fair value of Structural Derivative liability 600 0
Other income, net (4,617) (1,992)
Interest and other expense (income), net (596) 95
Loss before provision for income taxes (13,059) (47,361)
Provision for income taxes 10 23
Net loss $ (13,069) $ (47,384)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.08) $ (5.05)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.08) $ (5.05)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 168,739,298 9,387,142
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) 168,739,298 9,387,142
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Contingently Redeemable Convertible Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 [1]   114,795,000 0      
Temporary equity, balances at beginning of period at Dec. 31, 2021 [1]   $ 487,918 $ 0      
Increase (Decrease) in Temporary Equity [Roll Forward]            
Issuance of convertible common stock (in shares) [1]     2,750,000      
Issuance of convertible common stock [1]     $ 27,473      
Temporary equity, balances at ending of period (in shares) at Mar. 31, 2022 [1]   114,795,000 2,750,000      
Temporary equity, balances at ending of period at Mar. 31, 2022 [1]   $ 487,918 $ 27,473      
Balances at beginning of period (in shares) at Dec. 31, 2021 [1]       9,368,000    
Balances at beginning of period at Dec. 31, 2021 $ (456,279)     $ 1 [1] $ 33,863 $ (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) [1]       87,000    
Issuance of common stock upon exercise of stock options 171       171  
Reduction in transaction costs 0          
Vesting of early exercise of options 125       125  
Stock-based compensation 4,501       4,501  
Net loss (47,384)         (47,384)
Balances at ending of period (in shares) at Mar. 31, 2022 [1]       9,455,000    
Balances at ending of period at Mar. 31, 2022 $ (498,866)     $ 1 [1] 38,660 (537,527)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2022 0          
Temporary equity, balances at beginning of period at Dec. 31, 2022 $ 0          
Temporary equity, balances at ending of period (in shares) at Mar. 31, 2023 0          
Temporary equity, balances at ending of period at Mar. 31, 2023 $ 0          
Balances at beginning of period (in shares) at Dec. 31, 2022       177,857,000    
Balances at beginning of period at Dec. 31, 2022 $ 26,533     $ 18 604,373 (577,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 178,564     179,000    
Issuance of common stock upon exercise of stock options $ 68       68  
Cancellation of Earn-Out Shares (in shares) (985,722)     (986,000)    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)       1,695,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings $ (356)       (356)  
Reduction in transaction costs 9,609       9,609  
Stock-based compensation 4,915       4,915  
Net loss (13,069)         (13,069)
Balances at ending of period (in shares) at Mar. 31, 2023       178,745,000    
Balances at ending of period at Mar. 31, 2023 $ 27,700     $ 18 $ 618,609 $ (590,927)
[1] (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - Parenthetical
Jun. 16, 2022
2022 Equity Incentive Plan | Class B Common Stock  
Recapitalization exchange ratio 1.1760
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Cash Flows from Operating Activities    
Net loss $ (13,069) $ (47,384)
Adjustments to reconcile net loss to net cash used in operating activities:    
Remeasurement of convertible preferred stock warrant liability 0 (1,886)
Stock-based compensation 4,893 4,460
Depreciation and amortization 1,448 1,410
Changes in fair value of derivative liabilities 292 0
Reduction in transaction costs allocated to derivative liabilities upon Business Combination (3,745) 0
Non-cash interest expense 948 195
Inventory reserve 124 856
Other non-cash expenses 77 8
Changes in operating assets and liabilities:    
Inventory 3,078 3,038
Prepaids and other assets (828) (3,312)
Accounts payable 1,554 10,287
Accrued expenses 162 2,917
Deferred revenue (1,726) 159
Operating lease right-of-use assets and liabilities (261) (22)
Other liabilities 316 (229)
Net cash used in operating activities (6,737) (29,503)
Cash Flows from Investing Activities    
Purchase of property and equipment (784) (1,352)
Net cash used in investing activities (784) (1,352)
Cash Flows from Financing Activities    
Proceeds from issuance of contingently redeemable convertible common stock 0 27,500
Payment of transaction costs related to the Business Combination (4,150) (489)
Proceeds from issuance of debt 7,500 0
Payment of debt issuance costs (837) 0
Repayment of debt (235) (275)
Proceeds from exercise of stock options and settlement of restricted stock units, net of withholding taxes paid related to common stock issued to employees (288) 171
Net cash provided by financing activities 1,990 26,907
Net decrease in cash, cash equivalents and restricted cash (5,531) (3,948)
Cash, cash equivalents and restricted cash at beginning of period 95,985 78,376
Cash, cash equivalents and restricted cash at end of period 90,454 74,428
Supplemental Disclosure    
Cash paid for taxes 9 21
Cash paid for interest 2,734 1,461
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Purchase of property and equipment in accounts payable and accrued liabilities 113 286
Reduction in transaction costs allocated to equity instruments 9,609 0
Transaction and contingently redeemable convertible common stock issuance costs in accounts payable and accrued liabilities 0 2,582
Vesting of early exercised stock options 0 125
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 81,653 74,428
Restricted cash 8,801 0
Total cash, cash equivalents and restricted cash $ 90,454 $ 74,428
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Description of Business
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business Description of Business
Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II, or “VGAC II”) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016.

On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”).

The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing.
Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 7, Common Stock and Warrants for additional details.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Liquidity
The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.
These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should be read in conjunction with the Company’s financial statements and accompanying notes as of and for the year ended
December 31, 2022 (the “audited financial statements”) that were included in the Company’s Form 10-K filed with the SEC on March 16, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and the results of operations for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any other future interim or annual period.
The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $590.9 million as of March 31, 2023. The Company’s existing sources of liquidity as of March 31, 2023 include cash and cash equivalents of $81.7 million and availability of debt from the Siena Revolver (defined in Note 5, Debt). Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock, contingently redeemable convertible common stock and the incurrence of debt. The Company believes its existing cash and cash equivalents will be sufficient to fund its operations for a period of at least one year from the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.
Comprehensive Loss
Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.
Significant Accounting Policies
There have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, Summary of Significant Accounting Policies, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2022.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, the fair value of Additional Shares liabilities, the fair value of the Structural Derivative Liability and stock based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.

Restricted Cash
Short-term restricted cash primarily represents cash on deposit with a financial institution to collateralize short-term obligations related to company credit cards. Long-term restricted cash primarily represents cash on deposit with a financial institution to collateralize letters of credit related to the Company’s non-cancellable operating leases for its corporate headquarters. Restricted cash is stated at cost, which approximates fair value.
Concentration of Risks
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains the majority of its cash, cash equivalents and restricted cash in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
The Company depends on a limited number of vendors to supply products sold by the Company. For the three months ended March 31, 2023 and 2022, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases.
Revenue Recognition
The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment.
The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.
In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.
A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.
The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a
select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).
At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. The Company records a refund reserve based on historical refund patterns. As of March 31, 2023 and December 31, 2022 the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was not material.
Disaggregation of Revenue
The following table sets forth revenue by product type (in thousands):
Three Months Ended
March 31,
20232022
Revenue, net:
Grove Brands $34,976 $46,796 
Third-party products36,589 43,683 
Total revenue, net$71,565 $90,479 
Contractual Liabilities
The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. Contractual liabilities included in deferred revenue and other current liabilities were $9.2 million and $0.2 million, respectively, as of March 31, 2023 and $10.9 million and $0.2 million, respectively, as of December 31, 2022. The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the three months ended March 31, 2023 that was previously included in deferred revenue and other current liabilities as of December 31, 2022 was $6.6 million and $0.2 million, respectively.
Fulfillment Costs
Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative
expenses in the condensed consolidated statements of operations. For the three months ended March 31, 2023 and 2022, the Company recorded fulfillment costs of $17.0 million and $24.4 million, respectively, which included $10.4 million and $14.3 million in shipping and handling expenses, respectively, and $3.9 million and $6.6 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements and Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Fair Value of Financial Instruments Fair Value Measurements and Fair Value of Financial Instruments
The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt, Additional Shares, Earn-Out Shares Public and Private Placement Warrants and Structural Derivative. Cash equivalents, Earn-Out Shares, Public and Private Placement Warrants and Structural Derivative are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.
The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exceptions as defined in Note 7, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.
The Structural Derivative Liability is a compound embedded derivative related to features within the Structural Debt Facility, including an increase in interest rate upon an event of default and the contingent issuance of the Structural Subsequent Shares as defined in Note 5, Debt. This liability is classified as Level 3 and is valued using a risk-neutral income approach related to an event of default occurring and expected cash flows in such a scenario and an income and Black-Scholes pricing model for the contingent issuance of the Structural Subsequent Shares utilizing assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 by level within the fair value hierarchy (in thousands):
March 31, 2023
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$78,213 $— $— $78,213 
Total$78,213 $— $— $78,213 
Financial Liabilities:
Additional Shares— — 803 803 
Earn-Out Shares— — 4,265 4,265 
Private Placement Warrants— 364 — 364 
Public Warrants437 — — 437 
Structural Derivative Liability— — 7,650 7,650 
Total$437 $364 $12,718 $13,519 
December 31, 2022
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$74,990 $— $— $74,990 
Total$74,990 $— $— $74,990 
Financial Liabilities:
Additional Shares— — 580 580 
Earn-Out Shares— — 4,122 4,122 
Private Placement Warrants— 670 — 670 
Public Warrants805 — — 805 
Structural Derivative Liability— — 7,050 7,050 
Total$805 $670 $11,752 $13,227 
There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented.
Additional Shares Liability
At the closing of the HGI Subscription Agreement defined in Note 7, Common Stock and Warrants, the Company recorded a liability related to the potential issuance of Additional Shares. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations.
The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):
Balance at December 31, 2022$580 
Change in fair value of Additional Shares Liability223 
Balance at March 31, 2023$803 
Earn-Out Shares
At Closing of the Business Combination, certain Earn-Out Shares were accounted for as a liability. Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations.
The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):
Balance at December 31, 2022$4,122 
Cancellation of Earn-Out Shares$(347)
Change in fair value490 
Balance at March 31, 2023$4,265 
Private Placement and Public Warrant Liabilities
As of March 31, 2023, the Company has Private Placement and Public Warrants. Such warrants are measured at fair value on a recurring basis.
The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands):

Private Placement WarrantsPublic Warrants
Balance at December 31, 2022$670 $805 
Changes in fair value(306)(368)
Balance at March 31, 2023$364 $437 
Structural Derivative Liability
At closing of the Structural Debt Facility, the Company recorded a liability related to the features that are required to be bifurcated and accounted for as a compound derivative at fair value. Subsequent changes in fair value of the Structural Derivative Liability until settlement is recognized in the statement of operations.
The following table provides a summary of changes in the estimated fair value of the Structural Derivative Liability (in thousands):
Balance at December 31, 2022$7,050 
Change in fair value600 
Balance at March 31, 2023$7,650 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued Expenses
3 Months Ended
Mar. 31, 2023
Payables and Accruals [Abstract]  
Accrued Expenses Accrued Expenses
Accrued expenses consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Inventory purchases$2,530 $2,757 
Compensation and benefits2,861 1,714 
Advertising costs1,020 1,203 
Fulfillment costs1,335 1,725 
Sales taxes1,509 1,374 
Transaction costs— 17,500 
Other accrued expenses4,712 5,081 
Total accrued expenses$13,967 $31,354 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Debt
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt Debt
The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Structural Debt Facility$61,549 $60,620 
Siena Revolver7,500 — 
Atel Loan Facility Draw 3292 480 
Atel Loan Facility Draw 448 95 
Total debt69,389 61,195 
Less: debt, current(340)(575)
Total debt, noncurrent$69,049 $60,620 
Structural Debt Facility
In December 2022, the Company entered into a Loan and Security Agreement (“Structural Debt Facility”) with Structural Capital Investments III, LP, Structural Capital Investments IV, LP and Series PCI Grove series of Structural Capital Primary Co-Investment Fund, LLC (collectively, “Structural Funds”) and Avenue Sustainable Solutions Fund, L.P. (“Avenue”) (collectively “Structural Lenders”) to borrow $72.0 million which was used primarily to settle previously outstanding obligations with a prior lender. The Structural Debt Facility bears an annual rate of interest at the greater of 15.00% or 7.50% plus the prime rate, payable monthly. The principal repayment period commences on July 1, 2025 and continues until the maturity date of December 21, 2026. The Company may prepay all outstanding amounts under this facility at anytime. Under the agreement, when amounts are prepaid or repaid in full at the Maturity Date, the Company may be obligated to pay additional fees which would allow for Structural Funds and Avenue to reach a Minimum Return, as defined by the agreement.
The Structural Debt Facility is collateralized by the assets of the Company and includes financial covenants the Company must meet in order to avoid an Event of Default, as defined by the agreement. Such covenants include (i) maintaining a minimum of $57.0 million in unrestricted cash at all times and (ii) achieving certain revenue targets for the trailing four quarter period beginning with this fiscal quarter ended March 31, 2023. The Structural Debt Facility contains a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, Structural has been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that Structural Lenders would exercise the subjective acceleration clause is remote. As of March 31, 2023, the Company was in compliance with these debt covenants.
On December 21, 2022, in connection with the closing of the Structural Debt Facility, the Company issued to Structural Funds, including certain affiliates, and to Avenue a total of 4,950,000 shares of the Company’s Class A common stock (the “Structural Closing Shares”). The Company recorded a debt discount of $1.1 million related to the issuance of these shares, with a corresponding offset to the Company’s Class A common stock and additional paid-in capital. Further, if there are outstanding obligations relating to the Structural Debt Facility on July 21, 2025, representing the thirty-month anniversary of such closing, the Company agrees to issue to Structural Funds, including certain affiliates, and to Avenue, the aggregate number of shares of the Company’s Class A common stock equal to $9,900,000, divided by the lower of (i) $2.00 and (ii) the volume weighted average price of the Company’s Class A common stock for the sixty trading days prior to such date, as further described in the related issuance agreements (the "Structural Subsequent Shares”).
The Company has identified several features within the Structural Debt Facility consisting of the contingent obligation to issue the Structural Subsequent Shares, mandatory and voluntary prepayment features and default interest rate (“Structural Derivative Liability”), which are required to be bifurcated and accounted for as a compound embedded derivative at fair value. Changes in fair value of the Structural Derivative Liability are recognized through the statements of operations and was $0.6 million for the three months ended March 31, 2023.
Closing costs consisted of $3.3 million in costs directly related to the issuance of the Structural Facility to third parties, issuance of certain Structural Closing Shares amounting to $1.1 million and incurrence of an additional Structural Derivative Liability amount of $7.1 million. At March 31, 2023, the Company had $72.0 million in principal outstanding under the Structural Debt Facility with an effective interest rate of 20.34%.
Siena Revolver
In March 2023, the Company entered into a Loan and Security Agreement (the “Siena Revolver”) with Siena Lending Group, LLC (“Siena”) which permits the Company to receive funding through a revolving line of credit with an initial commitment of $35.0 million. The Company’s borrowing capacity under the Siena Revolver is subject to certain conditions, including the Company’s eligible inventory and accounts receivable balances among other limitations as specified in the agreement. In connection with this facility the Company incurred $1.0 million of debt issuance costs which have been included in other assets on the Company’s balance sheet and being amortized through the Revolver’s scheduled maturity date. Additional borrowing capacity from the Siena Revolver was $10.2 million as of March 31, 2023.
The interest rates applicable to borrowings under the Siena Revolver are based on a fluctuating rate of interest measured by reference to either, at the Company’s option, (i) a Base Rate, plus an applicable margin, or (ii) the Term SOFR rate then in effect, plus 0.10% and an applicable margin. The Base Rate is defined as the greatest of: (1) Prime Rate as published in the Wall Street Journal, (2) Federal Funds Rate plus 0.5% and (3) 5.0% per annum. The applicable margin for Siena Revolver borrowings is based on the Company’s monthly average principal balance outstanding and ranges from 2.75% to 4.50% per annum in the case of Base Rate Borrowings and 3.75% to 5.50% per annum in the case of Term SOFR borrowings. The Siena Revolver also contains various financial covenants the Company must maintain to avoid an Event of Default, as defined by the agreement, including a subjective acceleration clause in the event that Siena determines that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the agreement, Siena has been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that Siena would exercise the subjective acceleration clause is remote. As of March 31, 2023, the Company was in compliance with these debt covenants.

The Siena Revolver matures at the earlier of March 10, 2026 or the maturity date of the Structural Debt Facility. As of March 31, 2023, the Company has an outstanding principal balance of $7.5 million under the Siena Revolver. The interest rate on the outstanding balance at March 31, 2023 is 8.52%.
Atel Loan Facility
In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default.
As of March 31, 2023, the Company had $0.3 million outstanding on its third draw and less than $0.1 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Merchandise Purchase Commitments
As of March 31, 2023 and December 31, 2022, the Company had obligations to purchase $15.3 million and $18.7 million, respectively, of merchandise.
Letters of Credit
The Company had irrevocable standby letters of credit in the amount of $3.5 million and $3.1 million as of March 31, 2023 and December 31, 2022, respectively, primarily related to the Company’s operating leases. The letters of credit have expiration dates through January 2029.
Contingencies
The Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Warrants
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Common Stock and Warrants Common Stock and Warrants
As discussed in Note 1, Description of the Business, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination. During the year ended December 31, 2022, the Company recorded $24.4 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were allocated on a relative fair value basis between the issuance of equity and liability instruments.

Direct and incremental transaction costs allocated to equity-classified instruments were recorded within equity as an offset against proceeds upon accounting for the consummation of the Business Combination in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net in the condensed consolidated statements of operations. The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows.

As per the original agreement, the Company had $17.5 million of transaction costs accrued as of December 31, 2022. In March 2023, the Company entered into an amended agreement with a vendor to reduce this liability by $13.4 million. This reduction of costs was allocated between the liability and equity instruments with $3.8 million being recorded to other income, net on the Company’s statement of operations and $9.6 million recorded to additional paid-in capital, within equity.

On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of approximately 1.1760, each outstanding restricted
stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760.

Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant.
Earn-Out
At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of the Company’s Class B Common Stock (“Earn-Out Shares”). During the three months ended March 31, 2023, certain shareholders surrendered an aggregate 985,722 Earn-Out Shares which, per terms of the Merger Agreement, were cancelled by the Company and not reallocated among the remaining holders. The remaining 13,014,238 Earn-Out Shares will vest (i) with respect to 6,507,310 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,506,928 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Business Combination (the “Earn-Out Period”).
If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.
If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of March 31, 2023, the Company did not meet any Earn-Out thresholds.
Class A Common Stock Warrants
As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assumed 6,700,000 Private Placement Warrants for the Company’s Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 of the Company’s Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation.
Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of the Company’s Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock, and therefore classified as liabilities on the condensed consolidated balance sheets. As of March 31, 2023, the following Warrants were outstanding:

Warrant TypeSharesExercise Price
Public Warrants8,050,000 $11.50 
Private Placement Warrants6,700,000 $11.50 
Public Warrants
The Public Warrants become exercisable into shares of the Company’s Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments.
The Company may redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any twenty trading days within the thirty trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.
Private Placement Warrants
The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants were not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. At Closing, the Company assumed 6,700,000 Private Placement Warrants.
Backstop Warrants

In connection with the Business Combination, the Company issued to the Corvina Holdings limited 3,875,028 warrants to purchase the Company’s Class A common stock (each warrant exercisable to purchase one share of the Company’s Class A common stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. None of these warrants have been exercised as of March 31, 2023.
Standby Equity Purchase Agreement
On July 18, 2022, the Company entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, LTD (“Yorkville” or “SEPA Investor”), pursuant to which Yorkville has agreed to purchase up to $100 million of common stock from time to time over a period of 36 months, subject to certain conditions. The shares of the Company’s common stock that may be issued under the SEPA may be sold by us to Yorkville at our discretion from time to time and sales of the Company’s common stock under the SEPA will depend upon market conditions and other factors. Additionally, in no event may the Company sell more than 32,557,664 shares of common stock to Yorkville under the SEPA, which number of shares is equal to 19.99% of the shares of the Company's common stock outstanding immediately prior to the execution of the Equity Purchase Agreement (the “Exchange Cap”), unless stockholder approval is obtained to issue shares of common stock in excess of the Exchange Cap in accordance with applicable NYSE rules or comply with certain other requirements as described in the Equity Purchase Agreement. As a result, unless the Company’s stock price exceeds $3.07, the Company will be unable to sell the full $100.0 million commitment to Yorkville without seeking stockholder approval to issue additional shares in excess of the Exchange Cap. The purchase price per share for Class A common stock will be 97.55% of the Volume-Weighted Average Price (“VWAP”) of the Company’s Class A common stock over the Pricing Period, as defined by the agreement. The Company deferred $0.7 million of transaction costs related to the SEPA and will offset these costs against proceeds of any sales under the SEPA. As of March 31, 2023, the Company has sold 739,825 shares under the SEPA for total gross proceeds of $2.4 million. Issuance costs related to these shares are not material. As of March 31, 2023, there were 31,817,839 shares available to be sold to Yorkville under the Exchange Cap.
HGI Subscription Agreement
On November 10, 2022, the Company entered into a subscription agreement (the “HGI Subscription Agreement”) with HCI Grove LLC (“HGI”), pursuant to which, among other things, the Company issued to HGI 1,984,126 shares of the Company’s Class A common stock (“Subscribed Shares”) for aggregate proceeds of $2.5 million. Under the terms of the HGI Subscription Agreement, the Company is required to file a registration statement for the Subscribed Shares upon the Company becoming eligible to file a registration statement on Form S-3 and in any event prior to July 15, 2023 (the “Subscribed Shares Registration Statement”).
The HGI Subscription Agreement also provides that the Company will issue additional shares (the “HGI Additional Shares”) of the Company’s Class A common stock to HGI in the event that the volume weighted average price of the Company’s Class A common stock is less than $1.26 during the three trading days commencing on the first trading day after (i) the Company files the Subscribed Shares Registration Statement (the “Registration Date”), (ii) the three-month anniversary of the Registration Date, (iii) the six-month anniversary of the Registration Date, or (iv) the nine-month anniversary of the Registration Date (“Measurement Periods” and each “Measurement Period”) upon HGI’s election to receive such additional shares. HGI may use all or a portion of each Subscribed Share once to determine the amount of any issuance of Additional Shares in connection with the Measurement Periods such that HGI may utilize, for example, half of the Subscribed Shares to receive further Additional Shares, and leave the remaining half of the Subscribed Shares available to utilize in connection with the remaining Measurement Periods. HGI must elect to receive HGI Additional Shares for one Measurement Period, or the right lapses or is superseded by the next measurement period. There have been no shares have been issued related to the HGI Additional shares as of March 31, 2023.
Concurrent with the HGI Subscription Agreement, the Company also entered into a consulting services agreement (the “Consulting Agreement”) with HCI Grove Management LLC (the “Consultant”). In consideration for the services under the Consulting Agreement, the Company (i) paid the Consultant an upfront fee of $150,000 and (ii) issued the Consultant 4,525,000 warrants (the “HGI Warrant Shares”) to purchase shares of the Company’s Class A common stock (the “HGI Warrants”), at an exercise price per share of $1.26 (the “Exercise Price”). On November 10, 2022, 40% of the HGI Warrant Shares vested and became issuable (the “Vested Warrants”), and the remaining HGI Warrant Shares (the “Unvested Warrants”) shall vest and become exercisable if, prior to December 31, 2024, the Company achieves at least $100.0 million in quarterly net revenue on a consolidated basis or if the Company consummates a Change of Control, as defined in HGI Warrants. If, as a result of the Change of Control, the Company’s equity holders own less than 25% of the equity securities of the surviving entity in such Change of Control, the Exercise Price shall be increased by 50%.
The Company determined the Vested Warrants and Unvested Warrants qualify as stock based compensation to a nonemployee. The Company recorded $1.2 million in stock based compensation expense on the execution date of the HGI Subscription Agreement. The Company performs a probability reassessment related to the Unvested Warrants each reporting period and will recognize the cumulative catch-up adjustment based on the grant-date fair value when the vesting conditions are probable of being achieved. Any remaining expense will continue to ratably recognized until the date the revenue target is achieved, and the Unvested Warrants are fully vested.
The fair value of Vested Warrants and Unvested Warrants granted to HGI was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
Fair value of common stock$1.26
Expected term (in years)4.5
Volatility62.50%
Risk-free interest rate4.00%
Dividend yield

Reserved for Issuance
The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:
March 31, 2023December 31, 2022
Class A Common StockClass B Common StockClass A Common StockClass B Common Stock
Private Placement Warrants6,700,000 — 6,700,000 — 
Public Warrants8,050,000 — 8,050,000 — 
Backstop Warrants3,875,028 — 3,875,028 — 
Common Stock Warrants4,525,000 568,905 4,525,000 568,905 
Outstanding Stock Options5,969,813 4,202,678 6,318,978 4,198,917 
Outstanding Restricted Stock Units29,238,710 175,184 19,322,240 263,052 
Remaining Shares available for issuance under 2022 Equity Incentive Plan9,338,297 — 20,794,363 — 
Shares available for issuance under 2022 Employee Stock Purchase Plan5,052,643 — 3,274,070 — 
Total shares of common stock reserved72,749,491 4,946,767 72,859,679 5,030,874 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Stock Options
Stock option activity under the Company’s incentive plan is as follows (in thousands, except share and per share amounts):
Options Outstanding
Number of Options Weighted–Average Exercise PriceWeighted-Average Remaining Contractual Life (years)Aggregate Intrinsic Value
Balance – December 31, 202210,521,571 $1.59 4.87$61 
Exercised(178,564)0.38 
Cancelled/forfeited(170,516)2.82 
Balance – March 31, 202310,172,491 1.59 4.0598 
Options vested and exercisable – March 31, 20239,040,393 $1.32 3.58$98 
No options were granted during three months ended March 31, 2023 and 2022. The total grant date fair value of options that vested during three months ended March 31, 2023 and 2022 was $0.1 million and $4.4 million, respectively. The aggregate intrinsic value of options exercised during the three months ended March 31, 2023 and 2022 was nominal and $0.4 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options.
Market-Based Stock Options
In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of the stock options vest upon
valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for service periods completed prior to the Business Combination. As of March 31, 2023, the market-based vesting criteria had not been met.
Restricted Stock Units
The following table summarizes the activity for all RSU’s under all of the Company’s equity incentive plans for the three months ended March 31, 2023:
Number of shares Weighted–Average Grant Date Fair Value Per Share
Unvested – December 31, 202219,482,427 $1.75 
Granted13,314,042 0.43 
Vested(2,549,326)2.28 
Cancelled/forfeited(833,249)2.69 
Balance – March 31, 202329,413,894 1.08 

Employee Stock Purchase Plan
In May 2022, the Company’s board of directors adopted the 2022 Employee Stock Purchase Plan (the “ESPP”), which was subsequently approved by the Company’s stockholders. The ESPP went into effect on November 16, 2022. Subject to certain limitations contained therein, the ESPP allows eligible employees to contribute, through payroll deductions, up to 20% of their eligible compensation to purchase the Company’s Class A common stock at a discounted price per share. As of March 31, 2023, no shares of Class A common stock had been purchased under the ESPP.

Stock-Based Compensation Expense
For the three months ended March 31, 2023 and 2022, the Company recognized a total of $4.9 million and $4.5 million of stock-based compensation expense, respectively, related to stock options and RSUs granted to employees and non-employees. Stock-based compensation expense was predominately recorded in selling, general and administrative expenses in the statements of operations for each period presented. As of March 31, 2023, the total unrecognized compensation expense related to unvested options and RSUs was $28.6 million, which the Company expects to recognize over an estimated weighted average period of 2.3 years.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Net loss Per Share Attributable to Common Stockholders
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Net loss Per Share Attributable to Common Stockholders Net loss Per Share Attributable to Common Stockholders
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
March 31,
20232022
Convertible preferred stock— 115,287,015 
Contingently redeemable convertible common stock— 2,750,000 
Common stock options10,172,491 25,691,329 
Restricted stock units29,413,894 3,224,181 
Convertible preferred stock warrants— 735,763 
Common stock warrants5,093,905 688,362 
Private and Public Placement Warrants14,750,000 — 
Earn-Out Shares13,005,238 — 
Shares subject to repurchase— 16,539 
Total72,435,528 148,393,189 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events Subsequent EventsOn April 19, 2023, the Company entered into an amendment to the lease agreement for its warehousing facility located in St. Peters, Missouri to provide for, among other things, an extension of the lease term to September 2028. At the option of the Company, the lease may be extended an additional 5 years. The amendment requires the Company to make escalating undiscounted annual payments of up to $0.7 million, payable monthly. The Company is currently evaluating all the terms of this lease modification and its impact on the consolidated financial statements.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Liquidity
Basis of Presentation and Liquidity
The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.
These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should be read in conjunction with the Company’s financial statements and accompanying notes as of and for the year ended
December 31, 2022 (the “audited financial statements”) that were included in the Company’s Form 10-K filed with the SEC on March 16, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and the results of operations for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any other future interim or annual period.
Comprehensive Loss
Comprehensive Loss
Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.
Use of Estimates
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, the fair value of Additional Shares liabilities, the fair value of the Structural Derivative Liability and stock based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.
Restricted Cash Restricted CashShort-term restricted cash primarily represents cash on deposit with a financial institution to collateralize short-term obligations related to company credit cards. Long-term restricted cash primarily represents cash on deposit with a financial institution to collateralize letters of credit related to the Company’s non-cancellable operating leases for its corporate headquarters. Restricted cash is stated at cost, which approximates fair value.
Concentration of Risks
Concentration of Risks
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains the majority of its cash, cash equivalents and restricted cash in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
Revenue Recognition
Revenue Recognition
The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment.
The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.
In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.
A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.
The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a
select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).
At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. Contractual LiabilitiesThe Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer.
Fulfillment Costs Fulfillment CostsFulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs.
Fair Value Measurement
The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt, Additional Shares, Earn-Out Shares Public and Private Placement Warrants and Structural Derivative. Cash equivalents, Earn-Out Shares, Public and Private Placement Warrants and Structural Derivative are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.
The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exceptions as defined in Note 7, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.
The Structural Derivative Liability is a compound embedded derivative related to features within the Structural Debt Facility, including an increase in interest rate upon an event of default and the contingent issuance of the Structural Subsequent Shares as defined in Note 5, Debt. This liability is classified as Level 3 and is valued using a risk-neutral income approach related to an event of default occurring and expected cash flows in such a scenario and an income and Black-Scholes pricing model for the contingent issuance of the Structural Subsequent Shares utilizing assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.
Contingencies ContingenciesThe Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Disaggregation of Revenue
The following table sets forth revenue by product type (in thousands):
Three Months Ended
March 31,
20232022
Revenue, net:
Grove Brands $34,976 $46,796 
Third-party products36,589 43,683 
Total revenue, net$71,565 $90,479 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements and Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 by level within the fair value hierarchy (in thousands):
March 31, 2023
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$78,213 $— $— $78,213 
Total$78,213 $— $— $78,213 
Financial Liabilities:
Additional Shares— — 803 803 
Earn-Out Shares— — 4,265 4,265 
Private Placement Warrants— 364 — 364 
Public Warrants437 — — 437 
Structural Derivative Liability— — 7,650 7,650 
Total$437 $364 $12,718 $13,519 
December 31, 2022
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$74,990 $— $— $74,990 
Total$74,990 $— $— $74,990 
Financial Liabilities:
Additional Shares— — 580 580 
Earn-Out Shares— — 4,122 4,122 
Private Placement Warrants— 670 — 670 
Public Warrants805 — — 805 
Structural Derivative Liability— — 7,050 7,050 
Total$805 $670 $11,752 $13,227 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):
Balance at December 31, 2022$580 
Change in fair value of Additional Shares Liability223 
Balance at March 31, 2023$803 
The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):
Balance at December 31, 2022$4,122 
Cancellation of Earn-Out Shares$(347)
Change in fair value490 
Balance at March 31, 2023$4,265 
The following table provides a summary of changes in the estimated fair value of the Structural Derivative Liability (in thousands):
Balance at December 31, 2022$7,050 
Change in fair value600 
Balance at March 31, 2023$7,650 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation
Private Placement WarrantsPublic Warrants
Balance at December 31, 2022$670 $805 
Changes in fair value(306)(368)
Balance at March 31, 2023$364 $437 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued expenses consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Inventory purchases$2,530 $2,757 
Compensation and benefits2,861 1,714 
Advertising costs1,020 1,203 
Fulfillment costs1,335 1,725 
Sales taxes1,509 1,374 
Transaction costs— 17,500 
Other accrued expenses4,712 5,081 
Total accrued expenses$13,967 $31,354 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Structural Debt Facility$61,549 $60,620 
Siena Revolver7,500 — 
Atel Loan Facility Draw 3292 480 
Atel Loan Facility Draw 448 95 
Total debt69,389 61,195 
Less: debt, current(340)(575)
Total debt, noncurrent$69,049 $60,620 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Warrants (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Warrants Outstanding As of March 31, 2023, the following Warrants were outstanding:
Warrant TypeSharesExercise Price
Public Warrants8,050,000 $11.50 
Private Placement Warrants6,700,000 $11.50 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The fair value of Vested Warrants and Unvested Warrants granted to HGI was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
Fair value of common stock$1.26
Expected term (in years)4.5
Volatility62.50%
Risk-free interest rate4.00%
Dividend yield
Schedule of Reserved for Issuance The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:
March 31, 2023December 31, 2022
Class A Common StockClass B Common StockClass A Common StockClass B Common Stock
Private Placement Warrants6,700,000 — 6,700,000 — 
Public Warrants8,050,000 — 8,050,000 — 
Backstop Warrants3,875,028 — 3,875,028 — 
Common Stock Warrants4,525,000 568,905 4,525,000 568,905 
Outstanding Stock Options5,969,813 4,202,678 6,318,978 4,198,917 
Outstanding Restricted Stock Units29,238,710 175,184 19,322,240 263,052 
Remaining Shares available for issuance under 2022 Equity Incentive Plan9,338,297 — 20,794,363 — 
Shares available for issuance under 2022 Employee Stock Purchase Plan5,052,643 — 3,274,070 — 
Total shares of common stock reserved72,749,491 4,946,767 72,859,679 5,030,874 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement, Option, Activity
Stock option activity under the Company’s incentive plan is as follows (in thousands, except share and per share amounts):
Options Outstanding
Number of Options Weighted–Average Exercise PriceWeighted-Average Remaining Contractual Life (years)Aggregate Intrinsic Value
Balance – December 31, 202210,521,571 $1.59 4.87$61 
Exercised(178,564)0.38 
Cancelled/forfeited(170,516)2.82 
Balance – March 31, 202310,172,491 1.59 4.0598 
Options vested and exercisable – March 31, 20239,040,393 $1.32 3.58$98 
Schedule of Performance-based Restricted Stock Units Activity
The following table summarizes the activity for all RSU’s under all of the Company’s equity incentive plans for the three months ended March 31, 2023:
Number of shares Weighted–Average Grant Date Fair Value Per Share
Unvested – December 31, 202219,482,427 $1.75 
Granted13,314,042 0.43 
Vested(2,549,326)2.28 
Cancelled/forfeited(833,249)2.69 
Balance – March 31, 202329,413,894 1.08 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Net loss Per Share Attributable to Common Stockholders (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
March 31,
20232022
Convertible preferred stock— 115,287,015 
Contingently redeemable convertible common stock— 2,750,000 
Common stock options10,172,491 25,691,329 
Restricted stock units29,413,894 3,224,181 
Convertible preferred stock warrants— 735,763 
Common stock warrants5,093,905 688,362 
Private and Public Placement Warrants14,750,000 — 
Earn-Out Shares13,005,238 — 
Shares subject to repurchase— 16,539 
Total72,435,528 148,393,189 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Class of Stock [Line Items]      
Accumulated deficit $ 590,927   $ 577,858
Cash and cash equivalents $ 81,653 $ 74,428 81,084
Customer complementary membership period 60 days    
Contractual liabilities $ 9,152   10,878
Fulfillment cost 17,000 24,400  
Deferred Revenue      
Class of Stock [Line Items]      
Contractual liabilities 9,200   10,900
Contract with customer, liability, revenue recognized 6,600    
Other Current Liabilities      
Class of Stock [Line Items]      
Contractual liabilities 200   $ 200
Contract with customer, liability, revenue recognized 200    
Shipping and Handling      
Class of Stock [Line Items]      
Fulfillment cost 10,400 14,300  
Fulfillment Labor      
Class of Stock [Line Items]      
Fulfillment cost $ 3,900 $ 6,600  
Revenue Benchmark | Supplier Concentration Risk | Five Suppliers      
Class of Stock [Line Items]      
Concentration risk, percentage 50.00% 50.00%  
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Total revenue, net $ 71,565 $ 90,479
Grove Brands    
Disaggregation of Revenue [Line Items]    
Total revenue, net 34,976 46,796
Third-party products    
Disaggregation of Revenue [Line Items]    
Total revenue, net $ 36,589 $ 43,683
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: $ 78,213 $ 74,990
Financial Liabilities: 13,519 13,227
Structural Derivative    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 7,650 7,050
Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 803 580
Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 4,265 4,122
Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 364 670
Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 437 805
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 78,213 74,990
Financial Liabilities: 437 805
Level 1 | Structural Derivative    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 1 | Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 1 | Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 1 | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 1 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 437 805
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 0 0
Financial Liabilities: 364 670
Level 2 | Structural Derivative    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 2 | Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 2 | Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 2 | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 364 670
Level 2 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 0 0
Financial Liabilities: 12,718 11,752
Level 3 | Structural Derivative    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 7,650 7,050
Level 3 | Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 803 580
Level 3 | Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 4,265 4,122
Level 3 | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Level 3 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0 0
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 78,213 74,990
Money market funds | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 78,213 74,990
Money market funds | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 0 0
Money market funds | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: $ 0 $ 0
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Level 3
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Earn-Out Shares  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Balance at December 31, 2022 $ 4,122
Cancellation of Earn-Out Shares (347)
Changes in fair value 490
Balance at March 31, 2023 4,265
Structural Derivative  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Balance at December 31, 2022 7,050
Changes in fair value 600
Balance at March 31, 2023 7,650
Additional Share  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Balance at December 31, 2022 580
Changes in fair value 223
Balance at March 31, 2023 $ 803
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Private Placement Warrants | Level 2  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]  
Balance at December 31, 2022 $ 670
Changes in fair value (306)
Balance at March 31, 2023 364
Public Warrants | Level 1  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]  
Balance at December 31, 2022 805
Changes in fair value (368)
Balance at March 31, 2023 $ 437
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Inventory purchases $ 2,530 $ 2,757
Compensation and benefits 2,861 1,714
Advertising costs 1,020 1,203
Fulfillment costs 1,335 1,725
Sales taxes 1,509 1,374
Transaction costs 0 17,500
Other accrued expenses 4,712 5,081
Accrued expenses $ 13,967 $ 31,354
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Total debt $ 69,389 $ 61,195
Debt, current (340) (575)
Debt, noncurrent 69,049 60,620
Structural Lenders | Structural Debt Facility    
Debt Instrument [Line Items]    
Other long-term debt 61,549 60,620
Siena Lending Group, LLC | Siena Revolver    
Debt Instrument [Line Items]    
Other long-term debt 7,500 0
Atel | Atel Loan Facility Draw 3    
Debt Instrument [Line Items]    
Other long-term debt 292 480
Atel | Atel Loan Facility Draw 4    
Debt Instrument [Line Items]    
Other long-term debt $ 48 $ 95
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended
Dec. 21, 2022
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Jul. 21, 2025
Mar. 10, 2023
Debt Instrument [Line Items]              
Change in fair value of structural derivative liability       $ 600,000 $ 0    
Payment of debt issuance costs       $ 837,000 $ 0    
Atel Loan Facility Draw 3              
Debt Instrument [Line Items]              
Debt instrument, interest rate, effective percentage   19.23%   19.23%      
Atel Loan Facility Draw 4              
Debt Instrument [Line Items]              
Debt instrument, interest rate, effective percentage   19.23%   19.23%      
Line of Credit | Revolving Credit Facility              
Debt Instrument [Line Items]              
Long-term line of credit   $ 7,500,000   $ 7,500,000      
Line of Credit | Revolving Credit Facility | Loan And Security Agreement              
Debt Instrument [Line Items]              
Debt issuance costs, gross   1,000,000   1,000,000      
Line of credit facility, additional borrowing capacity   $ 10,200,000   $ 10,200,000      
Long-term debt, percentage bearing variable interest, percentage rate   8.52%   8.52%      
Line of Credit | Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   0.10%          
Line of Credit | Federal Funds Rate | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   0.50%          
Line of Credit | Base Rate | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   5.00%          
Line of Credit | Minimum | Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   3.75%          
Line of Credit | Minimum | Base Rate | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   2.75%          
Line of Credit | Maximum | Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   5.50%          
Line of Credit | Maximum | Base Rate | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate   4.50%          
Structural Lenders | Structural Debt Facility              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 72,000,000        
Debt instrument, interest rate, effective percentage   20.34%   20.34%      
Debt instrument, covenant, minimum unrestricted cash required to maintain     57,000,000        
Debt instrument, unamortized discount (premium), net $ 1,100,000            
Payment of debt issuance costs     3,300,000        
Long-term debt, gross   $ 72,000,000   $ 72,000,000      
Other long-term debt   61,549,000 60,620,000 61,549,000      
Structural Lenders | Structural Debt Facility | Structural Derivative | Level 3              
Debt Instrument [Line Items]              
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases     $ 7,100,000        
Structural Lenders | Structural Debt Facility | Forecast              
Debt Instrument [Line Items]              
Debt instrument, anniversary of closing date           30 months  
Trading days prior to such date           60 days  
Structural Lenders | Structural Debt Facility | Class A Common Stock              
Debt Instrument [Line Items]              
Number of shares issued 4,950,000            
Structural Lenders | Structural Debt Facility | Class A Common Stock | Forecast              
Debt Instrument [Line Items]              
Contingently issuable shares, calculation, numerator           $ 9,900,000  
Contingently issuable shares, calculation, maximum denominator           $ 2.00  
Structural Lenders | Structural Debt Facility | Prime Rate              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate     7.50%        
Structural Lenders | Structural Debt Facility | Minimum              
Debt Instrument [Line Items]              
Debt instrument, interest rate, effective percentage     15.00%        
Siena Lending Group, LLC | Loan And Security Agreement | Revolving Credit Facility              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity             $ 35,000,000
Atel | Atel Loan Facility | Tranche Three              
Debt Instrument [Line Items]              
Other long-term debt   300,000   300,000      
Atel | Atel Loan Facility | Tranche Four              
Debt Instrument [Line Items]              
Other long-term debt   $ 100,000   $ 100,000      
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Long-Term Purchase Commitment [Line Items]    
Purchase obligation $ 15.3 $ 18.7
Standby Letters of Credit    
Long-Term Purchase Commitment [Line Items]    
Line of credit facility, maximum borrowing capacity $ 3.5 $ 3.1
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Warrants - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 5 Months Ended
Nov. 10, 2022
Jul. 18, 2022
Jun. 16, 2022
Mar. 31, 2023
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Dec. 31, 2022
Jul. 16, 2022
Class of Warrant or Right [Line Items]                  
Reverse recapitalization, percentage of voting interests acquired     100.00%            
Proceeds from issuance of common stock, reverse recapitalization     $ 97,100            
Reverse recapitalization, transaction costs     $ 24,400            
Transaction costs       $ 0 $ 0   $ 0 $ 17,500  
Decrease in accrued transaction costs       13,400          
Increase to other income, net       3,800          
Increase to additional paid in capital due to reduction of transaction costs       $ 9,600 $ 9,609 $ 0      
Common stock, par value (in dollars per share)       $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001  
Cancellation of earn-out shares (in shares)         985,722        
Reverse recapitalization, contingent consideration, liability, earnout period     10 years            
Consulting fee expense $ 150                
Stock-based compensation expense         $ 4,900 $ 4,500      
Standby Equity Purchase Agreement                  
Class of Warrant or Right [Line Items]                  
Purchase agreement, equity interests issuable, not yet issued   $ 100,000              
Purchase agreement, equity interests issuable, not yet issued, transaction period   36 months              
Sale of stock, exchange cap, maximum number of shares authorized to sell (in shares)   32,557,664              
Sale of stock, exchange cap, percentage of shares outstanding   19.99%              
Sale of stock, ability to sell full commitment, share price threshold (in dollars per share)   $ 3.07              
Purchase agreement, volume weighted average price, percentage   97.55%              
Purchase agreement, deferred transaction cost   $ 700              
Sale of stock, number of shares issued in transaction (in shares)         739,825        
Sale of stock, consideration received on transaction         $ 2,400        
Sale of stock, number of shares available in transaction (in shares)         31,817,839        
HGI Subscription Agreement, Additional Shares | Sale Of Stock, Measurement Period One                  
Class of Warrant or Right [Line Items]                  
Sale of stock, covenant, volume weighted average price threshold, measurement period 3 months                
HGI Subscription Agreement, Additional Shares | Sale Of Stock, Measurement Period Two                  
Class of Warrant or Right [Line Items]                  
Sale of stock, covenant, volume weighted average price threshold, measurement period 6 months                
HGI Subscription Agreement, Additional Shares | Sale Of Stock, Measurement Period Three                  
Class of Warrant or Right [Line Items]                  
Sale of stock, covenant, volume weighted average price threshold, measurement period 9 months                
Private Placement Warrants                  
Class of Warrant or Right [Line Items]                  
Class of warrant or right, outstanding (in shares)       6,700,000 6,700,000   6,700,000    
Exercise price (in dollars per share)       $ 11.50 $ 11.50   $ 11.50   $ 11.50
Number of days after the completion of an initial business combination       30 days 30 days   30 days    
Public Warrants                  
Class of Warrant or Right [Line Items]                  
Class of warrant or right, outstanding (in shares)       8,050,000 8,050,000   8,050,000    
Exercise price (in dollars per share)       $ 11.50 $ 11.50   $ 11.50    
HGI Warrants                  
Class of Warrant or Right [Line Items]                  
Exercise price (in dollars per share) $ 1.26                
Warrants issued (in shares) 4,525,000                
Warrant shares, shares vesting rights, percentage 40.00%                
Warrants, covenant, quarterly net revenue $ 100,000                
Warrants, equity ownership percentage 25.00%                
Warrant, exercise price, increase, percentage 50.00%                
Vested Warrants                  
Class of Warrant or Right [Line Items]                  
Stock-based compensation expense         $ 1,200        
Class B Common Stock                  
Class of Warrant or Right [Line Items]                  
Common stock, par value (in dollars per share)     $ 0.0001            
Reverse recapitalization, contingent consideration, liability (in shares)     13,999,960            
Class A Common Stock                  
Class of Warrant or Right [Line Items]                  
Class of warrant or right, number of securities called by each warrant or right (in shares)     1            
Reverse recapitalization, contingent consideration, liability (in shares)         13,014,238        
Class A Common Stock | Corvina Holdings Limited                  
Class of Warrant or Right [Line Items]                  
Class of warrant or right, number of securities called by each warrant or right (in shares)       1 1   1    
Class of warrants or rights warrants issued during period (in shares)       3,875,028 3,875,028   3,875,028    
Share price (in dollars per share)       $ 0.01 $ 0.01   $ 0.01    
Number of shares exercised by warrants at period end       0 0   0    
Class A Common Stock | HGI Subscription Agreement                  
Class of Warrant or Right [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares) 1,984,126                
Sale of stock, consideration received on transaction $ 2,500                
Class A Common Stock | HGI Subscription Agreement, Additional Shares                  
Class of Warrant or Right [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares)             0    
Sale of stock, covenant, volume weighted average price threshold (in dollars per share) $ 1.26                
Sale of stock, covenant, volume weighted average price threshold, trading period 3 days                
Class A Common Stock | Public Warrants                  
Class of Warrant or Right [Line Items]                  
Number of warrant or right, entitles to purchase (in shares)                 1
Class of warrants redemption notice period                 30 days
Class of warrants or rights redemption price per unit (in dollars per share)                 $ 0.01
Share redemption trigger price (in dollars per share)                 $ 18.00
Class A Common Stock | Public Warrants | Minimum                  
Class of Warrant or Right [Line Items]                  
Class of warrant or right redemption threshold consecutive trading days                 20 days
Class A Common Stock | Public Warrants | Maximum                  
Class of Warrant or Right [Line Items]                  
Class of warrant or right redemption threshold consecutive trading days                 30 days
Class A Common Stock | Reverse Recapitalization Tranche One                  
Class of Warrant or Right [Line Items]                  
Reverse recapitalization, contingent consideration, liability (in shares)     6,507,310            
Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share)     $ 12.50            
Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days     20 days            
Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period     30 days            
Class A Common Stock | Reverse Recapitalization Tranche Two                  
Class of Warrant or Right [Line Items]                  
Reverse recapitalization, contingent consideration, liability (in shares)     6,506,928            
Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share)     $ 15.00            
Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days     20 days            
Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period     30 days            
2022 Equity Incentive Plan | Class B Common Stock                  
Class of Warrant or Right [Line Items]                  
Recapitalization exchange ratio     1.1760            
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Warrants - Schedule of Warrants Oustanding (Details) - $ / shares
Mar. 31, 2023
Jul. 16, 2022
Public Warrants    
Class of Warrant or Right [Line Items]    
Class of warrant or right, outstanding (in shares) 8,050,000  
Exercise price (in dollars per share) $ 11.50  
Private Placement Warrants    
Class of Warrant or Right [Line Items]    
Class of warrant or right, outstanding (in shares) 6,700,000  
Exercise price (in dollars per share) $ 11.50 $ 11.50
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Warrants - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details)
3 Months Ended
Mar. 31, 2023
$ / shares
Unvested Warrant  
Class of Warrant or Right [Line Items]  
Fair value of common stock (in dollars per share) $ 1.26
Expected term (in years) 4 years 6 months
Volatility 62.50%
Risk-free interest rate 4.00%
Dividend yield 0.00%
Vested Warrants  
Class of Warrant or Right [Line Items]  
Fair value of common stock (in dollars per share) $ 1.26
Expected term (in years) 4 years 6 months
Volatility 62.50%
Risk-free interest rate 4.00%
Dividend yield 0.00%
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Warrants - Schedule of Reserved for Issuance (Details) - shares
Mar. 31, 2023
Dec. 31, 2022
Class A Common Stock    
Class of Warrant or Right [Line Items]    
Private placement warrant, shares reserved for future issuance (in shares) 6,700,000 6,700,000
Public warrant, shares reserved for future issuance (in shares) 8,050,000 8,050,000
Backstop warrant, shares reserved for future issuance (in shares) 3,875,028 3,875,028
Common stock warrant, shares reserved for future issuance (in shares) 4,525,000 4,525,000
Outstanding stock option, shares reserved for future issuance (in shares) 5,969,813 6,318,978
Outstanding restricted stock unit, shares reserved for future issuance (in shares) 29,238,710 19,322,240
Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares) 5,052,643 3,274,070
Total shares of common stock reserved (in shares) 72,749,491 72,859,679
Class B Common Stock    
Class of Warrant or Right [Line Items]    
Private placement warrant, shares reserved for future issuance (in shares) 0 0
Public warrant, shares reserved for future issuance (in shares) 0 0
Backstop warrant, shares reserved for future issuance (in shares) 0 0
Common stock warrant, shares reserved for future issuance (in shares) 568,905 568,905
Outstanding stock option, shares reserved for future issuance (in shares) 4,202,678 4,198,917
Outstanding restricted stock unit, shares reserved for future issuance (in shares) 175,184 263,052
Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares) 0 0
Total shares of common stock reserved (in shares) 4,946,767 5,030,874
2022 Equity Incentive Plan | Class A Common Stock    
Class of Warrant or Right [Line Items]    
Shares available for future issuance under equity incentive plan (in shares) 9,338,297 20,794,363
2022 Equity Incentive Plan | Class B Common Stock    
Class of Warrant or Right [Line Items]    
Shares available for future issuance under equity incentive plan (in shares) 0 0
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2022
Dec. 31, 2022
Number of Options      
Options outstanding, beginning of period (in shares) 10,521,571    
Exercised (in shares) (178,564)    
Cancelled/forfeited (in shares) (170,516)    
Options outstanding, ending of period (in shares) 10,172,491    
Options vested and exercisable (in shares) 9,040,393    
Weighted–Average Exercise Price      
Options outstanding, beginning of period (in dollars per share) $ 1.59    
Exercised (in dollars per share) 0.38    
Cancelled/forfeited (in dollars per share) 2.82    
Options outstanding, ending of period (in dollars per share) 1.59    
Options vested and exercisable (in dollars per share) $ 1.32    
Weighted-Average Remaining Contractual Life (years)      
Options, outstanding (in years) 4 years 18 days 4 years 10 months 13 days  
Options vested and exercisable (in years) 3 years 6 months 29 days    
Aggregate Intrinsic Value      
Options, outstanding, aggregate intrinsic value $ 98   $ 61
Options, vested and exercisable, aggregate intrinsic value $ 98    
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation - Narrative (Details)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 11 Months Ended
May 31, 2022
Feb. 28, 2021
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
shares
Mar. 31, 2022
USD ($)
shares
Mar. 31, 2023
USD ($)
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | shares     0 0  
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value     $ 0.1 $ 4.4  
Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value     0.0 0.4 $ 0.0
Stock-based compensation expense     4.9 $ 4.5  
Share-based payment arrangement, nonvested award, cost not yet recognized, amount     $ 28.6   $ 28.6
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years)     2 years 3 months 18 days    
Market-based Stock Options          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | shares   1,017,170      
Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share) | $ / shares   $ 3.77      
Vesting rights, percentage   100.00%      
Share-based compensation arrangement by share-based payment award, options, grant date, fair value   $ 5.5      
Stock-based compensation expense   $ 4.6      
Employee Stock          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation arrangement by share-based payment award, maximum employee contributions, percentage of eligible compensation 0.20        
Number of shares purchased | shares         0
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) - Restricted stock units
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 19,482,427
Granted (in shares) | shares 13,314,042
Vested (in shares) | shares (2,549,326)
Cancelled/forfeited (in shares) | shares (833,249)
Outstanding and unvested, ending of period (in shares) | shares 29,413,894
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ 1.75
Granted (in dollars per share) | $ / shares 0.43
Vested (in dollars per share) | $ / shares 2.28
Cancelled/forfeited (in dollars per share) | $ / shares 2.69
Outstanding and unvested, ending of period (in dollars per share) | $ / shares $ 1.08
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Net loss Per Share Attributable to Common Stockholders (Details) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 72,435,528 148,393,189
Convertible preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 0 115,287,015
Contingently redeemable convertible common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 0 2,750,000
Common stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 10,172,491 25,691,329
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 29,413,894 3,224,181
Convertible preferred stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 0 735,763
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 5,093,905 688,362
Private and Public Placement Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 14,750,000 0
Earn-Out Shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 13,005,238 0
Shares subject to repurchase    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares) 0 16,539
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details) - Subsequent Event
$ in Millions
Apr. 19, 2023
USD ($)
Subsequent Event [Line Items]  
Operating lease, renewal term 5 years
Operating lease, liability, undiscounted annual amount $ 0.7
XML 55 grov-20230331_htm.xml IDEA: XBRL DOCUMENT 0001841761 2023-01-01 2023-03-31 0001841761 us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001841761 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001841761 us-gaap:CommonClassAMember 2023-05-05 0001841761 us-gaap:CommonClassBMember 2023-05-05 0001841761 2023-03-31 0001841761 2022-12-31 0001841761 us-gaap:CommonClassAMember 2022-12-31 0001841761 us-gaap:CommonClassAMember 2023-03-31 0001841761 us-gaap:CommonClassBMember 2023-03-31 0001841761 us-gaap:CommonClassBMember 2022-12-31 0001841761 2022-01-01 2022-03-31 0001841761 us-gaap:CommonStockMember 2022-12-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001841761 us-gaap:RetainedEarningsMember 2022-12-31 0001841761 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001841761 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001841761 us-gaap:CommonStockMember 2023-03-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001841761 us-gaap:RetainedEarningsMember 2023-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2021-12-31 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2021-12-31 0001841761 us-gaap:CommonStockMember 2021-12-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001841761 us-gaap:RetainedEarningsMember 2021-12-31 0001841761 2021-12-31 0001841761 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-01-01 2022-03-31 0001841761 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-03-31 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-03-31 0001841761 us-gaap:CommonStockMember 2022-03-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001841761 us-gaap:RetainedEarningsMember 2022-03-31 0001841761 2022-03-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassBMember 2022-06-16 0001841761 grov:FiveSuppliersMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-03-31 0001841761 grov:FiveSuppliersMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-03-31 0001841761 grov:GroveBrandsMember 2023-01-01 2023-03-31 0001841761 grov:GroveBrandsMember 2022-01-01 2022-03-31 0001841761 grov:ThirdPartyProductsMember 2023-01-01 2023-03-31 0001841761 grov:ThirdPartyProductsMember 2022-01-01 2022-03-31 0001841761 grov:DeferredRevenueMember 2023-03-31 0001841761 us-gaap:OtherCurrentLiabilitiesMember 2023-03-31 0001841761 grov:DeferredRevenueMember 2022-12-31 0001841761 us-gaap:OtherCurrentLiabilitiesMember 2022-12-31 0001841761 grov:DeferredRevenueMember 2023-01-01 2023-03-31 0001841761 us-gaap:OtherCurrentLiabilitiesMember 2023-01-01 2023-03-31 0001841761 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-03-31 0001841761 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-03-31 0001841761 grov:FulfillmentLaborMember 2023-01-01 2023-03-31 0001841761 grov:FulfillmentLaborMember 2022-01-01 2022-03-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:AdditionalSharesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member 2023-01-01 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-03-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001841761 grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2023-03-31 0001841761 grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2022-12-31 0001841761 grov:SienaRevolverMember grov:SienaLendingGroupLLCMember 2023-03-31 0001841761 grov:SienaRevolverMember grov:SienaLendingGroupLLCMember 2022-12-31 0001841761 grov:AtelLoanFacilityTrancheThreeMember grov:AtelMember 2023-03-31 0001841761 grov:AtelLoanFacilityTrancheThreeMember grov:AtelMember 2022-12-31 0001841761 grov:AtelLoanFacilityTrancheFourMember grov:AtelMember 2023-03-31 0001841761 grov:AtelLoanFacilityTrancheFourMember grov:AtelMember 2022-12-31 0001841761 srt:MinimumMember grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2022-12-31 0001841761 grov:StructuralDebtFacilityMember us-gaap:PrimeRateMember grov:StructuralLendersMember 2022-12-01 2022-12-31 0001841761 grov:StructuralDebtFacilityMember us-gaap:CommonClassAMember grov:StructuralLendersMember 2022-12-21 2022-12-21 0001841761 grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2022-12-21 0001841761 srt:ScenarioForecastMember grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2025-07-21 0001841761 srt:ScenarioForecastMember grov:StructuralDebtFacilityMember us-gaap:CommonClassAMember grov:StructuralLendersMember 2025-07-21 0001841761 grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2022-12-01 2022-12-31 0001841761 grov:StructuralDerivativeMember us-gaap:FairValueInputsLevel3Member grov:StructuralDebtFacilityMember grov:StructuralLendersMember 2022-12-01 2022-12-31 0001841761 us-gaap:RevolvingCreditFacilityMember grov:LoanAndSecurityAgreementMember grov:SienaLendingGroupLLCMember 2023-03-10 0001841761 us-gaap:RevolvingCreditFacilityMember grov:LoanAndSecurityAgreementMember us-gaap:LineOfCreditMember 2023-03-31 0001841761 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember grov:SecuredOvernightFinancingRateSOFRMember 2023-03-01 2023-03-31 0001841761 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember grov:FederalFundsRateMember 2023-03-01 2023-03-31 0001841761 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-03-01 2023-03-31 0001841761 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-03-01 2023-03-31 0001841761 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-03-01 2023-03-31 0001841761 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember grov:SecuredOvernightFinancingRateSOFRMember 2023-03-01 2023-03-31 0001841761 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember grov:SecuredOvernightFinancingRateSOFRMember 2023-03-01 2023-03-31 0001841761 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-03-31 0001841761 grov:AtelLoanFacilityMember grov:AtelMember grov:TrancheThreeMember 2023-03-31 0001841761 grov:AtelLoanFacilityMember grov:AtelMember grov:TrancheFourMember 2023-03-31 0001841761 grov:AtelLoanFacilityTrancheThreeMember 2023-03-31 0001841761 grov:AtelLoanFacilityTrancheFourMember 2023-03-31 0001841761 us-gaap:StandbyLettersOfCreditMember 2023-03-31 0001841761 us-gaap:StandbyLettersOfCreditMember 2022-12-31 0001841761 2022-06-16 0001841761 2022-06-16 2022-06-16 0001841761 2023-03-01 2023-03-31 0001841761 us-gaap:CommonClassBMember 2022-06-16 0001841761 us-gaap:CommonClassAMember 2022-06-16 0001841761 us-gaap:CommonClassBMember 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheOneMember 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheOneMember 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheTwoMember 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheTwoMember 2022-06-16 0001841761 grov:PrivatePlacementWarrantMember 2023-03-31 0001841761 grov:PublicWarrantMember 2023-03-31 0001841761 grov:PublicWarrantMember us-gaap:CommonClassAMember 2022-07-16 0001841761 grov:PrivatePlacementWarrantMember 2022-07-16 0001841761 srt:MinimumMember grov:PublicWarrantMember us-gaap:CommonClassAMember 2022-07-16 0001841761 srt:MaximumMember grov:PublicWarrantMember us-gaap:CommonClassAMember 2022-07-16 0001841761 grov:CorvinaHoldingsLimitedMember us-gaap:CommonClassAMember 2023-03-31 0001841761 grov:StandbyEquityPurchaseAgreementMember 2022-07-18 2022-07-18 0001841761 grov:StandbyEquityPurchaseAgreementMember 2022-07-18 0001841761 grov:StandbyEquityPurchaseAgreementMember 2023-01-01 2023-03-31 0001841761 us-gaap:CommonClassAMember grov:HGISubscriptionAgreementMember 2022-11-10 2022-11-10 0001841761 us-gaap:CommonClassAMember grov:HGISubscriptionAgreementAdditionalSharesMember 2022-11-10 0001841761 us-gaap:CommonClassAMember grov:HGISubscriptionAgreementAdditionalSharesMember 2022-11-10 2022-11-10 0001841761 grov:HGISubscriptionAgreementAdditionalSharesMember grov:SaleOfStockMeasurementPeriodOneMember 2022-11-10 2022-11-10 0001841761 grov:HGISubscriptionAgreementAdditionalSharesMember grov:SaleOfStockMeasurementPeriodTwoMember 2022-11-10 2022-11-10 0001841761 grov:HGISubscriptionAgreementAdditionalSharesMember grov:SaleOfStockMeasurementPeriodThreeMember 2022-11-10 2022-11-10 0001841761 us-gaap:CommonClassAMember grov:HGISubscriptionAgreementAdditionalSharesMember 2022-11-10 2023-03-31 0001841761 2022-11-10 2022-11-10 0001841761 grov:HGIWarrantsMember 2022-11-10 2022-11-10 0001841761 grov:HGIWarrantsMember 2022-11-10 0001841761 grov:VestedWarrantsMember 2023-01-01 2023-03-31 0001841761 grov:UnvestedWarrantMember 2023-01-01 2023-03-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassAMember 2023-03-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassBMember 2023-03-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassAMember 2022-12-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassBMember 2022-12-31 0001841761 2022-01-01 2022-06-30 0001841761 grov:MarketBasedStockOptionsMember 2021-02-01 2021-02-28 0001841761 grov:MarketBasedStockOptionsMember 2021-02-28 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001841761 us-gaap:EmployeeStockMember 2022-05-01 2022-05-31 0001841761 us-gaap:EmployeeStockMember 2022-05-01 2023-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001841761 grov:ContingentlyRedeemableConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001841761 grov:ContingentlyRedeemableConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001841761 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001841761 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001841761 grov:ConvertiblePreferredStockWarrantsMember 2023-01-01 2023-03-31 0001841761 grov:ConvertiblePreferredStockWarrantsMember 2022-01-01 2022-03-31 0001841761 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001841761 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001841761 grov:PrivateAndPublicPlacementWarrantsMember 2023-01-01 2023-03-31 0001841761 grov:PrivateAndPublicPlacementWarrantsMember 2022-01-01 2022-03-31 0001841761 grov:EarnOutShareMember 2023-01-01 2023-03-31 0001841761 grov:EarnOutShareMember 2022-01-01 2022-03-31 0001841761 grov:SharesSubjectToRepurchaseMember 2023-01-01 2023-03-31 0001841761 grov:SharesSubjectToRepurchaseMember 2022-01-01 2022-03-31 0001841761 us-gaap:SubsequentEventMember 2023-04-19 shares iso4217:USD iso4217:USD shares pure 0001841761 --12-31 2023 Q1 false P60D P20D P30D P3D 10-Q true 2023-03-31 false 001-40263 Grove Collaborative Holdings, Inc. DE 88-2840659 1301 Sansome Street San Francisco CA 94111 800 231-8527 Class A common stock, par value $0.0001 GROV NYSE Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share GROV.WS NYSE Yes Yes Non-accelerated Filer true true false false 128876248 49874913 81653000 81084000 5850000 11950000 40930000 44132000 5806000 4844000 134239000 142010000 2951000 2951000 13852000 14530000 11721000 12362000 2817000 2192000 165580000 174045000 12293000 10712000 13967000 31354000 9152000 10878000 3762000 3705000 565000 249000 340000 575000 40079000 57473000 69049000 60620000 15233000 16192000 13519000 13227000 137880000 147512000 0.0001 0.0001 100000000 100000000 0 0 0 0 0 0 0.0001 0.0001 600000000 600000000 128870368 128870368 125617015 125617015 200000000 200000000 49874913 49874913 52240311 52240311 18000 18000 618609000 604373000 -590927000 -577858000 27700000 26533000 165580000 174045000 71565000 90479000 34310000 47742000 37255000 42737000 8673000 32793000 4216000 6240000 38021000 50970000 -13655000 -47266000 3729000 2087000 223000 0 143000 0 -674000 0 600000 0 4617000 1992000 596000 -95000 -13059000 -47361000 10000 23000 -13069000 -47384000 -0.08 -0.08 -5.05 -5.05 168739298 168739298 9387142 9387142 177857000 18000 604373000 -577858000 26533000 179000 68000 68000 986000 1695000 -356000 -356000 9609000 9609000 4915000 4915000 -13069000 -13069000 178745000 18000 618609000 -590927000 27700000 114795000 487918000 0 0 9368000 1000 33863000 -490143000 -456279000 87000 171000 171000 2750000 27473000 125000 125000 4501000 4501000 -47384000 -47384000 114795000 487918000 2750000 27473000 9455000 1000 38660000 -537527000 -498866000 1.1760 -13069000 -47384000 0 -1886000 4893000 4460000 1448000 1410000 292000 0 -3745000 0 948000 195000 124000 856000 77000 8000 -3078000 -3038000 828000 3312000 1554000 10287000 162000 2917000 -1726000 159000 261000 22000 316000 -229000 -6737000 -29503000 784000 1352000 -784000 -1352000 0 27500000 4150000 489000 7500000 0 837000 0 235000 275000 -288000 171000 1990000 26907000 -5531000 -3948000 95985000 78376000 90454000 74428000 9000 21000 2734000 1461000 113000 286000 9609000 0 0 2582000 0 125000 81653000 74428000 8801000 0 90454000 74428000 Description of Business<div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II, or “VGAC II”) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”).</span></div><div style="text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 7,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Common Stock and Warrants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details.</span></div> Summary of Significant Accounting Policies <div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Liquidity</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should be read in conjunction with the Company’s financial statements and accompanying notes as of and for the year ended </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022 (the “audited financial statements”) that were included in the Company’s Form 10-K filed with the SEC on March 16, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and the results of operations for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any other future interim or annual period.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $590.9 million as of March 31, 2023. The Company’s existing sources of liquidity as of March 31, 2023 include cash and cash equivalents of $81.7 million and availability of debt from the Siena Revolver (defined in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock, contingently redeemable convertible common stock and the incurrence of debt. The Company believes its existing cash and cash equivalents will be sufficient to fund its operations for a period of at least one year from the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2022.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, the fair value of Additional Shares liabilities, the fair value of the Structural Derivative Liability and stock based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term restricted cash primarily represents cash on deposit with a financial institution to collateralize short-term obligations related to company credit cards. Long-term restricted cash primarily represents cash on deposit with a financial institution to collateralize letters of credit related to the Company’s non-cancellable operating leases for its corporate headquarters. Restricted cash is stated at cost, which approximates fair value.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains the majority of its cash, cash equivalents and restricted cash in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company depends on a limited number of vendors to supply products sold by the Company. For the three months ended March 31, 2023 and 2022, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evenue is recognized. The C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany records a refund reserve based on historical refund patterns. As of March 31, 2023 an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d December 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was not material.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenue by product type (in thousands):</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.575%"><tr><td style="width:1.0%"/><td style="width:65.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.268%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grove Brands </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,976 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,683 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,565 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,479 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Liabilities</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual liabilities included in deferred revenue and other current liabilities were $9.2 million and $0.2 million, respectively, as of March 31, 2023 and $10.9 million and $0.2 million, respectively, as of December 31, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the three months ended March 31, 2023 that was previously included in deferred revenue and other current liabilities as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022 was $6.6 million and $0.2 million, respectively.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fulfillment Costs</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative </span></div>expenses in the condensed consolidated statements of operations. For the three months ended March 31, 2023 and 2022, the Company recorded fulfillment costs of $17.0 million and $24.4 million, respectively, which included $10.4 million and $14.3 million in shipping and handling expenses, respectively, and $3.9 million and $6.6 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors. <div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Liquidity</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should be read in conjunction with the Company’s financial statements and accompanying notes as of and for the year ended </span></div>December 31, 2022 (the “audited financial statements”) that were included in the Company’s Form 10-K filed with the SEC on March 16, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and the results of operations for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any other future interim or annual period. -590900000 81700000 <div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.</span></div> <div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, the fair value of Additional Shares liabilities, the fair value of the Structural Derivative Liability and stock based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.</span></div> Restricted CashShort-term restricted cash primarily represents cash on deposit with a financial institution to collateralize short-term obligations related to company credit cards. Long-term restricted cash primarily represents cash on deposit with a financial institution to collateralize letters of credit related to the Company’s non-cancellable operating leases for its corporate headquarters. Restricted cash is stated at cost, which approximates fair value. <div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains the majority of its cash, cash equivalents and restricted cash in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.</span></div> 0.50 0.50 <div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.</span></div>The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. Contractual LiabilitiesThe Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. P60D <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenue by product type (in thousands):</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.575%"><tr><td style="width:1.0%"/><td style="width:65.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.268%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grove Brands </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,976 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,683 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,565 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,479 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 34976000 46796000 36589000 43683000 71565000 90479000 9200000 200000 10900000 200000 6600000 200000 Fulfillment CostsFulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. 17000000 24400000 10400000 14300000 3900000 6600000 Fair Value Measurements and Fair Value of Financial Instruments<div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt, Additional Shares, Earn-Out Shares Public and Private Placement Warrants and Structural Derivative. Cash equivalents, Earn-Out Shares, Public and Private Placement Warrants and Structural Derivative are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exceptions as defined in Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock and Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Structural Derivative Liability is a compound embedded derivative related to features within the Structural Debt Facility, including an increase in interest rate upon an event of default and the contingent issuance of the Structural Subsequent Shares as defined in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This liability is classified as Level 3 and is valued using a risk-neutral income approach related to an event of default occurring and expected cash flows in such a scenario and an income and Black-Scholes pricing model for the contingent issuance of the Structural Subsequent Shares utilizing assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023 and December 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by level within the fair value hierarchy (in thousands):</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Derivative Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,718 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,519 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Derivative Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,752 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,227 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Shares Liability</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the HGI Subscription Agreement defined in Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock and Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded a liability related to the potential issuance of Additional Shares. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of Additional Shares Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earn-Out Shares</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Closing of the Business Combination, certain Earn-Out Shares were accounted for as a liability. Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of Earn-Out Shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement and Public Warrant Liabilities</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company has Private Placement and Public Warrants. Such warrants are measured at fair value on a recurring basis.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Public Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Structural Derivative Liability</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At closing of the Structural Debt Facility, the Company recorded a liability related to the features that are required to be bifurcated and accounted for as a compound derivative at fair value. Subsequent changes in fair value of the Structural Derivative Liability until settlement is recognized in the statement of operations.</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Structural Derivative Liability (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt, Additional Shares, Earn-Out Shares Public and Private Placement Warrants and Structural Derivative. Cash equivalents, Earn-Out Shares, Public and Private Placement Warrants and Structural Derivative are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exceptions as defined in Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock and Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Structural Derivative Liability is a compound embedded derivative related to features within the Structural Debt Facility, including an increase in interest rate upon an event of default and the contingent issuance of the Structural Subsequent Shares as defined in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This liability is classified as Level 3 and is valued using a risk-neutral income approach related to an event of default occurring and expected cash flows in such a scenario and an income and Black-Scholes pricing model for the contingent issuance of the Structural Subsequent Shares utilizing assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption using an average of the implied volatility of its publicly traded warrants and an implied volatility based on its peer companies.</span></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023 and December 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by level within the fair value hierarchy (in thousands):</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Derivative Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,718 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,519 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,990 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Derivative Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,752 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,227 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 78213000 0 0 78213000 78213000 0 0 78213000 0 0 803000 803000 0 0 4265000 4265000 0 364000 0 364000 437000 0 0 437000 0 0 7650000 7650000 437000 364000 12718000 13519000 74990000 0 0 74990000 74990000 0 0 74990000 0 0 580000 580000 0 0 4122000 4122000 0 670000 0 670000 805000 0 0 805000 0 0 7050000 7050000 805000 670000 11752000 13227000 <div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of Additional Shares Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of Earn-Out Shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Structural Derivative Liability (in thousands):</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 580000 -223000 803000 4122000 347000 -490000 4265000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Public Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 670000 805000 306000 368000 364000 437000 7050000 -600000 7650000 Accrued Expenses<div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:18pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.060%"><tr><td style="width:1.0%"/><td style="width:70.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,861 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,967 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,354 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:18pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.060%"><tr><td style="width:1.0%"/><td style="width:70.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,861 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,967 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,354 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2530000 2757000 2861000 1714000 1020000 1203000 1335000 1725000 1509000 1374000 0 17500000 4712000 5081000 13967000 31354000 Debt <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:70.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Debt Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,620 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Siena Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,389 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, noncurrent</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,049 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,620 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Structural Debt Facility</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company entered into a Loan and Security Agreement (“Structural Debt Facility”) with Structural Capital Investments III, LP, Structural Capital Investments IV, LP and Series PCI Grove series of Structural Capital Primary Co-Investment Fund, LLC (collectively, “Structural Funds”) and Avenue Sustainable Solutions Fund, L.P. (“Avenue”) (collectively “Structural Lenders”) to borrow $72.0 million which was used primarily to settle previously outstanding obligations with a prior lender. The Structural Debt Facility bears an annual rate of interest at the greater of 15.00% or 7.50% plus the prime rate, payable monthly. The principal repayment period commences on July 1, 2025 and continues until the maturity date of December 21, 2026. The Company may prepay all outstanding amounts under this facility at anytime. Under the agreement, when amounts are prepaid or repaid in full at the Maturity Date, the Company may be obligated to pay additional fees which would allow for Structural Funds and Avenue to reach a Minimum Return, as defined by the agreement.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Structural Debt Facility is collateralized by the assets of the Company and includes financial covenants the Company must meet in order to avoid an Event of Default, as defined by the agreement. Such covenants include (i) maintaining a minimum of $57.0 million in unrestricted cash at all times and (ii) achieving certain revenue targets for the trailing four quarter period beginning with this fiscal quarter ended March 31, 2023. The Structural Debt Facility contains a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, Structural has been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that Structural Lenders would exercise the subjective acceleration clause is remote. As of March 31, 2023, the Company was in compliance with these debt covenants.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2022, in connection with the closing of the Structural Debt Facility, the Company issued to Structural Funds, including certain affiliates, and to Avenue a total of 4,950,000 shares of the Company’s Class A common stock (the “Structural Closing Shares”). The Company recorded a debt discount of $1.1 million related to the issuance of these shares, with a corresponding offset to the Company’s Class A common stock and additional paid-in capital. Further, if there are outstanding obligations relating to the Structural Debt Facility on July 21, 2025, representing the thirty-month anniversary of such closing, the Company agrees to issue to Structural Funds, including certain affiliates, and to Avenue, the aggregate number of shares of the Company’s Class A common stock equal to $9,900,000, divided by the lower of (i) $2.00 and (ii) the volume weighted average price of the Company’s Class A common stock for the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjY2Y2FmYTc4ZmYwNDRlMDRiODQxZjA4NDRjYjI3Yzg5L3NlYzo2NmNhZmE3OGZmMDQ0ZTA0Yjg0MWYwODQ0Y2IyN2M4OV80OS9mcmFnOjg1ODliYmY3ZTY4MTQ3Mzc4OTA5YTgwZjgxYzUyNDA1L3RleHRyZWdpb246ODU4OWJiZjdlNjgxNDczNzg5MDlhODBmODFjNTI0MDVfMzg0ODI5MDc0MjY2Mg_019e89f1-1b66-42ab-b8f4-20f4154117fd">sixty</span> trading days prior to such date, as further described in the related issuance agreements (the "Structural Subsequent Shares”).</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified several features within the Structural Debt Facility consisting of the contingent obligation to issue the Structural Subsequent Shares, mandatory and voluntary prepayment features and default interest rate (“Structural Derivative Liability”), which are required to be bifurcated and accounted for as a compound embedded derivative at fair value. Changes in fair value of the Structural Derivative Liability are recognized through the statements of operations and was $0.6 million for the three months ended March 31, 2023.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Closing costs consisted of $3.3 million in costs directly related to the issuance of the Structural Facility to third parties, issuance of certain Structural Closing Shares amounting to $1.1 million and incurrence of an additional Structural Derivative Liability amount of $7.1 million. At March 31, 2023, the Company had $72.0 million in principal outstanding under the Structural Debt Facility with an effective interest rate of 20.34%.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Siena Revolver</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company entered into a Loan and Security Agreement (the “Siena Revolver”) with Siena Lending Group, LLC (“Siena”) which permits the Company to receive funding through a revolving line of credit with an initial commitment of $35.0 million. The Company’s borrowing capacity under the Siena Revolver is subject to certain conditions, including the Company’s eligible inventory and accounts receivable balances among other limitations as specified in the agreement. In connection with this facility the Company incurred $1.0 million of debt issuance costs which have been included in other assets on the Company’s balance sheet and being amortized through the Revolver’s scheduled maturity date. Additional borrowing capacity from the Siena Revolver was $10.2 million as of March 31, 2023. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rates applicable to borrowings under the Siena Revolver are based on a fluctuating rate of interest measured by reference to either, at the Company’s option, (i) a Base Rate, plus an applicable margin, or (ii) the Term SOFR rate then in effect, plus 0.10% and an applicable margin. The Base Rate is defined as the greatest of: (1) Prime Rate as published in the Wall Street Journal, (2) Federal Funds Rate plus 0.5% and (3) 5.0% per annum. The applicable margin for Siena Revolver borrowings is based on the Company’s monthly average principal balance outstanding and ranges from 2.75% to 4.50% per annum in the case of Base Rate Borrowings and 3.75% to 5.50% per annum in the case of Term SOFR borrowings. The Siena Revolver also contains various financial covenants the Company must maintain to avoid an Event of Default, as defined by the agreement, including a subjective acceleration clause in the event that Siena determines that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the agreement, Siena has been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that Siena would exercise the subjective acceleration clause is remote. As of March 31, 2023, the Company was in compliance with these debt covenants.</span></div><div style="padding-left:18pt;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Siena Revolver matures at the earlier of March 10, 2026 or the maturity date of the Structural Debt Facility. As of March 31, 2023, the Company has an outstanding principal balance of $7.5 million under the Siena Revolver. The interest rate on the outstanding balance at March 31, 2023 is 8.52%.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atel Loan Facility</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had $0.3 million outstanding on its third draw and less than $0.1 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.</span> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:70.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Debt Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,620 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Siena Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,389 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, noncurrent</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,049 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,620 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 61549000 60620000 7500000 0 292000 480000 48000 95000 69389000 61195000 340000 575000 69049000 60620000 72000000 0.1500 0.0750 57000000 4950000 1100000 P30M 9900000 2.00 600000 3300000 1100000 7100000 72000000 0.2034 35000000 1000000 10200000 0.0010 0.005 0.050 0.0275 0.0450 0.0375 0.0550 7500000 0.0852 300000 100000 0.1923 0.1923 Commitments and Contingencies<div style="margin-top:6pt;padding-left:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merchandise Purchase Commitments</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023 and December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had obligations to purchase $15.3 million and $18.7 million, respectively, of merchandise. </span></div><div style="margin-top:12pt;padding-left:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had irrevocable standby letters of credit in the amount of $3.5 million and $3.1 million as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023 and December 31, 2022, respectively, primarily related to the Company’s operating leases. The letters of credit have expiration dates through January 2029.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.</span></div> 15300000 18700000 3500000 3100000 ContingenciesThe Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows Common Stock and Warrants<div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination. During the year ended December 31, 2022, the Company recorded $24.4 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated on a relative fair value basis between the issuance of equity and liability instruments. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct and incremental transaction costs allocated to equity-classified instruments were recorded within equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as an offset against proceeds upon accounting for the consummation of the Business Combination </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the condensed consolidated statements of operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As per the original agreement, the Company had $17.5 million of transaction costs accrued as of December 31, 2022. In March 2023, the Company entered into an amended agreement with a vendor to reduce this liability by $13.4 million. This reduction of costs was allocated between the liability and equity instruments with $3.8 million being recorded to other income, net on the Company’s statement of operations and $9.6 million recorded to additional paid-in capital, within equity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately 1.1760, each outstanding restricted </span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earn-Out</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of the Company’s Class B Common Stock (“Earn-Out Shares”). During the three months ended March 31, 2023, certain shareholders surrendered an aggregate 985,722 Earn-Out Shares which, per terms of the Merger Agreement, were cancelled by the Company and not reallocated among the remaining holders. The remaining 13,014,238 Earn-Out Shares will vest </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) with respect to 6,507,310 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,506,928 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Business Combination (the “Earn-Out Period”).</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of March 31, 2023, the Company did not meet any Earn-Out thresholds.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Class A Common Stock Warrants</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assume</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 6,700,000 P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rivate Placement Warrants for the Company’s Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 of the Company’s Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of the Company’s Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock, and therefore classified as liabilities on the condensed consolidated balance sheets. As of March 31, 2023, the following Warrants were outstanding:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.969%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Warrants</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants become exercisable into shares of the Company’s Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjY2Y2FmYTc4ZmYwNDRlMDRiODQxZjA4NDRjYjI3Yzg5L3NlYzo2NmNhZmE3OGZmMDQ0ZTA0Yjg0MWYwODQ0Y2IyN2M4OV81OC9mcmFnOmM1M2Q5YTBjZTMxYzQyNDg5MGQ3MDUyNTg1M2Q5ZmJjL3RleHRyZWdpb246YzUzZDlhMGNlMzFjNDI0ODkwZDcwNTI1ODUzZDlmYmNfNTA1NA_9997a556-6205-4efa-bd10-b12c27b302da">twenty</span> trading days within the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjY2Y2FmYTc4ZmYwNDRlMDRiODQxZjA4NDRjYjI3Yzg5L3NlYzo2NmNhZmE3OGZmMDQ0ZTA0Yjg0MWYwODQ0Y2IyN2M4OV81OC9mcmFnOmM1M2Q5YTBjZTMxYzQyNDg5MGQ3MDUyNTg1M2Q5ZmJjL3RleHRyZWdpb246YzUzZDlhMGNlMzFjNDI0ODkwZDcwNTI1ODUzZDlmYmNfNTA4MQ_a74d0612-cd1b-46cf-b141-266d8a7fdb65">thirty</span> trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Placement Warrants</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants were not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Closing, the Company assumed 6,700,000 Private Placement Warrants.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Backstop Warrants</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Business Combination, the Company issued to the Corvina Holdings limited 3,875,028 warrants to purchase the Company’s Class A common stock (each warrant exercisable to purchase one share of the Company’s Class A common stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. None of these warrants have been exercised as of March 31, 2023.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Equity Purchase Agreement</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 18, 2022, the Company entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, LTD (“Yorkville” or “SEPA Investor”), pursuant to which Yorkville has agreed to purchase up to $100 million of common stock from time to time over a period of 36 months, subject to certain conditions. The shares of the Company’s common stock that may be issued under the SEPA may be sold by us to Yorkville at our discretion from time to time and sales of the Company’s common stock under the SEPA will depend upon market conditions and other factors. Additionally, in no event may the Company sell more than 32,557,664 shares of common stock to Yorkville under the SEPA, which number of shares is equal to 19.99% of the shares of the Company's common stock outstanding immediately prior to the execution of the Equity Purchase Agreement (the “Exchange Cap”), unless stockholder approval is obtained to issue shares of common stock in excess of the Exchange Cap in accordance with applicable NYSE rules or comply with certain other requirements as described in the Equity Purchase Agreement. As a result, unless the Company’s stock price exceeds $3.07, the Company will be unable to sell the full $100.0 million commitment to Yorkville without seeking stockholder approval to issue additional shares in excess of the Exchange Cap. The purchase price per share for Class A common stock will be 97.55% of the Volume-Weighted Average Price (“VWAP”) of the Company’s Class A common stock over the Pricing Period, as defined by the agreement. The Company deferred $0.7 million of transaction costs related to the SEPA and will offset these costs against proceeds of any sales under the SEPA. As of March 31, 2023, the Company has sold 739,825 shares under the SEPA for total gross proceeds of $2.4 million. Issuance costs related to these shares are not material. As of March 31, 2023, there were 31,817,839 shares available to be sold to Yorkville under the Exchange Cap.</span></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HGI Subscription Agreement</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2022, the Company entered into a subscription agreement (the “HGI Subscription Agreement”) with HCI Grove LLC (“HGI”), pursuant to which, among other things, the Company issued to HGI 1,984,126 shares of the Company’s Class A common stock (“Subscribed Shares”) for aggregate proceeds of $2.5 million. Under the terms of the HGI Subscription Agreement, the Company is required to file a registration statement for the Subscribed Shares upon the Company becoming eligible to file a registration statement on Form S-3 and in any event prior to July 15, 2023 (the “Subscribed Shares Registration Statement”).</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HGI Subscription Agreement also provides that the Company will issue additional shares (the “HGI Additional Shares”) of the Company’s Class A common stock to HGI in the event that the volume weighted average price of the Company’s Class A common stock is less than $1.26 during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjY2Y2FmYTc4ZmYwNDRlMDRiODQxZjA4NDRjYjI3Yzg5L3NlYzo2NmNhZmE3OGZmMDQ0ZTA0Yjg0MWYwODQ0Y2IyN2M4OV81OC9mcmFnOmM1M2Q5YTBjZTMxYzQyNDg5MGQ3MDUyNTg1M2Q5ZmJjL3RleHRyZWdpb246YzUzZDlhMGNlMzFjNDI0ODkwZDcwNTI1ODUzZDlmYmNfMzg0ODI5MDc3MjUwMQ_e2be3688-a8b2-4808-9160-aa4476ab494e">three</span> trading days commencing on the first trading day after (i) the Company files the Subscribed Shares Registration Statement (the “Registration Date”), (ii) the three-month anniversary of the Registration Date, (iii) the six-month anniversary of the Registration Date, or (iv) the nine-month anniversary of the Registration Date (“Measurement Periods” and each “Measurement Period”) upon HGI’s election to receive such additional shares. HGI may use all or a portion of each Subscribed Share once to determine the amount of any issuance of Additional Shares in connection with the Measurement Periods such that HGI may utilize, for example, half of the Subscribed Shares to receive further Additional Shares, and leave the remaining half of the Subscribed Shares available to utilize in connection with the remaining Measurement Periods. HGI must elect to receive HGI Additional Shares for one Measurement Period, or the right lapses or is superseded by the next measurement period. There have been no shares have been issued related to the HGI Additional shares as of March 31, 2023.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrent with the HGI Subscription Agreement, the Company also entered into a consulting services agreement (the “Consulting Agreement”) with HCI Grove Management LLC (the “Consultant”). In consideration for the services under the Consulting Agreement, the Company (i) paid the Consultant an upfront fee of $150,000 and (ii) issued the Consultant 4,525,000 warrants (the “HGI Warrant Shares”) to purchase shares of the Company’s Class A common stock (the “HGI Warrants”), at an exercise price per share of $1.26 (the “Exercise Price”). On November 10, 2022, 40% of the HGI Warrant Shares vested and became issuable (the “Vested Warrants”), and the remaining HGI Warrant Shares (the “Unvested Warrants”) shall vest and become exercisable if, prior to December 31, 2024, the Company achieves at least $100.0 million in quarterly net revenue on a consolidated basis or if the Company consummates a Change of Control, as defined in HGI Warrants. If, as a result of the Change of Control, the Company’s equity holders own less than 25% of the equity securities of the surviving entity in such Change of Control, the Exercise Price shall be increased by 50%.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the Vested Warrants and Unvested Warrants qualify as stock based compensation to a nonemployee. The Company recorded $1.2 million in stock based compensation expense on the execution date of the HGI Subscription Agreement. The Company performs a probability reassessment related to the Unvested Warrants each reporting period and will recognize the cumulative catch-up adjustment based on the grant-date fair value when the vesting conditions are probable of being achieved. Any remaining expense will continue to ratably recognized until the date the revenue target is achieved, and the Unvested Warrants are fully vested.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Vested Warrants and Unvested Warrants granted to HGI was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"><tr><td style="width:1.0%"/><td style="width:83.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.26</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-4.5pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Reserved for Issuance</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis: </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.757%"><tr><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backstop Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,969,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202,678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,318,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Restricted Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,238,710 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,322,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining Shares available for issuance under 2022 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,338,297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,794,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for issuance under 2022 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,052,643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,749,491 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946,767 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,859,679 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,030,874 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1 97100000 24400000 17500000 -13400000 3800000 9600000 1.1760 0.0001 1.1760 1.1760 1.1760 1 13999960 985722 13014238 6507310 12.50 P20D P30D 6506928 15.00 P20D P30D P30D P10Y 6700000 11.50 8050000 11.50 As of March 31, 2023, the following Warrants were outstanding:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.969%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 8050000 11.50 6700000 11.50 8050000 1 11.50 P30D 0.01 18.00 11.50 P30D 6700000 3875028 1 0.01 0 100000000 P36M 32557664 0.1999 3.07 100000000 0.9755 700000 739825 2400000 31817839 1984126 2500000 1.26 P3M P6M P9M 0 150000 4525000 1.26 0.40 100000000 0.25 0.50 1200000 <div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Vested Warrants and Unvested Warrants granted to HGI was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"><tr><td style="width:1.0%"/><td style="width:83.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.26</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div> 1.26 1.26 P4Y6M P4Y6M 0.6250 0.6250 0.0400 0.0400 0 0 The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.757%"><tr><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backstop Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,969,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202,678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,318,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Restricted Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,238,710 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,322,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining Shares available for issuance under 2022 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,338,297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,794,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for issuance under 2022 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,052,643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,749,491 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946,767 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,859,679 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,030,874 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 6700000 0 6700000 0 8050000 0 8050000 0 3875028 0 3875028 0 4525000 568905 4525000 568905 5969813 4202678 6318978 4198917 29238710 175184 19322240 263052 9338297 0 20794363 0 5052643 0 3274070 0 72749491 4946767 72859679 5030874 Stock-Based Compensation<div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity under the Company’s incentive plan is as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:42.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,521,571 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,172,491 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable – March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,040,393 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No options were granted during three months ended March 31, 2023 and 2022. The total grant date fair value of options that vested during three months ended March 31, 2023 and 2022 was $0.1 million and $4.4 million, respectively. The aggregate intrinsic value of options exercised during the three months ended March 31, 2023 and 2022 was nominal and $0.4 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market-Based Stock Options</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of the stock options vest upon </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for service periods completed prior to the Business Combination. As of March 31, 2023, the market-based vesting criteria had not been met.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for all RSU’s under all of the Company’s equity incentive plans for the three months ended March 31, 2023:</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested – December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482,427 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,314,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,549,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,413,894 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company’s board of directors adopted the 2022 Employee Stock Purchase Plan (the “ESPP”), which was subsequently approved by the Company’s stockholders. The ESPP went into effect on November 16, 2022. Subject to certain limitations contained therein, the ESPP allows eligible employees to contribute, through payroll deductions, up to 20% of their eligible compensation to purchase the Company’s Class A common stock at a discounted price per share. As of March 31, 2023, no shares of Class A common stock had been purchased under the ESPP.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognized a total of $4.9 million and $4.5 million of stock-based compensation expense, respectively, related to stock options and RSUs granted to employees and non-employees. Stock-based compensation expense was predominately recorded in selling, general and administrative expenses in the statements of operations for each period presented. As of March 31, 2023, the total unrecognized compensation expense related to unvested options and RSUs was $28.6 million, which the Company expects to recognize over an estimated weighted average period of 2.3 years.</span></div> <div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity under the Company’s incentive plan is as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:42.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,521,571 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,172,491 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable – March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,040,393 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10521571 1.59 P4Y10M13D 61000 178564 0.38 170516 2.82 10172491 1.59 P4Y18D 98000 9040393 1.32 P3Y6M29D 98000 0 0 100000 4400000 0 400000 1017170 3.77 1 5500000 4600000 <div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for all RSU’s under all of the Company’s equity incentive plans for the three months ended March 31, 2023:</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested – December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482,427 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,314,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,549,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,413,894 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19482427 1.75 13314042 0.43 2549326 2.28 833249 2.69 29413894 1.08 0.20 0 4900000 4500000 28600000 P2Y3M18D Net loss Per Share Attributable to Common Stockholders<div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.424%"><tr><td style="width:1.0%"/><td style="width:61.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.103%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently redeemable convertible common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,172,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,691,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,413,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224,181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,763 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,093,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,362 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Private and Public Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,005,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,435,528 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,393,189 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):</span></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.424%"><tr><td style="width:1.0%"/><td style="width:61.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.103%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently redeemable convertible common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,172,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,691,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,413,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224,181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,763 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,093,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,362 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Private and Public Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,005,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,435,528 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,393,189 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0 115287015 0 2750000 10172491 25691329 29413894 3224181 0 735763 5093905 688362 14750000 0 13005238 0 0 16539 72435528 148393189 Subsequent EventsOn April 19, 2023, the Company entered into an amendment to the lease agreement for its warehousing facility located in St. Peters, Missouri to provide for, among other things, an extension of the lease term to September 2028. At the option of the Company, the lease may be extended an additional 5 years. The amendment requires the Company to make escalating undiscounted annual payments of up to $0.7 million, payable monthly. The Company is currently evaluating all the terms of this lease modification and its impact on the consolidated financial statements. P5Y 700000 (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 220 288 1 true 80 0 false 4 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.grove.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.grove.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets - Parenthetical Sheet http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets - Parenthetical Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Equity (Deficit) Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Equity (Deficit) Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Equity (Deficit) - Parenthetical Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Equity (Deficit) - Parenthetical Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Disclosure - Description of Business Sheet http://www.grove.com/role/DescriptionofBusiness Description of Business Notes 8 false false R9.htm 0000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.grove.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 0000010 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments Fair Value Measurements and Fair Value of Financial Instruments Notes 10 false false R11.htm 0000011 - Disclosure - Accrued Expenses Sheet http://www.grove.com/role/AccruedExpenses Accrued Expenses Notes 11 false false R12.htm 0000012 - Disclosure - Debt Sheet http://www.grove.com/role/Debt Debt Notes 12 false false R13.htm 0000013 - Disclosure - Commitments and Contingencies Sheet http://www.grove.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 13 false false R14.htm 0000014 - Disclosure - Common Stock and Warrants Sheet http://www.grove.com/role/CommonStockandWarrants Common Stock and Warrants Notes 14 false false R15.htm 0000015 - Disclosure - Stock-Based Compensation Sheet http://www.grove.com/role/StockBasedCompensation Stock-Based Compensation Notes 15 false false R16.htm 0000016 - Disclosure - Net loss Per Share Attributable to Common Stockholders Sheet http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholders Net loss Per Share Attributable to Common Stockholders Notes 16 false false R17.htm 0000017 - Disclosure - Subsequent Events Sheet http://www.grove.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 0000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.grove.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 0000019 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.grove.com/role/SummaryofSignificantAccountingPolicies 19 false false R20.htm 0000020 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables Fair Value Measurements and Fair Value of Financial Instruments (Tables) Tables http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments 20 false false R21.htm 0000021 - Disclosure - Accrued Expenses (Tables) Sheet http://www.grove.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.grove.com/role/AccruedExpenses 21 false false R22.htm 0000022 - Disclosure - Debt and Convertible Preferred Stock and Common Stock Warrants (Tables) Sheet http://www.grove.com/role/DebtandConvertiblePreferredStockandCommonStockWarrantsTables Debt and Convertible Preferred Stock and Common Stock Warrants (Tables) Tables 22 false false R23.htm 0000023 - Disclosure - Common Stock and Warrants (Tables) Sheet http://www.grove.com/role/CommonStockandWarrantsTables Common Stock and Warrants (Tables) Tables http://www.grove.com/role/CommonStockandWarrants 23 false false R24.htm 0000024 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.grove.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.grove.com/role/StockBasedCompensation 24 false false R25.htm 0000025 - Disclosure - Net loss Per Share Attributable to Common Stockholders (Tables) Sheet http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersTables Net loss Per Share Attributable to Common Stockholders (Tables) Tables http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholders 25 false false R26.htm 0000026 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 26 false false R27.htm 0000027 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Details 27 false false R28.htm 0000028 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 28 false false R29.htm 0000029 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) Details 29 false false R30.htm 0000030 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) Details 30 false false R31.htm 0000031 - Disclosure - Accrued Expenses (Details) Sheet http://www.grove.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://www.grove.com/role/AccruedExpensesTables 31 false false R32.htm 0000032 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.grove.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 32 false false R33.htm 0000033 - Disclosure - Debt - Narrative (Details) Sheet http://www.grove.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 33 false false R34.htm 0000034 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.grove.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.grove.com/role/CommitmentsandContingencies 34 false false R35.htm 0000035 - Disclosure - Common Stock and Warrants - Narrative (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails Common Stock and Warrants - Narrative (Details) Details 35 false false R36.htm 0000036 - Disclosure - Common Stock and Warrants - Schedule of Warrants Oustanding (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails Common Stock and Warrants - Schedule of Warrants Oustanding (Details) Details 36 false false R37.htm 0000037 - Disclosure - Common Stock and Warrants - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails Common Stock and Warrants - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) Details 37 false false R38.htm 0000038 - Disclosure - Common Stock and Warrants - Schedule of Reserved for Issuance (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails Common Stock and Warrants - Schedule of Reserved for Issuance (Details) Details 38 false false R39.htm 0000039 - Disclosure - Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) Sheet http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) Details 39 false false R40.htm 0000040 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.grove.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 40 false false R41.htm 0000041 - Disclosure - Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) Sheet http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) Details 41 false false R42.htm 0000042 - Disclosure - Net loss Per Share Attributable to Common Stockholders (Details) Sheet http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails Net loss Per Share Attributable to Common Stockholders (Details) Details http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersTables 42 false false R43.htm 0000043 - Disclosure - Subsequent Events (Details) Sheet http://www.grove.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.grove.com/role/SubsequentEvents 43 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: grov:ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays, grov:ContingentlyIssuableSharesCalculationDenominatorTradingDaysPriorToThirtyMonthAnniversaryOfClosingDate, grov:SaleOfStockCovenantVolumeWeightedAveragePriceThresholdTradingPeriod - grov-20230331.htm 4 grov-20230331.htm exhibit1032groveformofperf.htm exhibit1034structural-amen.htm exhibit311q12023.htm exhibit312q12023.htm exhibit321q12023.htm grov-20230331.xsd grov-20230331_cal.xml grov-20230331_def.xml grov-20230331_lab.xml grov-20230331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "grov-20230331.htm": { "axisCustom": 5, "axisStandard": 24, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 482, "http://xbrl.sec.gov/dei/2022": 34 }, "contextCount": 220, "dts": { "calculationLink": { "local": [ "grov-20230331_cal.xml" ] }, "definitionLink": { "local": [ "grov-20230331_def.xml" ] }, "inline": { "local": [ "grov-20230331.htm" ] }, "labelLink": { "local": [ "grov-20230331_lab.xml" ] }, "presentationLink": { "local": [ "grov-20230331_pre.xml" ] }, "schema": { "local": [ "grov-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 477, "entityCount": 1, "hidden": { "http://www.grove.com/20230331": 4, "http://xbrl.sec.gov/dei/2022": 5, "total": 9 }, "keyCustom": 82, "keyStandard": 206, "memberCustom": 43, "memberStandard": 28, "nsprefix": "grov", "nsuri": "http://www.grove.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.grove.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments", "menuCat": "Notes", "order": "10", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Accrued Expenses", "menuCat": "Notes", "order": "11", "role": "http://www.grove.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Debt", "menuCat": "Notes", "order": "12", "role": "http://www.grove.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "13", "role": "http://www.grove.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Common Stock and Warrants", "menuCat": "Notes", "order": "14", "role": "http://www.grove.com/role/CommonStockandWarrants", "shortName": "Common Stock and Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Stock-Based Compensation", "menuCat": "Notes", "order": "15", "role": "http://www.grove.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Net loss Per Share Attributable to Common Stockholders", "menuCat": "Notes", "order": "16", "role": "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholders", "shortName": "Net loss Per Share Attributable to Common Stockholders", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "17", "role": "http://www.grove.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "18", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Accrued Expenses (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.grove.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.grove.com/role/DebtandConvertiblePreferredStockandCommonStockWarrantsTables", "shortName": "Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Common Stock and Warrants (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.grove.com/role/CommonStockandWarrantsTables", "shortName": "Common Stock and Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Stock-Based Compensation (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.grove.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Net loss Per Share Attributable to Common Stockholders (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersTables", "shortName": "Net loss Per Share Attributable to Common Stockholders (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "menuCat": "Details", "order": "26", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "lang": "en-US", "name": "grov:RevenueFromContractWithCustomerComplementaryMembershipPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)", "menuCat": "Details", "order": "27", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails", "shortName": "Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i1e654fb89ca04d1a819b2042472b1812_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "ic42721e43d0348a7bc526804c8da5e75_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "menuCat": "Details", "order": "28", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "ic42721e43d0348a7bc526804c8da5e75_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i0cf216e6d6744f6498d8f1c0faa9d489_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)", "menuCat": "Details", "order": "29", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i0cf216e6d6744f6498d8f1c0faa9d489_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:TemporaryEquityParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets - Parenthetical", "menuCat": "Statements", "order": "3", "role": "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets - Parenthetical", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:TemporaryEquityParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "grov:FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "iec75da2413384318b8b4e1424a342ab5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details)", "menuCat": "Details", "order": "30", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "grov:FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "iec75da2413384318b8b4e1424a342ab5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:InventoryPurchasesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Accrued Expenses (Details)", "menuCat": "Details", "order": "31", "role": "http://www.grove.com/role/AccruedExpensesDetails", "shortName": "Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:InventoryPurchasesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Debt - Schedule of Debt (Details)", "menuCat": "Details", "order": "32", "role": "http://www.grove.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:FairValueAdjustmentOfDerivativeInstrument", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Debt - Narrative (Details)", "menuCat": "Details", "order": "33", "role": "http://www.grove.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i55916a5e1b7a48199965f226b027be72_D20230301-20230331", "decimals": "4", "lang": "en-US", "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Commitments and Contingencies (Details)", "menuCat": "Details", "order": "34", "role": "http://www.grove.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i3d496fdd6ed04b3788f0da45fa6b0d8e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i5ec429f4a76e488fb8e41d9b010393ab_I20220616", "decimals": "2", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Common Stock and Warrants - Narrative (Details)", "menuCat": "Details", "order": "35", "role": "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "shortName": "Common Stock and Warrants - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i5ec429f4a76e488fb8e41d9b010393ab_I20220616", "decimals": "2", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i516d181d57a143e389ee9e0509af2b37_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Common Stock and Warrants - Schedule of Warrants Oustanding (Details)", "menuCat": "Details", "order": "36", "role": "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails", "shortName": "Common Stock and Warrants - Schedule of Warrants Oustanding (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i1311b3a40e284d338a4321e731ead3fb_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Common Stock and Warrants - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details)", "menuCat": "Details", "order": "37", "role": "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "shortName": "Common Stock and Warrants - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i1311b3a40e284d338a4321e731ead3fb_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "iff01b58248b74d06a700c0f334bd6011_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "grov:PrivatePlacementWarrantSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Common Stock and Warrants - Schedule of Reserved for Issuance (Details)", "menuCat": "Details", "order": "38", "role": "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "shortName": "Common Stock and Warrants - Schedule of Reserved for Issuance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "iff01b58248b74d06a700c0f334bd6011_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "grov:PrivatePlacementWarrantSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "ibdd95e84e0534d3b9693b823d6f6cd8e_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details)", "menuCat": "Details", "order": "39", "role": "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails", "shortName": "Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "ibdd95e84e0534d3b9693b823d6f6cd8e_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Stock-Based Compensation - Narrative (Details)", "menuCat": "Details", "order": "40", "role": "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "shortName": "Stock-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i9344561784c84d5ea930c44e06b35376_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details)", "menuCat": "Details", "order": "41", "role": "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "shortName": "Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i9344561784c84d5ea930c44e06b35376_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Net loss Per Share Attributable to Common Stockholders (Details)", "menuCat": "Details", "order": "42", "role": "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails", "shortName": "Net loss Per Share Attributable to Common Stockholders (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i9182eee6cc8a4a9fb32187767c13b23e_I20230419", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "43", "role": "http://www.grove.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i9182eee6cc8a4a9fb32187767c13b23e_I20230419", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "iff323d4f303040cb8a7bb053979bd756_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Equity (Deficit)", "menuCat": "Statements", "order": "5", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "iff323d4f303040cb8a7bb053979bd756_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i2d98482315d94a01b63755c80a41d428_I20220616", "decimals": "4", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationExchangeRatio", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Equity (Deficit) - Parenthetical", "menuCat": "Statements", "order": "6", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical", "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Equity (Deficit) - Parenthetical", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Condensed Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "grov:AdjustmentOfConvertiblePreferredStockWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Description of Business", "menuCat": "Notes", "order": "8", "role": "http://www.grove.com/role/DescriptionofBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20230331.htm", "contextRef": "i507855afde2c4e6385b724482770e597_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 80, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "grov_AccruedFulfillmentCostsCurrent": { "auth_ref": [], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Fulfillment Costs, Current", "label": "Accrued Fulfillment Costs, Current", "terseLabel": "Fulfillment costs" } } }, "localname": "AccruedFulfillmentCostsCurrent", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "grov_AdditionalShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Share", "label": "Additional Share [Member]", "terseLabel": "Additional Share" } } }, "localname": "AdditionalShareMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_AdditionalSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Shares", "label": "Additional Shares [Member]", "terseLabel": "Additional Shares" } } }, "localname": "AdditionalSharesMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "grov_AdjustmentOfConvertiblePreferredStockWarrantLiability": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment of Convertible Preferred Stock Warrant Liability", "label": "Adjustment of Convertible Preferred Stock Warrant Liability", "terseLabel": "Remeasurement of convertible preferred stock warrant liability" } } }, "localname": "AdjustmentOfConvertiblePreferredStockWarrantLiability", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_AdjustmentsToAdditionalPaidInCapitalEarlyExerciseOfStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid-In-Capital, Early Exercise Of Stock Options", "label": "Adjustments To Additional Paid-In-Capital, Early Exercise Of Stock Options", "terseLabel": "Vesting of early exercise of options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEarlyExerciseOfStockOptions", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "grov_AdjustmentsToAdditionalPaidInCapitalReductionOfTransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital, Reduction Of Transaction Costs", "label": "Adjustments To Additional Paid In Capital, Reduction Of Transaction Costs", "netLabel": "Reduction in transaction costs allocated to equity instruments", "terseLabel": "Reduction in transaction costs", "verboseLabel": "Increase to additional paid in capital due to reduction of transaction costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalReductionOfTransactionCosts", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "grov_AdjustmentsToTransactionCostsDerivativeInstrumentReverseRecapitalization": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Transaction Costs, Derivative Instrument, Reverse Recapitalization", "label": "Adjustments To Transaction Costs, Derivative Instrument, Reverse Recapitalization", "terseLabel": "Reduction in transaction costs allocated to derivative liabilities upon Business Combination" } } }, "localname": "AdjustmentsToTransactionCostsDerivativeInstrumentReverseRecapitalization", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement", "label": "Agreement [Axis]", "terseLabel": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Domain]", "label": "Agreement [Domain]", "terseLabel": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_AtelLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel Loan Facility", "label": "Atel Loan Facility [Member]", "terseLabel": "Atel Loan Facility" } } }, "localname": "AtelLoanFacilityMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_AtelLoanFacilityTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel Loan Facility Tranche Four", "label": "Atel Loan Facility Tranche Four [Member]", "terseLabel": "Atel Loan Facility Draw 4" } } }, "localname": "AtelLoanFacilityTrancheFourMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_AtelLoanFacilityTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel Loan Facility Tranche Three", "label": "Atel Loan Facility Tranche Three [Member]", "terseLabel": "Atel Loan Facility Draw 3" } } }, "localname": "AtelLoanFacilityTrancheThreeMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_AtelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel", "label": "Atel [Member]", "terseLabel": "Atel" } } }, "localname": "AtelMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_BackstopWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 7.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Backstop Warrant, Shares Reserved for Future Issuance", "label": "Backstop Warrant, Shares Reserved for Future Issuance", "terseLabel": "Backstop warrant, shares reserved for future issuance (in shares)" } } }, "localname": "BackstopWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ClassOfWarrantOrRightCovenantQuarterlyNetRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Covenant, Quarterly Net Revenue", "label": "Class Of Warrant Or Right, Covenant, Quarterly Net Revenue", "terseLabel": "Warrants, covenant, quarterly net revenue" } } }, "localname": "ClassOfWarrantOrRightCovenantQuarterlyNetRevenue", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ClassOfWarrantOrRightEquityOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Equity Ownership Percentage", "label": "Class Of Warrant Or Right, Equity Ownership Percentage", "terseLabel": "Warrants, equity ownership percentage" } } }, "localname": "ClassOfWarrantOrRightEquityOwnershipPercentage", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_ClassOfWarrantOrRightExercisePriceIncreasePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Exercise Price, Increase, Percentage", "label": "Class Of Warrant Or Right, Exercise Price, Increase, Percentage", "terseLabel": "Warrant, exercise price, increase, percentage" } } }, "localname": "ClassOfWarrantOrRightExercisePriceIncreasePercentage", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_ClassOfWarrantOrRightIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Issued", "label": "Class Of Warrant Or Right, Issued", "terseLabel": "Warrants issued (in shares)" } } }, "localname": "ClassOfWarrantOrRightIssued", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ClassOfWarrantOrRightNumberOfSecuritiesExercisedByWarrantsOrRightsAtPeriodEnd": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Number Of Securities Exercised By Warrants Or Rights At Period End", "label": "Class Of Warrant Or Right, Number Of Securities Exercised By Warrants Or Rights At Period End", "terseLabel": "Number of shares exercised by warrants at period end" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesExercisedByWarrantsOrRightsAtPeriodEnd", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Redemption Threshold Consecutive Trading Days", "label": "Class of Warrant or Right Redemption Threshold Consecutive Trading Days", "terseLabel": "Class of warrant or right redemption threshold consecutive trading days" } } }, "localname": "ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ClassOfWarrantOrRightVestedPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Shares, Shares Vesting Rights, Percentage", "label": "Class Of Warrant Or Right, Vested Percent", "terseLabel": "Warrant shares, shares vesting rights, percentage" } } }, "localname": "ClassOfWarrantOrRightVestedPercent", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_ClassOfWarrantsOrRightsRedemptionPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrants or Rights Redemption Price Per Unit", "label": "Class of Warrants or Rights Redemption Price Per Unit", "terseLabel": "Class of warrants or rights redemption price per unit (in dollars per share)" } } }, "localname": "ClassOfWarrantsOrRightsRedemptionPricePerUnit", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_ClassOfWarrantsOrRightsWarrantsIssuedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrants or Rights Warrants Issued During Period", "label": "Class of Warrants or Rights Warrants Issued During Period", "terseLabel": "Class of warrants or rights warrants issued during period (in shares)" } } }, "localname": "ClassOfWarrantsOrRightsWarrantsIssuedDuringPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ClassOfWarrantsRedemptionNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrants Redemption Notice Period", "label": "Class of Warrants Redemption Notice Period", "terseLabel": "Class of warrants redemption notice period" } } }, "localname": "ClassOfWarrantsRedemptionNoticePeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_CommonStockWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 4.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Common Stock Warrant, Shares Reserved for Future Issuance", "label": "Common Stock Warrant, Shares Reserved for Future Issuance", "terseLabel": "Common stock warrant, shares reserved for future issuance (in shares)" } } }, "localname": "CommonStockWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ConsultingFeeExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting Fee Expense", "label": "Consulting Fee Expense", "terseLabel": "Consulting fee expense" } } }, "localname": "ConsultingFeeExpense", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ContingentlyIssuableSharesCalculationDenominatorTradingDaysPriorToThirtyMonthAnniversaryOfClosingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingently Issuable Shares, Calculation, Denominator, Trading Days Prior To Thirty-Month Anniversary Of Closing Date", "label": "Contingently Issuable Shares, Calculation, Denominator, Trading Days Prior To Thirty-Month Anniversary Of Closing Date", "terseLabel": "Trading days prior to such date" } } }, "localname": "ContingentlyIssuableSharesCalculationDenominatorTradingDaysPriorToThirtyMonthAnniversaryOfClosingDate", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ContingentlyIssuableSharesCalculationMaximumDenominator": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingently Issuable Shares, Calculation, Maximum Denominator", "label": "Contingently Issuable Shares, Calculation, Maximum Denominator", "terseLabel": "Contingently issuable shares, calculation, maximum denominator" } } }, "localname": "ContingentlyIssuableSharesCalculationMaximumDenominator", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ContingentlyIssuableSharesCalculationNumerator": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingently Issuable Shares, Calculation, Numerator", "label": "Contingently Issuable Shares, Calculation, Numerator", "terseLabel": "Contingently issuable shares, calculation, numerator" } } }, "localname": "ContingentlyIssuableSharesCalculationNumerator", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ContingentlyRedeemableConvertibleCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingently Redeemable Convertible Common Stock", "label": "Contingently Redeemable Convertible Common Stock [Member]", "terseLabel": "Contingently Redeemable Convertible Common Stock" } } }, "localname": "ContingentlyRedeemableConvertibleCommonStockMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "grov_ContingentlyRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingently Redeemable Convertible Preferred Stock", "label": "Contingently Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Contingently redeemable convertible common stock" } } }, "localname": "ContingentlyRedeemableConvertiblePreferredStockMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "grov_ConvertiblePreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Warrants", "label": "Convertible Preferred Stock Warrants [Member]", "terseLabel": "Convertible preferred stock warrants" } } }, "localname": "ConvertiblePreferredStockWarrantsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "grov_CorvinaHoldingsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corvina Holdings Limited", "label": "Corvina Holdings Limited [Member]", "terseLabel": "Corvina Holdings Limited" } } }, "localname": "CorvinaHoldingsLimitedMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_DebtInstrumentAnniversaryOfClosingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Anniversary Of Closing Date", "label": "Debt Instrument, Anniversary Of Closing Date", "terseLabel": "Debt instrument, anniversary of closing date" } } }, "localname": "DebtInstrumentAnniversaryOfClosingDate", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_DebtInstrumentCovenantMinimumUnrestrictedCashRequiredToMaintain": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Minimum Unrestricted Cash Required To Maintain", "label": "Debt Instrument, Covenant, Minimum Unrestricted Cash Required To Maintain", "terseLabel": "Debt instrument, covenant, minimum unrestricted cash required to maintain" } } }, "localname": "DebtInstrumentCovenantMinimumUnrestrictedCashRequiredToMaintain", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_DeferredRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Revenue", "label": "Deferred Revenue [Member]", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenueMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_EarnOutShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earn-Out Share", "label": "Earn-Out Share [Member]", "terseLabel": "Earn-Out Shares" } } }, "localname": "EarnOutShareMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "grov_FairValueAdjustmentOfDerivativeInstrument": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment Of Derivative Instrument", "label": "Fair Value Adjustment Of Derivative Instrument", "terseLabel": "Change in fair value of Structural Derivative liability", "verboseLabel": "Change in fair value of structural derivative liability" } } }, "localname": "FairValueAdjustmentOfDerivativeInstrument", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueAdjustmentOfEarnOutLiability": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment of Earn-Out Liability", "label": "Fair Value Adjustment of Earn-Out Liability", "terseLabel": "Change in fair value of Earn-Out liability" } } }, "localname": "FairValueAdjustmentOfEarnOutLiability", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "grov_FairValueAdjustmentOfWarrantsAdditionalSharesLiability": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment of Warrants, Additional Shares Liability", "label": "Fair Value Adjustment of Warrants, Additional Shares Liability", "terseLabel": "Change in fair value of Additional Shares liability" } } }, "localname": "FairValueAdjustmentOfWarrantsAdditionalSharesLiability", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "grov_FairValueAdjustmentOfWarrantsPublicAndPrivate": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment of Warrants, Public and Private", "label": "Fair Value Adjustment of Warrants, Public and Private", "terseLabel": "Change in fair value of Public and Private Placement Warrants liability" } } }, "localname": "FairValueAdjustmentOfWarrantsPublicAndPrivate", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "grov_FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation", "label": "Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "grov_FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "label": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedTerseLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value", "label": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance at March 31, 2023", "periodStartLabel": "Balance at December 31, 2022" } } }, "localname": "FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCancellations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Cancellations", "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Cancellations", "negatedTerseLabel": "Cancellation of Earn-Out Shares" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCancellations", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisObservableInputReconciliationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisObservableInputReconciliationRollForward", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "grov_FederalFundsRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Funds Rate", "label": "Federal Funds Rate [Member]", "terseLabel": "Federal Funds Rate" } } }, "localname": "FederalFundsRateMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_FiveSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Suppliers", "label": "Five Suppliers [Member]", "terseLabel": "Five Suppliers" } } }, "localname": "FiveSuppliersMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_FulfillmentCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fulfillment Costs", "label": "Fulfillment Costs", "terseLabel": "Fulfillment cost" } } }, "localname": "FulfillmentCosts", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_FulfillmentCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fulfillment Costs", "label": "Fulfillment Costs [Policy Text Block]", "terseLabel": "Fulfillment Costs" } } }, "localname": "FulfillmentCostsPolicyTextBlock", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grov_FulfillmentLaborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fulfillment Labor", "label": "Fulfillment Labor [Member]", "terseLabel": "Fulfillment Labor" } } }, "localname": "FulfillmentLaborMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_GroveBrandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grove Brands", "label": "Grove Brands [Member]", "terseLabel": "Grove Brands" } } }, "localname": "GroveBrandsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "grov_HGISubscriptionAgreementAdditionalSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HGI Subscription Agreement, Additional Shares", "label": "HGI Subscription Agreement, Additional Shares [Member]", "terseLabel": "HGI Subscription Agreement, Additional Shares" } } }, "localname": "HGISubscriptionAgreementAdditionalSharesMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_HGISubscriptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HGI Subscription Agreement", "label": "HGI Subscription Agreement [Member]", "terseLabel": "HGI Subscription Agreement" } } }, "localname": "HGISubscriptionAgreementMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_HGIWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HGI Warrants", "label": "HGI Warrants [Member]", "terseLabel": "HGI Warrants" } } }, "localname": "HGIWarrantsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_IncreaseDecreaseInAccruedTransactionCostsCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Accrued Transaction Costs, Current", "label": "Increase (Decrease) In Accrued Transaction Costs, Current", "negatedTerseLabel": "Decrease in accrued transaction costs" } } }, "localname": "IncreaseDecreaseInAccruedTransactionCostsCurrent", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_IncreaseDecreaseInOperatingRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Operating Right of Use Asset", "label": "Increase (Decrease) in Operating Right of Use Asset", "negatedTerseLabel": "Operating lease right-of-use assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingRightOfUseAsset", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_IncreaseDecreaseToOtherNonoperatingIncomeExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) To Other Nonoperating Income (Expense)", "label": "Increase (Decrease) To Other Nonoperating Income (Expense)", "terseLabel": "Increase to other income, net" } } }, "localname": "IncreaseDecreaseToOtherNonoperatingIncomeExpense", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_InventoryPurchasesCurrent": { "auth_ref": [], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory Purchases, Current", "label": "Inventory Purchases, Current", "terseLabel": "Inventory purchases" } } }, "localname": "InventoryPurchasesCurrent", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "grov_LenderAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lender", "label": "Lender [Axis]", "terseLabel": "Lender [Axis]" } } }, "localname": "LenderAxis", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "grov_LenderDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lender [Domain]", "label": "Lender [Domain]", "terseLabel": "Lender [Domain]" } } }, "localname": "LenderDomain", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_LesseeOperatingLeaseLiabilityUndiscountedAnnualAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, Undiscounted Annual Amount", "label": "Lessee, Operating Lease, Liability, Undiscounted Annual Amount", "terseLabel": "Operating lease, liability, undiscounted annual amount" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedAnnualAmount", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "grov_LineOfCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Additional Borrowing Capacity", "label": "Line Of Credit Facility, Additional Borrowing Capacity", "terseLabel": "Line of credit facility, additional borrowing capacity" } } }, "localname": "LineOfCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_LoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan And Security Agreement", "label": "Loan And Security Agreement [Member]", "terseLabel": "Loan And Security Agreement" } } }, "localname": "LoanAndSecurityAgreementMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_MarketBasedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market-based Stock Options", "label": "Market-based Stock Options [Member]", "terseLabel": "Market-based Stock Options" } } }, "localname": "MarketBasedStockOptionsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_NumberOfDaysAfterTheCompletionOfAnInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Days After the Completion of an Initial Business Combination", "label": "Number of Days After the Completion of an Initial Business Combination", "terseLabel": "Number of days after the completion of an initial business combination" } } }, "localname": "NumberOfDaysAfterTheCompletionOfAnInitialBusinessCombination", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_NumberOfWarrantOrRightEntitlesToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Warrant or Right, Entitles to Purchase", "label": "Number of Warrant or Right, Entitles to Purchase", "terseLabel": "Number of warrant or right, entitles to purchase (in shares)" } } }, "localname": "NumberOfWarrantOrRightEntitlesToPurchase", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_OutstandingRestrictedStockUnitSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 8.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance", "label": "Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance", "terseLabel": "Outstanding restricted stock unit, shares reserved for future issuance (in shares)" } } }, "localname": "OutstandingRestrictedStockUnitSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_OutstandingStockOptionSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 3.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Outstanding Stock Option, Shares Reserved for Future Issuance", "label": "Outstanding Stock Option, Shares Reserved for Future Issuance", "terseLabel": "Outstanding stock option, shares reserved for future issuance (in shares)" } } }, "localname": "OutstandingStockOptionSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_PaymentOfTransactionCostsReverseRecapitalization": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment Of Transaction Costs, Reverse Recapitalization", "label": "Payment Of Transaction Costs, Reverse Recapitalization", "negatedTerseLabel": "Payment of transaction costs related to the Business Combination" } } }, "localname": "PaymentOfTransactionCostsReverseRecapitalization", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_PrivateAndPublicPlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private and Public Placement Warrants", "label": "Private and Public Placement Warrants [Member]", "terseLabel": "Private and Public Placement Warrants" } } }, "localname": "PrivateAndPublicPlacementWarrantsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "grov_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant", "label": "Private Placement Warrant [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_PrivatePlacementWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 5.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant, Shares Reserved for Future Issuance", "label": "Private Placement Warrant, Shares Reserved for Future Issuance", "terseLabel": "Private placement warrant, shares reserved for future issuance (in shares)" } } }, "localname": "PrivatePlacementWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ProceedFromIssuanceOfCommonStockReverseRecapitalization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceed from Issuance of Common Stock, Reverse Recapitalization", "label": "Proceed from Issuance of Common Stock, Reverse Recapitalization", "terseLabel": "Proceeds from issuance of common stock, reverse recapitalization" } } }, "localname": "ProceedFromIssuanceOfCommonStockReverseRecapitalization", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ProceedsFromIssuanceOfRedeemableConvertibleCommonStock": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Issuance of Redeemable Convertible Common Stock", "label": "Proceeds from Issuance of Redeemable Convertible Common Stock", "terseLabel": "Proceeds from issuance of contingently redeemable convertible common stock" } } }, "localname": "ProceedsFromIssuanceOfRedeemableConvertibleCommonStock", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_ProceedsFromIssuanceOfSharesPaymentsOfTaxWithholdingShareBasedPaymentArrangement": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Issuance of Shares (Payments Of Tax Withholding) Share-Based Payment Arrangement", "label": "Proceeds From Issuance of Shares (Payments Of Tax Withholding) Share-Based Payment Arrangement", "terseLabel": "Proceeds from exercise of stock options and settlement of restricted stock units, net of withholding taxes paid related to common stock issued to employees" } } }, "localname": "ProceedsFromIssuanceOfSharesPaymentsOfTaxWithholdingShareBasedPaymentArrangement", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrant", "label": "Public Warrant [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_PublicWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 6.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Public Warrant, Shares Reserved for Future Issuance", "label": "Public Warrant, Shares Reserved for Future Issuance", "terseLabel": "Public warrant, shares reserved for future issuance (in shares)" } } }, "localname": "PublicWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_PurchaseAgreementDeferredTransactionCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase Agreement, Deferred Transaction Cost", "label": "Purchase Agreement, Deferred Transaction Cost", "terseLabel": "Purchase agreement, deferred transaction cost" } } }, "localname": "PurchaseAgreementDeferredTransactionCost", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_PurchaseAgreementEquityInterestsIssuableNotYetIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued", "label": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued", "terseLabel": "Purchase agreement, equity interests issuable, not yet issued" } } }, "localname": "PurchaseAgreementEquityInterestsIssuableNotYetIssued", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_PurchaseAgreementEquityInterestsIssuableNotYetIssuedTransactionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period", "label": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period", "terseLabel": "Purchase agreement, equity interests issuable, not yet issued, transaction period" } } }, "localname": "PurchaseAgreementEquityInterestsIssuableNotYetIssuedTransactionPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_PurchaseAgreementVolumeWeightedAveragePricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase Agreement, Volume Weighted Average Price, Percentage", "label": "Purchase Agreement, Volume Weighted Average Price, Percentage", "terseLabel": "Purchase agreement, volume weighted average price, percentage" } } }, "localname": "PurchaseAgreementVolumeWeightedAveragePricePercentage", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_RevenueFromContractWithCustomerComplementaryMembershipPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue From Contract With Customer, Complementary, Membership Period", "label": "Revenue From Contract With Customer, Complementary, Membership Period", "terseLabel": "Customer complementary membership period" } } }, "localname": "RevenueFromContractWithCustomerComplementaryMembershipPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Earnout Period", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period", "terseLabel": "Reverse recapitalization, contingent consideration, liability, earnout period" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriodStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger", "terseLabel": "Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share)" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriodStockPriceTrigger", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDayPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Liability, Earnout Period, Threshold Trading Day Period", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Day Period", "terseLabel": "Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDayPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days", "terseLabel": "Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDays", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Shares", "label": "Reverse Recapitalization, Contingent Consideration, Shares", "terseLabel": "Reverse recapitalization, contingent consideration, liability (in shares)" } } }, "localname": "ReverseRecapitalizationContingentConsiderationShares", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ReverseRecapitalizationExchangeRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Exchange Ratio", "label": "Reverse Recapitalization, Exchange Ratio", "terseLabel": "Recapitalization exchange ratio" } } }, "localname": "ReverseRecapitalizationExchangeRatio", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical" ], "xbrltype": "pureItemType" }, "grov_ReverseRecapitalizationPercentageOfVotingInterestsAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Percentage of Voting Interests Acquired", "label": "Reverse Recapitalization, Percentage of Voting Interests Acquired", "terseLabel": "Reverse recapitalization, percentage of voting interests acquired" } } }, "localname": "ReverseRecapitalizationPercentageOfVotingInterestsAcquired", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_ReverseRecapitalizationTrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche", "label": "Reverse Recapitalization Tranche [Axis]", "terseLabel": "Reverse Recapitalization Tranche [Axis]" } } }, "localname": "ReverseRecapitalizationTrancheAxis", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_ReverseRecapitalizationTrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche [Domain]", "label": "Reverse Recapitalization Tranche [Domain]", "terseLabel": "Reverse Recapitalization Tranche [Domain]" } } }, "localname": "ReverseRecapitalizationTrancheDomain", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche One", "label": "Reverse Recapitalization Tranche One [Member]", "terseLabel": "Reverse Recapitalization Tranche One" } } }, "localname": "ReverseRecapitalizationTrancheOneMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche Two", "label": "Reverse Recapitalization Tranche Two [Member]", "terseLabel": "Reverse Recapitalization Tranche Two" } } }, "localname": "ReverseRecapitalizationTrancheTwoMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Transaction Costs", "label": "Reverse Recapitalization, Transaction Costs", "terseLabel": "Reverse recapitalization, transaction costs" } } }, "localname": "ReverseRecapitalizationTransactionCosts", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_SaleOfStockAbilityToSellFullCommitmentSharePriceThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Ability To Sell Full Commitment, Share Price Threshold", "label": "Sale Of Stock, Ability To Sell Full Commitment, Share Price Threshold", "terseLabel": "Sale of stock, ability to sell full commitment, share price threshold (in dollars per share)" } } }, "localname": "SaleOfStockAbilityToSellFullCommitmentSharePriceThreshold", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_SaleOfStockCovenantVolumeWeightedAveragePriceThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Covenant, Volume Weighted Average Price Threshold", "label": "Sale Of Stock, Covenant, Volume Weighted Average Price Threshold", "terseLabel": "Sale of stock, covenant, volume weighted average price threshold (in dollars per share)" } } }, "localname": "SaleOfStockCovenantVolumeWeightedAveragePriceThreshold", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_SaleOfStockCovenantVolumeWeightedAveragePriceThresholdMeasurementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Measurement Period", "label": "Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Measurement Period", "terseLabel": "Sale of stock, covenant, volume weighted average price threshold, measurement period" } } }, "localname": "SaleOfStockCovenantVolumeWeightedAveragePriceThresholdMeasurementPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_SaleOfStockCovenantVolumeWeightedAveragePriceThresholdTradingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Trading Period", "label": "Sale Of Stock, Covenant, Volume Weighted Average Price Threshold, Trading Period", "terseLabel": "Sale of stock, covenant, volume weighted average price threshold, trading period" } } }, "localname": "SaleOfStockCovenantVolumeWeightedAveragePriceThresholdTradingPeriod", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_SaleOfStockExchangeCapMaximumNumberOfSharesAuthorizedToSell": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Exchange Cap, Maximum Number Of Shares Authorized To Sell", "label": "Sale Of Stock, Exchange Cap, Maximum Number Of Shares Authorized To Sell", "terseLabel": "Sale of stock, exchange cap, maximum number of shares authorized to sell (in shares)" } } }, "localname": "SaleOfStockExchangeCapMaximumNumberOfSharesAuthorizedToSell", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_SaleOfStockExchangeCapPercentageOfSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Exchange Cap, Percentage Of Shares Outstanding", "label": "Sale Of Stock, Exchange Cap, Percentage Of Shares Outstanding", "terseLabel": "Sale of stock, exchange cap, percentage of shares outstanding" } } }, "localname": "SaleOfStockExchangeCapPercentageOfSharesOutstanding", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_SaleOfStockMeasurementPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Measurement Period", "label": "Sale Of Stock, Measurement Period [Axis]", "terseLabel": "Sale Of Stock, Measurement Period [Axis]" } } }, "localname": "SaleOfStockMeasurementPeriodAxis", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_SaleOfStockMeasurementPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Measurement Period [Domain]", "label": "Sale Of Stock, Measurement Period [Domain]", "terseLabel": "Sale Of Stock, Measurement Period [Domain]" } } }, "localname": "SaleOfStockMeasurementPeriodDomain", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_SaleOfStockMeasurementPeriodOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Measurement Period One", "label": "Sale Of Stock, Measurement Period One [Member]", "terseLabel": "Sale Of Stock, Measurement Period One" } } }, "localname": "SaleOfStockMeasurementPeriodOneMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_SaleOfStockMeasurementPeriodThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Measurement Period Three", "label": "Sale Of Stock, Measurement Period Three [Member]", "terseLabel": "Sale Of Stock, Measurement Period Three" } } }, "localname": "SaleOfStockMeasurementPeriodThreeMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_SaleOfStockMeasurementPeriodTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Measurement Period Two", "label": "Sale Of Stock, Measurement Period Two [Member]", "terseLabel": "Sale Of Stock, Measurement Period Two" } } }, "localname": "SaleOfStockMeasurementPeriodTwoMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_SaleOfStockNumberOfSharesAvailableInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of Stock, Number of Shares Available In Transaction", "label": "Sale of Stock, Number of Shares Available In Transaction", "terseLabel": "Sale of stock, number of shares available in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesAvailableInTransaction", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ScheduleOfReservedForIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Reserved for Issuance", "label": "Schedule of Reserved for Issuance [Table Text Block]", "terseLabel": "Schedule of Reserved for Issuance" } } }, "localname": "ScheduleOfReservedForIssuanceTableTextBlock", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "grov_SecuredOvernightFinancingRateSOFRMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Overnight Financing Rate (SOFR)", "label": "Secured Overnight Financing Rate (SOFR) [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR)" } } }, "localname": "SecuredOvernightFinancingRateSOFRMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeContributionsPercentageOfEligibleCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Contributions, Percentage Of Eligible Compensation", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Contributions, Percentage Of Eligible Compensation", "terseLabel": "Share-based compensation arrangement by share-based payment award, maximum employee contributions, percentage of eligible compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeContributionsPercentageOfEligibleCompensation", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "pureItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, grant date, fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted-Average Remaining Contractual Life (years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "grov_ShareRedemptionTriggerPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Redemption Trigger Price", "label": "Share Redemption Trigger Price", "terseLabel": "Share redemption trigger price (in dollars per share)" } } }, "localname": "ShareRedemptionTriggerPrice", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_SharesAvailableForFutureIssuanceUnderEquityIncentivePlan": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 1.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Shares Available For Future Issuance Under Equity Incentive Plan", "label": "Shares Available For Future Issuance Under Equity Incentive Plan", "terseLabel": "Shares available for future issuance under equity incentive plan (in shares)" } } }, "localname": "SharesAvailableForFutureIssuanceUnderEquityIncentivePlan", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_SharesAvailableForIssuanceUnderESPPSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 2.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance", "label": "Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance", "terseLabel": "Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares)" } } }, "localname": "SharesAvailableForIssuanceUnderESPPSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_SharesIssuedSharesDerivativeInstrumentContingentConsiderationCanceled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Issued, Shares, Derivative Instrument, Contingent Consideration, Canceled", "label": "Shares Issued, Shares, Derivative Instrument, Contingent Consideration, Canceled", "negatedTerseLabel": "Cancellation of Earn-Out Shares (in shares)", "terseLabel": "Cancellation of earn-out shares (in shares)" } } }, "localname": "SharesIssuedSharesDerivativeInstrumentContingentConsiderationCanceled", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "grov_SharesSubjectToRepurchaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Subject to Repurchase", "label": "Shares Subject to Repurchase [Member]", "terseLabel": "Shares subject to repurchase" } } }, "localname": "SharesSubjectToRepurchaseMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "grov_SienaLendingGroupLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Siena Lending Group, LLC", "label": "Siena Lending Group, LLC [Member]", "terseLabel": "Siena Lending Group, LLC" } } }, "localname": "SienaLendingGroupLLCMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_SienaRevolverMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Siena Revolver", "label": "Siena Revolver [Member]", "terseLabel": "Siena Revolver" } } }, "localname": "SienaRevolverMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_StandbyEquityPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standby Equity Purchase Agreement", "label": "Standby Equity Purchase Agreement [Member]", "terseLabel": "Standby Equity Purchase Agreement" } } }, "localname": "StandbyEquityPurchaseAgreementMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_StructuralDebtFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structural Debt Facility", "label": "Structural Debt Facility [Member]", "terseLabel": "Structural Debt Facility" } } }, "localname": "StructuralDebtFacilityMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_StructuralDerivativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structural Derivative", "label": "Structural Derivative [Member]", "terseLabel": "Structural Derivative" } } }, "localname": "StructuralDerivativeMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_StructuralLendersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structural Lenders", "label": "Structural Lenders [Member]", "terseLabel": "Structural Lenders" } } }, "localname": "StructuralLendersMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_TemporaryEquityStockIssuedDuringPeriodSharesConvertibleCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock", "label": "Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock", "terseLabel": "Issuance of convertible common stock (in shares)" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConvertibleCommonStock", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "grov_TemporaryEquityStockIssuedDuringPeriodValueConvertibleCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock", "label": "Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock", "terseLabel": "Issuance of convertible common stock" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueConvertibleCommonStock", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "grov_ThirdPartyProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third-party Products", "label": "Third-party Products [Member]", "terseLabel": "Third-party products" } } }, "localname": "ThirdPartyProductsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche", "label": "Tranche [Axis]", "terseLabel": "Tranche [Axis]" } } }, "localname": "TrancheAxis", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_TrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche [Domain]", "label": "Tranche [Domain]", "terseLabel": "Tranche [Domain]" } } }, "localname": "TrancheDomain", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Four", "label": "Tranche Four [Member]", "terseLabel": "Tranche Four" } } }, "localname": "TrancheFourMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Three", "label": "Tranche Three [Member]", "terseLabel": "Tranche Three" } } }, "localname": "TrancheThreeMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TransactionCostsCurrent": { "auth_ref": [], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs, Current", "label": "Transaction Costs, Current", "terseLabel": "Transaction costs" } } }, "localname": "TransactionCostsCurrent", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails", "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_TransactionCostsIncurredButNotYetPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs Incurred but Not yet Paid", "label": "Transaction Costs Incurred but Not yet Paid", "terseLabel": "Transaction and contingently redeemable convertible common stock issuance costs in accounts payable and accrued liabilities" } } }, "localname": "TransactionCostsIncurredButNotYetPaid", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_TwoThousandAndTwentyTwoEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand and Twenty Two Equity Incentive Plan", "label": "Two Thousand and Twenty Two Equity Incentive Plan [Member]", "terseLabel": "2022 Equity Incentive Plan" } } }, "localname": "TwoThousandAndTwentyTwoEquityIncentivePlanMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical" ], "xbrltype": "domainItemType" }, "grov_UnvestedWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unvested Warrant", "label": "Unvested Warrant [Member]", "terseLabel": "Unvested Warrant" } } }, "localname": "UnvestedWarrantMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "grov_VestedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vested Warrants", "label": "Vested Warrants [Member]", "terseLabel": "Vested Warrants" } } }, "localname": "VestedWarrantsMember", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "grov_VestingOfEarlyExercisedStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Vesting of Early Exercised Stock Options", "label": "Vesting of Early Exercised Stock Options", "terseLabel": "Vesting of early exercised stock options" } } }, "localname": "VestingOfEarlyExercisedStockOptions", "nsuri": "http://www.grove.com/20230331", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r163", "r164", "r242", "r271", "r411", "r413" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r219", "r426", "r471", "r514" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r225", "r226", "r227", "r228", "r309", "r387", "r395", "r406", "r407", "r423", "r434", "r437", "r469", "r506", "r507", "r508", "r509", "r510", "r511" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r225", "r226", "r227", "r228", "r309", "r387", "r395", "r406", "r407", "r423", "r434", "r437", "r469", "r506", "r507", "r508", "r509", "r510", "r511" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r219", "r426", "r471", "r514" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r217", "r389", "r424", "r436", "r464", "r465", "r471", "r513" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r217", "r389", "r424", "r436", "r464", "r465", "r471", "r513" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r225", "r226", "r227", "r228", "r302", "r309", "r336", "r337", "r338", "r386", "r387", "r395", "r406", "r407", "r423", "r434", "r437", "r463", "r469", "r507", "r508", "r509", "r510", "r511" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r225", "r226", "r227", "r228", "r302", "r309", "r336", "r337", "r338", "r386", "r387", "r395", "r406", "r407", "r423", "r434", "r437", "r463", "r469", "r507", "r508", "r509", "r510", "r511" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r163", "r164", "r242", "r271", "r412", "r413" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r310", "r459" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r179", "r310", "r446", "r459" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r179", "r310", "r446", "r447", "r459" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r12", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedAdvertisingCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Advertising, Current", "terseLabel": "Advertising costs" } } }, "localname": "AccruedAdvertisingCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r7", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r342", "r343", "r344", "r456", "r457", "r458", "r501" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r88", "r89", "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r345" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r112", "r123", "r140", "r161", "r208", "r211", "r215", "r220", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r351", "r353", "r367", "r435", "r467", "r468", "r504" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r136", "r146", "r161", "r220", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r351", "r353", "r367", "r435", "r467", "r468", "r504" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r93", "r96" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Liquidity" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r43", "r44", "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchase of property and equipment in accounts payable and accrued liabilities" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r40", "r138", "r409" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents:" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r41", "r111" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r35", "r40", "r46" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r35", "r104" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental Disclosure of Non-Cash Investing and Financing Activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r142", "r143", "r144", "r161", "r182", "r183", "r185", "r187", "r194", "r195", "r220", "r230", "r232", "r233", "r234", "r237", "r238", "r269", "r270", "r273", "r277", "r284", "r367", "r408", "r445", "r453", "r460" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r75", "r80" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Class of warrant or right, number of securities called by each warrant or right (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of warrant or right, outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r75", "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]", "terseLabel": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofWarrantsOustandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r21", "r116", "r129" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r57", "r223", "r224", "r404", "r466" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r58", "r405" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Stock" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical", "http://www.grove.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r22" ], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "totalLabel": "Total shares of common stock reserved (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r456", "r457", "r501" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r67" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balances at ending of period (in shares)", "periodStartLabel": "Balances at beginning of period (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r6", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock - $0.0001 par value \u2013 600,000,000 Class A shares authorized at March\u00a031, 2023 and December\u00a031, 2022; 128,870,368 and 125,617,015 shares issued and outstanding at March\u00a031, 2023 and December\u00a031, 2022, respectively; 200,000,000 Class B shares authorized at March\u00a031, 2023 and December\u00a031, 2022; 49,874,913 and 52,240,311 shares issued and outstanding at March\u00a031, 2023 and December\u00a031, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r77", "r78", "r79", "r90" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r50", "r51", "r102", "r103", "r219", "r403" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r50", "r51", "r102", "r103", "r219", "r401", "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r50", "r51", "r102", "r103", "r219", "r403", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r121", "r199" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Risks" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r50", "r51", "r102", "r103", "r219" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r50", "r51", "r102", "r103", "r219", "r403" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r287", "r288", "r299" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Contractual liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contract with customer, liability, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r269", "r270", "r273" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]", "terseLabel": "Convertible Preferred Stock", "verboseLabel": "Convertible preferred stock" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r27", "r389" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r61", "r159", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r255", "r262", "r263", "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r1", "r2", "r3", "r113", "r114", "r122", "r165", "r239", "r240", "r241", "r242", "r243", "r245", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r376", "r418", "r419", "r420", "r421", "r422", "r454" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r3", "r114", "r122", "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "terseLabel": "Long-term debt, gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r106", "r109", "r239", "r376", "r419", "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r19", "r106", "r268", "r376" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt instrument, interest rate, effective percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r20", "r165", "r239", "r240", "r241", "r242", "r243", "r245", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r376", "r418", "r419", "r420", "r421", "r422", "r454" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r20", "r68", "r71", "r72", "r73", "r105", "r106", "r109", "r120", "r165", "r239", "r240", "r241", "r242", "r243", "r245", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r376", "r418", "r419", "r420", "r421", "r422", "r454" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r105", "r106", "r107", "r108", "r109", "r470" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "terseLabel": "Debt instrument, unamortized discount (premium), net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs, gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r38", "r206" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r94", "r95", "r97", "r98", "r413" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r147" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r298", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r154", "r171", "r172", "r173", "r174", "r175", "r180", "r182", "r185", "r186", "r187", "r191", "r357", "r358", "r390", "r393", "r415" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r154", "r171", "r172", "r173", "r174", "r175", "r182", "r185", "r186", "r187", "r191", "r357", "r358", "r390", "r393", "r415" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share attributable to common stockholders, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r188", "r189", "r190", "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net loss Per Share Attributable to Common Stockholders" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholders" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "verboseLabel": "Common stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r67", "r134", "r150", "r151", "r152", "r166", "r167", "r168", "r170", "r176", "r178", "r193", "r221", "r286", "r342", "r343", "r344", "r347", "r348", "r356", "r368", "r369", "r370", "r371", "r372", "r373", "r379", "r396", "r397", "r398" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r38", "r62" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Changes in fair value of derivative liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r359", "r360", "r365" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r253", "r303", "r304", "r305", "r306", "r307", "r308", "r360", "r383", "r384", "r385", "r419", "r420", "r431", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r359", "r360", "r361", "r362", "r366" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements and Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r253", "r303", "r308", "r360", "r383", "r431", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r253", "r303", "r308", "r360", "r384", "r419", "r420", "r431", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r253", "r303", "r304", "r305", "r306", "r307", "r308", "r360", "r385", "r419", "r420", "r431", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r99", "r101" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedTerseLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "terseLabel": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r99" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance at March 31, 2023", "periodStartLabel": "Balance at December 31, 2022" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r253", "r303", "r304", "r305", "r306", "r307", "r308", "r383", "r384", "r385", "r419", "r420", "r431", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r364", "r366" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Financial Liabilities:" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r26", "r161", "r208", "r210", "r214", "r216", "r220", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r367", "r417", "r467" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r24", "r110", "r117", "r131", "r208", "r210", "r214", "r216", "r391", "r417" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r162", "r177", "r178", "r207", "r346", "r349", "r350", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r37" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r37" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r388", "r451" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r37" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r37" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r37" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Prepaids and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r107", "r119", "r153", "r205", "r375" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r155", "r157", "r158" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r145", "r410", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r222" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory reserve" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Operating lease, renewal term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r161", "r220", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r352", "r353", "r354", "r367", "r416", "r467", "r504", "r505" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r11", "r115", "r127", "r435", "r455", "r462", "r502" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r18", "r137", "r161", "r220", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r352", "r353", "r354", "r367", "r435", "r467", "r504", "r505" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r3", "r114", "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r14" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r3", "r114", "r124", "r252", "r267", "r419", "r420" ], "calculation": { "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.grove.com/role/DebtScheduleofDebtDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "negatedTerseLabel": "Debt, current", "terseLabel": "Debt, current" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r141" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Debt, noncurrent" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.", "label": "Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate", "terseLabel": "Long-term debt, percentage bearing variable interest, percentage rate" } } }, "localname": "LongTermDebtPercentageBearingVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Long-Term Purchase Commitment [Line Items]", "terseLabel": "Long-Term Purchase Commitment [Line Items]" } } }, "localname": "LongTermPurchaseCommitmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.", "label": "Long-Term Purchase Commitment [Table]", "terseLabel": "Long-Term Purchase Commitment [Table]" } } }, "localname": "LongTermPurchaseCommitmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r20", "r60" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-Term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r196", "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r156" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r156" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r35", "r36", "r39" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r25", "r39", "r118", "r130", "r135", "r148", "r149", "r152", "r161", "r169", "r171", "r172", "r173", "r174", "r177", "r178", "r184", "r208", "r210", "r214", "r216", "r220", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r358", "r367", "r417", "r467" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Interest and other expense (income), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses [Abstract]" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r208", "r210", "r214", "r216", "r417" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r378" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r378" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, noncurrent" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r377" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r139" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r17", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r3", "r114", "r124" ], "calculation": { "http://www.grove.com/role/DebtScheduleofDebtDetails_1": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-Term Debt", "terseLabel": "Other long-term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Other Noncash Expense", "terseLabel": "Other non-cash expenses" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r30" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedTerseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaidInKindInterest": { "auth_ref": [ "r38" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Paid-in-Kind Interest", "terseLabel": "Non-cash interest expense" } } }, "localname": "PaidInKindInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r34" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance costs", "terseLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r31" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r450" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r32" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r56", "r128", "r392", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r33" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedTerseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r91", "r133", "r512" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Product development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r40", "r46", "r111", "r125", "r138" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r448", "r452" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r402", "r449", "r452" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings", "terseLabel": "Issuance of common stock upon settlement of restricted stock units, net of tax withholdings" } } }, "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r8", "r74", "r126", "r399", "r400", "r435" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Accumulated deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r134", "r166", "r167", "r168", "r170", "r176", "r178", "r221", "r342", "r343", "r344", "r347", "r348", "r356", "r396", "r398" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r203", "r204", "r209", "r212", "r213", "r217", "r218", "r219", "r297", "r298", "r389" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue, net", "verboseLabel": "Total revenue, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r301", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Sale of stock, consideration received on transaction" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://www.grove.com/role/AccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales taxes" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r219", "r461" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtandConvertiblePreferredStockandCommonStockWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r359", "r360" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]", "terseLabel": "Schedule of Performance-based Restricted Stock Units Activity" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r311", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r81", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Share-Based Payment Arrangement, Option, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r63", "r65", "r66", "r68", "r69", "r70", "r71", "r72", "r73", "r74", "r142", "r143", "r144", "r194", "r269", "r270", "r271", "r273", "r277", "r282", "r284", "r423", "r445", "r453" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r75", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of Warrants Outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r28" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r37" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Cancelled/forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Cancelled/forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding and unvested, ending of period (in shares)", "periodStartLabel": "Outstanding and unvested, beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding and unvested, ending of period (in dollars per share)", "periodStartLabel": "Outstanding and unvested, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedTerseLabel": "Cancelled/forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Cancelled/forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, grants in period, gross" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Fair value of common stock (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r87" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Options, outstanding, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding, ending of period (in shares)", "periodStartLabel": "Options outstanding, beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options outstanding, ending of period (in dollars per share)", "periodStartLabel": "Options outstanding, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted\u2013Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Options, vested and exercisable, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Options vested and exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options vested and exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award", "terseLabel": "Number of shares purchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting rights, percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options, outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Options vested and exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, vested in period, fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r59", "r92", "r132", "r229" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby Letters of Credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r142", "r143", "r144", "r161", "r182", "r183", "r185", "r187", "r194", "r195", "r220", "r230", "r232", "r233", "r234", "r237", "r238", "r269", "r270", "r273", "r277", "r284", "r367", "r408", "r445", "r453", "r460" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r67", "r134", "r150", "r151", "r152", "r166", "r167", "r168", "r170", "r176", "r178", "r193", "r221", "r286", "r342", "r343", "r344", "r347", "r348", "r356", "r368", "r369", "r370", "r371", "r372", "r373", "r379", "r396", "r397", "r398" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r166", "r167", "r168", "r193", "r389" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficitParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r5", "r6", "r67", "r74" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r5", "r6", "r67", "r74", "r322" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Issuance of common stock upon exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r23", "r67", "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r6", "r9", "r10", "r55", "r435", "r455", "r462", "r502" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balances at ending of period", "periodStartLabel": "Balances at beginning of period", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r76", "r160", "r270", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r283", "r286", "r355" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Common Stock and Warrants" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r374", "r381" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r374", "r381" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r374", "r381" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r374", "r381" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r380", "r382" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Disclosure" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentration Risk" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r230", "r232", "r233", "r234", "r237", "r238" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Temporary equity, balances at ending of period", "periodStartLabel": "Temporary equity, balances at beginning of period", "terseLabel": "Preferred stock, $0.0001 par value - 100,000,000 shares authorized at March 31, 2023 and December 31, 2022; no shares outstanding at March 31, 2023 and December 31, 2022" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r0", "r64" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity, par value (in dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Temporary equity, shares authorized (in shares)" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity, shares issued (in shares)" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Temporary equity, balances at ending of period (in shares)", "periodStartLabel": "Temporary equity, balances at beginning of period (in shares)", "terseLabel": "Temporary equity, shares outstanding (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r52", "r53", "r54", "r197", "r198", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Common stock warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/NetlossPerShareAttributabletoCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r181", "r187" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r180", "r187" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r438": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r439": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r441": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r442": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r443": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r444": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 63 0001841761-23-000047-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001841761-23-000047-xbrl.zip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end